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ABSTRACT
Members of the genus Vibrio are Gram-negative, halophilic bacteria that inhabit warm
coastal and estuarine waters worldwide. Among pathogenic vibrios, Vibrio parahaemolyticus is
the leading cause of seafood-related illnesses and Vibrio vulnificus causes the highest number of
seafood-related deaths in the United States. Moreover, according to the U.S. Centers for Disease
Control and Prevention, the incidence of infections of the two vibrios due to the consumption of
oysters has shown a sustained increase since 2001, indicating further measures are needed to
prevent human Vibrio illness.
In this dissertation research, a total of 622 Vibrio isolates, consisting of 252 V.
parahaemolyticus and 370 V. vulnificus, were recovered from 82 Louisiana Gulf and retail raw
oysters between 2005 and 2006. A selected subset of the isolates (168 V. parahaemolyticus and
151 V. vulnificus) was determined for antimicrobial susceptibility profiles. In addition, V.
vulnificus isolates (n = 349) were characterized by the presence/absence of a viuB-associated
fragment and genotypes of three biomarkers: the virulence-correlated gene (vcg), 16S rRNA, and
the capsular polysaccharide operon (CPS). Then multiplex PCR assays using three biomarkers:
vcg, 16S rRNA and CPS, as well as species-specific vvhA were developed to simultaneously
detect and characterize V. vulnificus. Finally, loop-mediated isothermal amplification (LAMP)
assays were developed and evaluated to detect total or virulent-type V. vulnificus in raw oysters.
Compared to PCR, LAMP assay developed were highly specific, sensitive and quantitative.
The dissertation research provided comprehensive information on the genotypes,
population dynamics, and antimicrobial resistance profiles of the two important vibrios. The
rapid, specific, sensitive, and cost-effective molecular detection assays developed provided
invaluable tools for the regulatory agencies and seafood industry to facilitate better control of
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Vibrio in seafood, therefore reducing the incidence of foodborne illnesses and deaths resulted
from the consumption of raw oysters.
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CHAPTER 1: INTRODUCTION

1

Members of the genus Vibrio are Gram-negative, halophilic, and curved-rod shape
bacteria that inhabit warm coastal and estuarine waters worldwide, which are especially
abundant in the gut of filter-feeding shellfish such as oysters, clams, and mussels. Among
pathogenic vibrios, Vibrio parahaemolyticus causes the most seafood-associated bacterial
gastroenteritis in the United States and Asian countries, while Vibrio vulnificus is responsible for
more than 95% of seafood-related deaths in the U.S. Therefore, multi-faceted strategies are
needed to reduce the number of human infections caused by the two important vibrios.
In this dissertation research, detection methods, genotypes, and antimicrobial
susceptibility profiles of these two vibrios were investigated. Firstly, we isolated V.
parahaemolyticus and V. vulnificus from Louisiana Gulf and retail oysters between 2005 and
2006. Secondly, we characterized their antimicrobial susceptibility profiles and genotypic
patterns. Finally, we developed sensitive and specific molecular detection assays for the
detection and quantification of total and pathogenic V. vulnificus, in order to facilitate the
regulatory agencies and the seafood industry to better control the potential Vibrio risks in raw
oyster and reduce the incidence of oyster-related foodborne illnesses and deaths.
This dissertation is organized as following:
Chapter 1-Introduction.
Chapter 2-Literature review on general information of V. parahaemolyticus and V.
vulnificus, antimicrobial resistance profiles, and molecular detection.
Chapter 3-Prevalence and antimicrobial susceptibilities of V. parahaemolyticus and V.
vulnificus isolates from Louisiana Gulf and retail raw oysters from 2005 to 2006.
Chapter 4-Genotypic characterization of V. vulnificus isolates from Louisiana Gulf and
retail raw oysters. Part I shows the genotypic characterization of V. vulnificus from Louisiana
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oyster isolates, focusing on the differentiation of clinical-type from environmental-type strains.
Part II describes a multiplex PCR assay for the simultaneous detection and characterization of V.
vulnificus strains.
Chapter 5-Development of loop-mediated isothermal amplification (LAMP) assays to
detect total and virulent-type V. vulnificus strains. The LAMP assays developed include one
conventional LAMP for total V. vulnificus, a real-time LAMP on two real-time platforms for the
quantification of total V. vunificus, and a real-time LAMP for the detection and quantification of
virulent-type V. vulnificus strains in raw oysters.
Chapter 6-Conclusions.
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CHAPTER 2: LITERATURE REVIEW

4

Epidemiology
Human infections with Vibrio occur all over the world (Bauer et al., 2006; Dalsgaard et
al., 1996; Hoi et al., 1998; Wong et al., 1999). In the United States, it is estimated that Vibrio
cause 8,000 cases, 200 hospitalizations, and 50 deaths each year (Mead et al., 1999a). According
to the Centers for Disease Control and Prevention (CDC)’s report, Vibrio infections due to the
consumption of raw or undercooked oysters have shown an increase since year 2001, indicating
the need to control human Vibrio infections (Figure 2-1) (Centers for Disease Control and
Prevention, 2010). Among pathogenic vibrios, V. parahaemolyticus causes the highest number
of seafood-associated bacterial gastroenteritis in the United States and Asian countries (Mead et
al., 1999b) while V. vulnificus is responsible for more than 95% of seafood-related deaths in the
U.S. (Oliver, 2006).

Figure 2 - 1 Relative rates of laboratory-confirmed infections with Campylobacter, STEC
O157, Listeria, Salmonella, and Vibrio compared with 1996--1998 rates, by year --- Foodborne
Diseases Active Surveillance Network (FoodNet), United States, 1996—2009 (Centers for
Disease Control and Prevention, 2010)
Initiated by CDC, U.S. Food and Drug Administration (FDA), and the Gulf Coast states
(Alabama, Florida, Louisiana, Mississippi, and Texas) in 1988, the Cholera and Other Vibrio
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Illness Surveillance System (COVIS) has been collecting the information on Vibrio human
infections in order to obtain reliable information on illnesses associated with Vibrio species.
Figure 2-2 list the infection caused by V. parahaemolyticus and V. vulnificus reported to COVIS
from 1997 to 2007.

Figure 2 - 2 Vibrio parahaemolyticus and Vibrio vulnificus cases (excluding toxigenic Vibrio
cholerae) reported to COVIS, 1997-2007
In 2007, a total of 549 Vibrio cases (excluding toxigenic Vibrio cholerae) were reported
to COVIS, with 39% of patients hospitalized and 7% dies (Cholera and Other Vibrio Illness
Surveillance, 2009). Among all of these cases, V. parahaemolyticus was the most frequently
reported Vibrio species, isolated from 42% (232 of 549) of the patients; while V. vulnificus was
isolated from 17% (95 of 549) of the patients, with a 36% mortality rate. Most V.
parahaemolyticus and V. vulnificus infections had a clear seasonal peak during summer, with
most cases (70%) occurring during May to September, and the greatest frequency happening
during August (Figure 2-3).
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Figure 2 - 3 Numbers of cases of Vibrio illnesses (excluding toxigenic V. cholerae), by month of
illness onset or specimen isolation, 2007 (N = 549) (Cholera and Other Vibrio Illness
Surveillance, 2009)
Louisiana, as one of the five Gulf Coast states, reported a total of 1,007 Vibrio infections
to the Infectious Disease Epidemiology Department of the Louisiana Office of Public Health
between 1980 and 2005, with 249 (25%) V. parahaemolyticus and 257 (25%) V. vulnificus cases
(Thomas et al., 2007). The fatality rate for V. parahaemolyticus and V. vulnificus was 6% and
31%, respectively.
Given the number of illnesses and deaths caused by these two vibrios, research is needed
to provide data and strategies to better control the potential Vibrio risks in seafood, particularly
oysters.
Microbiology
V. parahaemolyticus and V. vulnificus are Gram-negative, motile bacteria that inhabit
warm coastal and estuarine waters worldwide, especially in the gut of filter-feeding shellfish
such as oysters, clams and mussels (Barbieri et al., 1999; Hervio-Heath et al., 2002; Hoi et al.,
1998). Both V. parahaemolyticus and V. vulnificus are halophilic, requiring a minimum of 0.5%
NaCl for growth (Kaysner & DePaola, 2001). They are mesophilic and proliferate in warm water
7

(Cook et al., 2002b). A seasonal preference has been demonstrated on all coasts in the U.S., with
the most abundant presence during warm weather (> 20oC) and moderate salinity (5 to 25 ppt)
(Bryan et al., 1999; DePaola et al., 2003a; Kaspar & Tamplin, 1993). In winter when the
temperature is below 10oC, they would enter a status termed viable but nonculturable (VBNC),
during which they will lose the ability to be cultured on routine media but retain their viability
(Bates & Oliver, 2004; Oliver et al., 1995)
Both of these two vibrios are sucrose-negative, thus forming green colonies on thiosulfate
citrate bile salts sucrose agar (TCBS) (Kobayashi et al., 1963). However, V. vulnificus is
cellobiose positive while most other vibrios including V. parahaemolyticus are cellobiose
negative. Therefore, modified cellobiose polymyxin B colistin (mCPC) agar, which takes
advantage of the resistance of V. vulnificus to colistin and polymyxin B and the fermentation of
cellobiose, has been reported to be effective for the isolation of V. vulnificus from environmental
sources (Massad & Oliver, 1987; Tamplin et al., 1991).
Clinical Symptoms
The clinical symptoms of V. parahaemolyticus infection include watery diarrhea,
abdominal cramps, nausea, vomiting, headache, fever, and chills, which may last for 2 to 10 days
and are normally self-limiting (Iida et al., 2006).
V. vulnificus, on the other hand, causes gastroenteritis, wound infections, and primary
septicemia. Gastroenteritis is the mildest human syndrome among the three, usually occurring
within 16 hours of ingesting the organism and mostly needing no hospitalization. In contrast,
primary septicemia, the most significant form of V. vulnificus infection, had > 50% motility rate,
especially for at-risk groups, which include people with immunocompromising conditions,
diabetes, and elevated serum iron concentrations due to chronic liver disease or alcohol abuse
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(Wright et al., 1981). Furthermore, most cases (> 88.5% of the U.S. cases between 2000 and
2003) of septicemia related to V. vulnificus infection are males over the age of 50, suggesting the
protective effect of women’s estrogen (Oliver, 2006). Symptoms of wound infection are pain,
erythema, and edema, with 20% to 25% fatality rate.
Prevalence in Seafood
The prevalence of V. parahaemolyticus and V. vulnificus in seafood varies greatly
depending on the variety of seafood, geographic area and temperature. It has been reported that
V. vulnificus abundance was 32-2,511 cells/ml in Mobile Bay, Alabama (DePaola et al., 1994),
0-200 cells/ml in Chesapeake Bay, Delaware (Wright et al., 1996), and 0-7,000 cells/ml in
Apalachicola Bay, Florida (Tamplin et al., 1982). In oyster sample, it was reported that 0-12,000
colony forming units per gram (CFU/g) of V. parahaemolyticus was found in Alabama oysters
from March 1999 to September 2000 (DePaola et al., 2003a). A national survey from June 1998
to July 1999 on V. parahaemolyticus and V. vulnificus in 370 oysters was conducted in coastal
and markets throughout the U.S. and the highest densities of both organisms were found in
oysters harvested from the Gulf Coast, which normally exceeded 10,000 MPN/g (Cook et al.,
2002b). One following study carried from 1999 to 2000 in Atlantic and Gulf Coast molluscan
shellfish found 5% of the samples contained more than 1,000 CFU/g V. parahaemolyticus, also
Gulf Coast had higher densities of V. parahaemolyticus in shellfish than that from the Atlantic
(Cook et al., 2002a). A recent study by FDA showed approximately 44% and 38% of samples
harvested from Louisiana in 2007 sampled from different lots exceeded 10,000 MPN/g for V.
vulnificus and V. parahaemolyticus, respectively, and Gulf oysters had significantly higher V.
vulnificus levels than either the North Atlantic and Pacific regions during each season (DePaola
et al., 2010).
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The occurrence of V. parahaemolyticus and V. vulnificus in Norwegian blue mussels was
10.3% and 0.1%, respectively after examining 885 blue mussel samples (Bauer et al., 2006). In
Japan, 2-13% V. parahaemolyticus and 1-4% V. vulnificus was dominant in shrimp samples from
multiple shrimp farm environment (Gopal et al., 2005). In China, a study showed 73.3% (165 of
225) of seafood samples were positive for V. parahaemolyticus, with a range of 0-719 CFU/g
(Luan et al., 2008).
Since multiple studies have showed Gulf Coast oysters normal contained significantly
high level of V. parahaemolyticus and V. vulnificus, and most current studies sampled oysters
from Coast regions, lacking the information from restaurant site, it is important to monitor both
of the two species from oysters sampled in Gulf Coast and retail sites. However, the last
comprehensive study could only trace to FDA’s studies in 2000s, so the prevalence of V.
parahaemolyticus and V. vulnificus in Gulf Coast oysters need to be studied to provide more
information for the risk assessment of the two species.
Antimicrobial Susceptibility Profiles
Since the introduction of penicillin in the 1920s, hundreds of antimicrobial agents have
been discovered, synthesized, and applied for either clinical use or food animals for therapy,
prophylaxis, and growth promotion (Aarestrup & Wegener, 1999). However, as a result, the
occurrence of antimicrobial resistance of bacteria in food animals has been reported to be
associated with the consumption of antimicrobial agents in animal husbandry, which could cause
the failure of clinical therapy (Aarestrup, 1999).
Traditionally, Vibrio is considered to be susceptible to all antibiotics, except that
ampicillin-resistance was observed in V. parahaemolyticus and V. vulnificus (Joseph et al., 1978;
Zanetti et al., 2001). However, some studies indicated that antimicrobial resistance has been
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surfaced into V. parahaemolyticus and V. vulnificus in Austria (Akinbowale et al., 2006), the
Philippines and Thailand (Maluping et al., 2005) by characterizing the antimicrobial
susceptibility profile of these two vibrios. One study in the past found very high ampicillin
resistance rate (> 90% for V. parahaemolyticus), indicating the exhibition of -lactamase activity
(Joseph et al., 1978). Another study in Italy tested antibiotics against eight V. parahaemolyticus,
six V. vulnificus and some other Vibrio strains isolated in the coastal waters of Italy. They found
that more than 80% of Vibrio isolates were resistant to ampicillin (Zanetti et al., 2001). A similar
susceptibility profile was found in V. parahaemolyticus from patients in Indonesia with 98%
resistance rate to ampicillin while all isolates (100%) were sensitive to chloramphenicol,
tetracycline, trimethoprim-sulfamethoxazole, gentamicin, and ciprofloxacin (Lesmana et al.,
2001). In 2008, a study screened 151 coastal isolated V. vulnificus and 10 primary septicemia
isolates against 26 antimicrobial agents. Surprisingly, 45% (68 of 151) of the environmental
sourced V. vulnificus strains were resistant to three or more classes of antibiotics (Baker-Austin
et al., 2009). However, weather V. parahaemolyticus and V. vulnificus has become more resistant
is unknown.
In clinical therapy, tetracycline has been recommended as the antimicrobial of choice to
treat severe V. parahaemolyticus and V. vulnificus infections (Morris & Tenney, 1985), and
alternative treatments are a combination of a third-generation cephalosporin (e.g., ceftazidime)
and doxycycline, or a fluoroquinolone alone (Tang et al., 2002). Trimethoprim-sulfamethoxazole
plus an aminoglycoside are used to treat children in whom doxycycline and fluoroquinolones are
contraindicated (Centers for Disease Control and Prevention, 2005).
Considering few recent studies have investigated the antimicrobial susceptibility testing
on these two species, especially information is lacking in the U.S. since the 1990s, research is
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needed to test first-line drugs if they remain highly effective against both V. parahaemolyticus
and V. vulnificus.
Virulence Properties
About 400-500 cases of Vibrio infections were reported to CDC annually; however,
considering millions pounds of oyster meats consumed in the U.S. each year, it is hypothesized
that not all environmental V. parahaemolyticus and V. vulnificus are virulent (Chatzidaki-Livanis
et al., 2006a).
For V. parahaemolyticus, the thermostable direct hemolysin (TDH) and TDH-related
hemolysin (TRH) have been considered the major virulent factors by multiple studies, and most
clinical strains carry one or both of the two hemolysins (DePaola et al., 2000; Takahashi et al.,
2000), while less than 1% of food or environmental strains have the tdh gene coding for TDH
(DePaola et al., 2003a). One study showed that most clinical isolates from the Pacific Northwest
of the U.S. are likely to have both tdh and trh genes (DePaola et al., 2003b). The prevalence of
pathogenic V. parahaemolyticus varies from 6% in Atlantic and Gulf coast mollusk shellfish
(Cook et al., 2002a) to 21.8% in Alabama oyster (DePaola et al., 2003a) depending on the
environmental parameters such as area, water temperature, and salinity.
For V. vulnificus, several potential virulent factors have been examined which included
the lipopolysacchride (LPS), flagella, and capsular polysaccharide (CPS) (Lee et al., 2004;
Linkous & Oliver, 1999; Strom & Paranjpye, 2000). LPS, endotoxin, was the factor reported to
cause shock and death by V. vulnificus infection (Oliver, 2006). A study tested intravenous
injections of V. vulnificus LPS into rats and the results showed decreased heart rate and blood
pressure within 10 min and further decline lead to death in 30 to 60 min (McPherson et al.,
1991). A follow up study found the lethal effect was reversed after using a LPS-induced enzyme
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(nitric oxide synthase) (Elmore et al., 1992). The presence and amount of CPS on any given
virulent isolate has been positively correlated with measures of virulence of V. vulnificus in
mouse model (Wright et al., 1990; Yoshida et al., 1985), which were demonstrated that the
presence of CPS protected the bacteria by conferring resistance to the bactericidal effects of
serum and phagocytosis by macrophages (Johnson et al., 1984; Yoshida et al., 1985). However,
whether one or more of those factors play an important role in the virulence of V. vulnificus
remains to be determined.
Given that unique virulence markers have not been identified, alternative strategies are
sought. Recently, several biomarkers have been explored to differentiate virulent- (i.e., clinical-)
from non-virulent- (i.e., environmental-) type V. vulnificus strains with varied degree of success.
A 200- to 178- bp segment was observed always present in the clinical strains while the segment
was occasionally present in the environmental isolates (Warner & Oliver, 1999). A follow up
study using the virulence-correlated gene (vcg) to screen 55 strains found that 90% of vcgC-type
(correlates with clinical origin) strains were clinical isolates, while 93% of environmental
isolates were vcgE-type (correlates with environmental origin) (Rosche et al., 2005). The same
group analyzed the RAPD genotype of V. vulnificus isolates from oysters and seawater and a
total of 880 isolates from oysters confirmed the previous study by showing 84.4% of the isolates
revealed the vcgE type, while 292 isolates from the seawater showed almost equal distribution
among the two genotypes of vcgE and vcgC (Warner & Oliver, 2008). Meanwhile, the
polymorphisms discrimination of the 16S rRNA has been reported as a virulence indicator
between the clinical and the environmental V. vulnificus isolates (Nilsson et al., 2003). One study
in 2003 examined 33 nonclinical isolates and 34 clinical isolates by terminal restriction fragment
length polymorphism (T-RFLP) of the 16S rRNA gene, and they found the majority (31 of 33) of
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the nonclinical strains belonged to 16S rRNA A type, while 26 of 34 clinical ones were 16S
rRNA B type (Nilsson et al., 2003). The same group did a following study by combining the TRFLP with real-time to be a new assay to analyze a total of 86 V. vulnificus isolates including 67
from the previous study strain collection (Vickery et al., 2007). Surprisingly, they found 15
strains, which were previously found as 16S rRNA A type showed as both A and B. A recent
study characterized the polysaccharide operon by identifying two CPS allele 1 and 2
(Chatzidaki-Livanis et al., 2006b), and a following study indicated significant relationship
between the clinical and capsular 1, while environmental isolates were predominantly capsular 2
(Chatzidaki-Livanis et al., 2006a). Beside the three biomarkers, a vulnibactin-encoding viuB
gene was reported to closely correlate with clinical-type V. vulnificus isolates in shellfish
(Panicker et al., 2004c), one of the siderophore genes involved in iron acquisition (Litwin et al.,
1996). However, none of those could serve as a unique virulence marker that to be used to screen
for virulent V. vulnificus isolates from oysters.
Given the lack information of the virulent factors, research is needed to apply single or a
combination of biomarkers for the identification of virulent-type V. parahaemolyticus and V.
vulnificus in seafood, especially oysters.
Isolation and Identification Methods
Traditional isolation and detection methods for V. parahaemolyticus and V. vulnificus,
approved by FDA as standard methods, are mainly based on microbiological culturing methods;
however, they are labor-intensive and time-consuming (Kaysner & DePaola, 2001). DNA probe
hybridization, also approved by FDA, is more rapid and specific, but it still takes 2-3 days
(Morris et al., 1987; Nordstrom et al., 2006). The detection limit by DNA hybridization was
between 102 to 104 CFU/g of oyster (Raghunath et al., 2007; Wright et al., 1993).
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Immunological-based assays, such as enzyme-linked immunosorbent assay (ELISA) used
the monoclonal antibody and achieved a detection limit of 2.0 × 103 cells (Tamplin et al., 1991).
A recent study on the use of anti-flagella protein monoclonal antibody to detect V.
parahaemolyticus exhibited about 35% to 45% binding of 102 to 103 cells in phosphate-buffered
saline (Datta et al., 2008). One problem of conventional ELISA is that the antibody for antigen
capture is nonspecifically and physically adsorbed onto ELISA plates, thus the antigen captured
by the antibody may easily detach from the ELISA plates during subsequent processing, so
chemically immobilizing antibody on nylon was developed to ensure the stable immobilization
of sufficient amounts of antibodies on nylon (Honda et al., 1995).
ELISA to detect V. vulnificus hemolysin has been reported, however, cross-reaction with
other Vibrio (Vibrio campbelli, Vibrio harveyi, Vibrio pelagius, and Vibrio splendidus)
(Nishibuchi

&

Seidler,

1985),

or

non-Vibrio

species

(Acinetobacter

calcoaceticus,

Achromobacter icthyodermis, Aeromonas hydrophila, and Pseudomonas aeruginosa) (Parker &
Lewis, 1995) were found, indicating specificity problem.
Compared to conventional method, immunological-based assays greatly eliminate the
lengthy and labor-intensive cultural assays for Vibrio identification, but the cross-reactions were
distinguished owing to the nature of the test method, which limits the application of such assays.
Molecular-based DNA detection assays, mainly PCR and real-time PCR (Campbell &
Wright, 2003; Gordon et al., 2008; Nordstrom et al., 2007; Panicker et al., 2004b; Panicker et
al., 2004c; Panicker & Bej, 2005), have been widely employed for the rapid and specific
detection of V. parahaemolyticus and V. vulnificus worldwide. A multiplex PCR detecting the
total and virulent strains of V. parahaemolyticus was developed by targeting tlh, tdh, and trh, and
the detection limit was found 10-100 CFU per 10 g of alkaline peptone water enriched seeded
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oyster tissue homogenate after 6 h enrichment (Bej et al., 1999). Compared to conventional PCR,
real-time PCR is more sensitive and rapid, and also quantitative. It is reported the real-time PCR
could detect 1 CFU V. parahaemolyticus in oyster tissue homogenate after overnight enrichment
(Ward & Bej, 2006). Another group developed a real-time multiplex PCR assay for the
simultaneous detection of tlh, tdh, and trh of V. parahaemolyticus, and the multiplex assay
detected <10 CFU/reaction of pathogenic V. parahaemolyticus in the presence of >104
CFU/reaction of total V. parahaemolyticus bacteria (Nordstrom et al., 2007). When applied to
oyster samples, compared to MPN, the multiplex real-time PCR assay detected more tubes
positive for total and pathogenic V. parahaemolyticus bacteria (Nordstrom et al., 2007).
Similar results were found by using PCR and real-time PCR for the detection of V.
vulnificus. Back to 1991, two studies have been reported by PCR for detecting general (Hill et
al., 1991) and nonculturable V. vulnificus cells (Brauns et al., 1991), all targeting vvhA. Later,
Multiplex PCR analysis for simultaneous identification of V. vulnificus and other vibrios, have
been reported (Dalmasso et al., 2009; Panicker et al., 2004a; Teh et al., 2009). When applied in
real-time, SYBR Green-based real-time PCR (Panicker et al., 2004b) and Taqman real-time PCR
(Campbell & Wright, 2003) both targeting vvhA have been reported to quantify V. vulnificus
from oysters, both of the assays are highly specific. SYBR Green-based real-time PCR was able
to detect the equivalent of 102 cells in pure culture and 102/ml in seawater without enrichment,
however, after 5h enrichment, the detection limit was found to one cell (Panicker et al., 2004b).
Taqman real-time PCR could detect the equivalent of six cells in pure culture, 102 CFU/g from
oyster homogenates using purified DNA templates (Campbell & Wright, 2003).
Compared to PCR, real-time offers quantitative analysis while reducing the need for postprocessing, thus providing more rapid analysis. However, for both PCR and real-time PCR, a
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dedicated thermal cycler is needed, which is rather expensive especially for real-time PCR, and
hinders the wide application of such assays.
A newer molecular method, loop-mediated isothermal amplification (LAMP), developed
by Tsugunori Notomi in Japan in 2000, applied four to six primers to specifically recognize six
to eight distinct sequences on the target DNA under isothermal conditions in less than one hour
(Notomi et al., 2000). Also this novel nucleic acid amplification method could be observed by
naked eye or real-time turbidity meter due to the formation of magnesium pyrophosphate as a
by-product (Mori et al., 2001). Since its invention, LAMP has been applied to detect multiple
bacterial and viral agents, including those of major food safety concerns, such as Salmonella
(Hara-Kudo et al., 2005; Ohtsuka et al., 2005), Campylobacter (Yamazaki et al., 2008c),
Flavobacterium (Yeh et al., 2006), E. coli (Hara-Kudo et al., 2007; Yano et al., 2007),
Staphylococcus aureus (Goto et al., 2007; Misawa et al., 2007), Vibrio (Chen & Ge, 2010;
Yamazaki et al., 2008a; Yamazaki et al., 2008b), and virus (Fukuda et al., 2007; Mekata et al.,
2006; Yamada et al., 2006). Meanwhile, real-time LAMP has been developed by using a
fluorescent DNA-intercalating dye in a real-time PCR format (Aoi et al., 2006) or measuring the
turbidity change during LAMP amplification in a turbidimeter (Chen & Ge, 2010; Mori et al.,
2001). Figure 2-3 shows the LAMP procedure (Eiken Genome Site, 2000).
Advantages of LAMP detection include: 1) isothermal (60-65oC), no special thermal
cycling instrument is required; 2) rapid, the assay can be completed in 15-60 min (Nagamine et
al., 2002); 3) specific, the assay targets 6-8 regions of the target gene sequence; 4) sensitive,
extremely large amount of DNA can be amplified from a few target cells; 5) detection by the
naked eye due to the formation of large quantities of a by-product, magnesium pyrophosphate,
which turns positive reaction tubes turbid (Mori et al., 2001); 6) direct amplification, there is no
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need to denature DNA templates before amplification (Nagamine et al., 2001); 7) robust, LAMP
is less subjective to inhibition by biological substances (Kaneko et al., 2007); and 8) quantitative,
real-time LAMP is used to quantify DNA in the reaction (Chen & Ge, 2010).

Figure 2 - 4 Loop-mediated isothermal amplification (LAMP) procedure
Given the lack of information on both the epidemiology and sensitive and cost-effective
method for the rapid detection of general and virulent-type of Vibrio, this dissertation research
was carried out to fulfill three objectives: 1) To isolate V. parahaemolyticus and V. vulnificus
from Louisiana Gulf and Retail oysters; 2) To characterize the V. parahaemolyticus and V.
vulnificus isolates, including antimicrobial susceptibility profile and genotypic patterns; and 3)
To develop and evaluate LAMP assays for real-time detection of general and virulent-type V.
vulnificus. The successful complete of this dissertation generated baseline data on the prevalence,
genotypes, and antimicrobial susceptibility profiles of the two vibrios from Louisiana oysters,
18

and rapid, specific, sensitive, and yet cost-effective molecular detection assays for both general
and virulent V. vulnificus were developed, which could contribute to developing effective control
strategies to reduce the incidences of human Vibrio infections due to the consumption of oysters
in the long run.
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Introduction
Members of the genus Vibrio are Gram-negative, motile bacteria that inhabit warm
coastal and estuarine waters worldwide (Barbieri et al., 1999; Hervio-Heath et al., 2002; Hoi et
al., 1998). However, the consumption of raw or undercooked seafood, particularly oysters, may
lead to their transmission to humans with clinical manifestations ranging from mild diarrhea to
death (Blake et al., 1980). Among pathogenic vibrios, Vibrio parahaemolyticus is the leading
cause of seafood-associated bacterial gastroenteritis in the United States (Mead et al., 1999) and
the most common foodborne pathogen in Asian countries (Joseph et al., 1982); whereas Vibrio
vulnificus inflicts the highest mortality rate (> 50% in primary septicemia patients and 25% for
those with wound infections) among all foodborne pathogens, responsible for more than 95% of
seafood-related deaths in the U.S. (Oliver, 2006). Fortunately, the vast majority of environmental
V. parahaemolyticus strains tested are not pathogenic (being both tdh and trh negative) (DePaola
et al., 2003), and for fatal V. vulnificus infections, predisposed risk factors have been identified,
which include compromised immune systems, diabetes, and elevated serum iron concentrations
due to liver disease or alcohol abuse (Strom & Paranjpye, 2000). Nonetheless, according to a
recent FoodNet report from the Centers for Disease Control and Prevention (CDC), amidst the
decrease of infections caused by all major foodborne pathogens, the incidence of V.
parahaemolyticus and V. vulnificus infections due to eating raw or undercooked oysters has
shown a sustained increase since 2001, indicating further measures are needed to prevent human
illness caused by these pathogens in oysters (Centers for Disease Control and Prevention, 2010).
Although most V. parahaemolyticus infections are self-limiting, antimicrobial therapy
may be necessary in patients with severe or prolonged diarrhea (Centers for Disease Control and
Prevention, 2005b). In the case of V. vulnificus primary septicemia and wound infection, prompt
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antimicrobial treatment can be lifesaving because of the extreme rapidity of disease progress and
severity of patient outcomes (Strom & Paranjpye, 2000). Tetracycline has been recommended as
the antimicrobial of choice to treat severe Vibrio infections (Morris & Tenney, 1985), and
alternative treatments are a combination of a third-generation cephalosporin (e.g., ceftazidime)
and doxycycline, or a fluoroquinolone alone (Tang et al., 2002). Trimethoprim-sulfamethoxazole
plus an aminoglycoside are used to treat children in whom doxycycline and fluoroquinolones are
contraindicated (Centers for Disease Control and Prevention, 2005a).
Traditionally, Vibrio is considered highly susceptible to virtually all antimicrobials,
although ampicillin resistance has been observed in both V. parahaemolyticus and V. vulnificus
(Joseph et al., 1978; Zanetti et al., 2001). During the past decade, however, antimicrobial
resistance has emerged and evolved in many species of microorganisms due to the excessive use
of antimicrobials in humans, agriculture, and aquaculture (Cabello, 2006; Mazel & Davies,
1999). Campylobacter and Salmonella, two major foodborne bacterial pathogens of terrestrial
sources, are part of the National Antimicrobial Resistance Monitoring System (NARMS) in the
U.S. (Centers for Disease Control and Prevention, 2006), and have been studied extensively for
the development and dissemination of antimicrobial resistance (Chen et al., 2004; D'Lima C et
al., 2007; Ge et al., 2005; Skov et al., 2007). In contrast, the awareness of antimicrobial-resistant
bacteria in the aquatic environment is not as well documented (Cabello, 2006). For both clinical
and environmental isolates of Vibrio cholera, antimicrobial resistance has been investigated
extensively (Dalsgaard et al., 2000; Hochhut et al., 2001; Iwanaga et al., 2004), and there are
some very recent reports examining the antimicrobial susceptibilities in other aquatic species
such as Aeromonas (Gordon et al., 2007; Jacobs & Chenia, 2007). But only a few recent studies
have investigated the antimicrobial resistance in non-cholera vibrios. These studies were
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conducted in Australia, India, the Philippines, and Thailand, and included small numbers of
either V. parahaemolyticus or V. vulnificus (Akinbowale et al., 2006; Maluping et al., 2005;
Vaseeharan et al., 2005). Antimicrobial resistance in these two bacterial species has not been
reported in the U.S. since the 1990s.
The objectives of this study were to determine the prevalence of V. parahaemolyticus and
V. vulnificus in oysters obtained from the Louisiana Gulf Coast and four retail outlets in Baton
Rouge, Louisiana, and more importantly, to determine the antimicrobial susceptibility profiles of
these Vibrio isolates by a broth microdilution method.
Materials and Methods
Sample Collection and Preparation. From June 2005 to September 2006, a total of 20
oyster samples were harvested, at quarterly intervals, from two sites near the Louisiana Gulf
Coast. Due to Hurricanes Katrina and Rita, no sampling trips were made in September 2005.
Both sites were in shellfish-growing areas approved by the National Shellfish Sanitation Program
and available for commercial harvesting. Another 74 oyster samples were obtained through retail
sampling conducted weekly in Baton Rouge, Louisiana from February to August 2006. One
grocery store that offered shellstock oysters for sale (February-April) and three seafood
restaurants with “oyster bars” where shellstock oysters were opened onsite for raw consumption
(April-August) were included in the sampling. On each sampling day, two paired oyster samples
(12 oysters/sample) were obtained from each site, transported on ice to the laboratory, and
analyzed within 4 h of collection. The oysters collected from both the Gulf and retail outlets
were Eastern oysters, Crassostrea virginica.
Oysters in the shell were scrubbed, and those belonging to one sample were shucked into
a sterile stomacher bag to make 200-250 g per sample. After adding equal volume of alkaline
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peptone water (APW; BD Diagnostic Systems, Sparks, MD), samples were homogenized in a
food stomacher (Model 400; Tekmar Company, Cincinnati, OH) for 90 seconds to produce 1:1
oyster-APW homogenate.
Bacterial Isolation. Dehydrated media and reagents were purchased from BD Diagnostic
Systems. Media formulations and procedures described in the Food and Drug Administration
Bacteriological Analytical Manual (BAM) (Kaysner & DePaola, 2001) and a previous study
(DePaola et al., 2003) were used to isolate V. parahaemolyticus and V. vulnificus with a few
modifications. Two isolation methods, direct plating and enrichment, were proceeded
simultaneously.
For direct plating, 200 µl of the 1:1 oyster-APW homogenate (i.e., 0.1 g homogenized
oyster tissue) and 100 µl of a 1:10 dilution of the oyster-APW homogenate in APW (i.e., 0.01 g
homogenized oyster tissue) were spread-plated in duplicate onto thiosulfate-citrate-bile saltssucrose (TCBS) agar and modified cellobiose-polymyxin B-colistin (mCPC) agar for isolating V.
parahaemolyticus and V. vulnificus, respectively. After 24 h of incubation at 35oC and 40oC for
TCBS and mCPC, respectively, five to ten presumptive V. parahaemolyticus colonies on TCBS
(green or bluish green, round, 2-4 mm in diameter) and V. vulnificus on mCPC (flat yellow, fried
egg shape, 1-2 mm in diameter) were subcultured on trypticase soy agar with 2% NaCl (TSAS)
and confirmed by PCR as described below. Following isolation and identification, the isolates
were stored at -80oC in brain heart infusion with 50% glycerol.
For enrichment, 50 g of the 1:1 oyster-APW homogenate was added into a sterile flask
containing 200 ml of APW and incubated at 35oC with shaking at 100 rpm for 24 h. The
enrichment broth was serially diluted in phosphate buffered saline (PBS) and appropriate

32

dilutions (10-2, 10-3, or 10-4) were plated in duplicate onto either TCBS or mCPC agar. The
remaining isolation procedures were the same as those described above for direct plating.
PCR Assays. Presumptive V. parahaemolyticus and V. vulnificus isolates were confirmed
by performing a multiplex PCR assay that targeted both V. parahaemolyticus thermolabile
hemolysin (encoded by tl) and V. vulnificus cytolysin (vvhA). For confirmed V.
parahaemolyticus by this PCR, another multiplex PCR targeting the thermostable direct
hemolysin (Tdh) encoded by tdh and the Tdh-related trh gene was conducted. Primer sequences
for all four genes were the same as those described in BAM (Kaysner & DePaola, 2001).
Bacterial DNA templates were prepared by heating cell suspensions in TE (10 mM Tris,
1 mM EDTA; pH 8.0) at 95oC for 10 min. Each multiplex PCR mixture contained 1 x PCR
buffer, 0.2 mM of deoxynucleotide triphosphate, 2.5 mM of MgCl2, 0.5 unit of Taq DNA
polymerase (Applied Biosystems, Foster City, CA), 0.5 µM of each primer, and 5 µl of DNA
template in a total volume of 25 µl. PCR was conducted using 30 cycles of denaturation at 94°C
for 1 min, primer annealing at 58°C for 1 min, extension at 72°C for 1 min, and a final extension
of 72°C for 7 min in a GeneAmp PCR System 2400 (Applied Biosystems). PCR products were
analyzed by electrophoresis on 2% agarose gel containing ethidium bromide, and visualized
under UV light. Gel images were documented by a Stratagene Eagle Eye II system (La Jolla,
CA).
Antimicrobial Susceptibility Testing. Minimal inhibitory concentrations (MICs) for a
randomly selected subset of 319 V. parahaemolyticus and V. vulnificus (Table 3-1, last three
columns, numbers in parenthesis) were determined using a broth microdilution testing method as
described in a document recently published by the Clinical and Laboratory Standards Institute
(CLSI; formerly the NCCLS) (Clinical and Laboratory Standards Institute, 2006b). Additionally,
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ten reference strains, including six V. parahaemolyticus (ATCC33847, ATCC49529, TX-2103,
CT-6636, NY-477, and 8332924) and four V. vulnificus (VV1007, ATCC29306, VV-WR1, and
515-4C2), provided by Dr. Angelo DePaola from the Gulf Coast Seafood Laboratory, Food and
Drug Administration, were tested. Eight antimicrobial agents of clinical relevance to treating
vibriosis were tested: ampicillin, cefotaxime, ceftazidime, chloramphenicol, ciprofloxacin,
gentamicin, imipenem, and tetracycline. All antimicrobials were purchased from Sigma-Aldrich
(St. Louis, MO) except for imipenem (United States Pharmacopeia, Rockville, MD). For
preparing stock solutions, antimicrobials were dissolved in distilled water or buffer as
recommended by CLSI (Clinical and Laboratory Standards Institute, 2006a). A custom designed
panel plate incorporating these antimicrobials at a concentration range of 0.03-64 μg/ml (for
chloramphenicol and gentamicin, the test ranges of 1-1024 μg/ml and 0.06-64 μg/ml were used,
respectively) was made with cation-adjusted Mueller-Hinton broth, sealed with perforated plate
seal (Trek Diagnostic Systems Inc., Cleveland, OH), and stored at -80oC.
Before testing, the susceptibility panels were warmed at room temperature for at least 30
min. Escherichia coli ATCC 25922 was used as the quality control organism (Clinical and
Laboratory Standards Institute, 2006b). Briefly, suspensions of Vibrio were prepared from fresh
cultures grown on TSAS plates into 3-4 ml of 0.85% NaCl (physiological saline) and adjusted to
a turbidity of 0.5 McFarland. Further dilutions were made in 10 ml of saline. A multichannel
pipette was used to inoculate the panels, leaving only the negative control well uninoculated.
Colony counts were performed regularly to validate the inoculum density to be around 5 x 105
CFU/ml in the wells. The panels were sealed and incubated at 35oC in ambient air for 16-20 h.
MICs were recorded as the lowest concentrations of antimicrobial agents that completely
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inhibited bacterial growth in the wells. The interpretive criteria followed CLSI document M45-A
(Clinical and Laboratory Standards Institute, 2006b).
Data Analysis. Prevalence data sorted by Vibrio species, sampling location, and
sampling season were analyzed by using the analysis of variance (ANOVA) (SAS for Windows,
Version 9; SAS Institute Inc., Cary, NC). Antimicrobial susceptibility data were organized by
each species for MIC50, MIC90, MIC range, and percentages of isolates that were susceptible,
intermediate, or resistant to each antimicrobial tested. The MIC values (expressed in log2 scale)
between the two species were also compared using ANOVA. Additionally, resistance plus
intermediate rates to ampicillin between species and among different sampling locations were
analyzed by Chi-square and Fisher’s exact two-tailed tests, and ANOVA. Differences between
mean values were considered significant when P < 0.05.
Results
Five sampling trips were made to the Louisiana Gulf Coast from June 2005 to September
2006. Four retail outlets, including one grocery store and three seafood restaurants, were visited
a total of 38 times between February and August 2006. Ninety-four oyster samples, 20 from the
Gulf and 74 at retail, were collected and analyzed for the prevalence of V. parahaemolyticus and
V. vulnificus, followed by susceptibility testing of some of the isolates.
Prevalence of V. parahaemolyticus and V. vulnificus. The prevalence rates of V.
parahaemolyticus and V. vulnificus in 94 Gulf and retail oyster samples are shown in Table 3-1.
A total of 622 Vibrio isolates, including 252 V. parahaemolyticus and 370 V. vulnificus, were
recovered from 82 (87.2%) of the oyster samples. Among 53 samples (56.4%) that contained V.
parahaemolyticus, the grocery store had the highest prevalence rate (85.7%), followed by
restaurant A (66.7%), the Gulf (50%), restaurant B (50%), and restaurant C (25%). In contrast,
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restaurant B (87.5%) had a significantly higher V. vulnificus prevalence rate (P < 0.05) in its
oyster samples than those of the Gulf (55%) and restaurant C (50%), but not significantly
different from that of restaurant A (66.7%) (Table 3-1). Interestingly, not a single V. vulnificus
was isolated from the grocery store during the period sampled (Table 3-1). Among twenty-five
(26.6%) oyster samples from which both V. parahaemolyticus and V. vulnificus were recovered,
nine, nine, five, and two originated from restaurants A, B, the Gulf, and restaurant C,
respectively. Overall the prevalence of one or both Vibrio species fell between 58.3% (restaurant
C) and 100% (restaurant B), with restaurant C having a significantly lower rate than other
sampling locations (P < 0.05) (Table 3-1). The average prevalence rate among the four retail
outlets was calculated to be 89.2%. About half of the 622 Vibrio isolates were recovered using
the direct plating method, and the other half through enrichment. For paired oyster samples
collected from the same collection site, there were nine out of 38 occasions from retail outlets
where the presence of Vibrio species differed (data not shown).
Seasonality of V. parahaemolyticus and V. vulnificus Presence in Oysters. The
prevalence of V. parahaemolyticus and V. vulnificus varied greatly during the sampling period
(Table 3-2). For example, there was an increase in the prevalence of V. vulnificus and
simultaneous decrease of V. parahaemolyticus as the survey proceeded in 2006. The Gulf and
retail samples in February and March were 75-100% culture positive for V. parahaemolyticus,
but decreased to 0-33% in or between April and September (Table 3-2). In contrast, the
prevalence rate of V. vulnificus in oysters was low in February/March (0 in the grocery store and
50% in the Gulf), and reached 100% in June and September for the retail and Gulf samples,
respectively. At the end of retail sampling in August, the culture positive rate for V. vulnificus
remained above 75%; whereas V. parahaemolyticus rates ranged between 0 to 67%. For the Gulf
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Coast sampling in September and December, prevalence rates for V. vulnificus were 100% and
25%, respectively; whereas the positive rates for V. parahaemolyticus were 0 in September and
25% in December (Table 3-2). Overall a prevalence rate of 100% was observed for oysters from
certain collecting sites between February and June for V. parahaemolyticus and June to
September for V. vulnificus.
Due to unavailable or few data points in certain months (Table 3-2), we grouped the
months arbitrarily into seasons, with December, February, and March as winter, April to June as
spring, and July to September as summer. When pooling the samples from all locations, the
prevalence of V. parahaemolyticus was significantly higher in winter (80%) and spring (77.8%)
than summer (23.7%), where V. vulnificus had a higher significantly higher prevalence rate in
summer (84.2%) than either spring (52.8%) or winter (15%), with the rates of spring and winter
being significantly different from each other as well (P < 0.05). However, when examining the
prevalence of either V. parahaemolyticus or V. vulnificus in oysters sampled during the seasons,
no significant difference was observed, and the prevalence rates were 91.7%, 86.8%, and 80%
for spring, summer, and winter, respectively.
Multiplex PCR Results. The first multiplex PCR confirmed the identity of presumptive
V. parahaemolyticus and V. vulnificus in approximately 60% and 70% of the isolates picked,
respectively (data not shown). However, there were a few cases (53 out of 252 V.
parahaemolyticus) where colonies from mCPC were tested by this PCR to be V.
parahaemolyticus, and even less frequently, 19 out of 370 V. vulnificus were isolated from the
TCBS plates and confirmed by this PCR. Based on the second multiplex PCR assay specific for
the tdh and trh genes in V. parahaemolyticus, none of the 252 V. parahaemolyticus recovered in
this study possessed these two virulence-related genes.
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Table 3 - 1 Prevalence of Vibrio parahaemolyticus and Vibrio vulnificus in 94 Louisiana Gulf and Retail Oysters
Isolates
No. of isolates belonging tob
No. (%) of samples positive fora
Oyster collecting Samples
recoveredb
Either
V.
V.
V.
V.
site
collected
species
parahaemolyticus
vulnificus
parahaemolyticus vulnificus
Gulf
20
10 (50) BC
11 (55) B
16 (80) A
114 (70)
57 (40)
57 (30)
A
C
A
Grocery Store
14
12 (85.7)
0 (0)
12 (85.7)
49 (46)
49 (46)
0 (0)
Restaurant A
24
16 (66.7) AB
16 (66.7) AB 23 (95.8) A
180 (86)
78 (44)
102 (42)
21 (87.5) A
24 (100) A
227 (96)
54 (30)
173 (66)
Restaurant B
24
12 (50) BC
Restaurant C
12
3 (25) C
6 (50) B
7 (58.3) B
52 (21)
14 (8)
38 (13)
Total
94
53 (56.4)
54 (57.4)
82 (87.2)
622 (319)
252 (168)
370 (151)
a
Prevalence rates under the same column followed by different letters are significantly different (P < 0.05). The letters A to C were
used to indicate a descending order of the mean values of each group.
b
The numbers in parenthesis are the number of isolates included for susceptibility testing.
Table 3 - 2 Prevalence of Vibrio parahaemolyticus and Vibrio vulnificus by month of isolation, in oyster samples obtained from the
Louisiana Gulf Coast and retail outlets in 2005-2006
Ratio of positive samples vs. samples purchased at that sitea
Vibrio
Site
Species
Jan
Feb
Mar
Apr
May Jun
Jul
Aug
Sep
Oct
Nov
Dec
Gulf
3/4
6/6
0/6
1/4
parahaemolyticus
2/4
2/6
6/6
1/4
vulnificus
Grocery store parahaemolyticus
2/2
10/10 0/2
0/2
0/10
0/2
vulnificus
Restaurant A parahaemolyticus
4/4
6/6
4/4
2/8
0/2
0/4
4/6
4/4
6/8
2/2
vulnificus
Restaurant B parahaemolyticus
4/4
3/6
1/8
4/6
1/4
6/6
8/8
6/6
vulnificus
Restaurant C parahaemolyticus
1/2
0/2
1/4
1/4
0/2
2/2
1/4
3/4
vulnificus
a
When multiple sampling visits were made at one site during a particular month, the average prevalence rates were used. Blank data
point means no sampling visits were made to that site in that month.
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Antimicrobial Susceptibility Profiles. The MIC distributions of the 319 V.
parahaemolyticus and V. vulnificus isolates sorted by species are presented in Table 3-3. The
MIC50, MIC90, and MIC range for V. parahaemolyticus tended to be one or more dilutions higher
than those for V. vulnificus, except in the case of imipenem where both V. vulnificus MIC50 and
MIC90 were about four-fold higher. For ampicillin, the differences in MIC distributions between
the two species were much greater (32-64 fold in MIC50 and MIC90), with V. parahaemolyticus
MIC50 falling in the resistance end of the MIC ranges, whereas V. vulnificus in the susceptible
end.
Based on the statistical comparison of log2MIC values among V. parahaemolyticus and
V. vulnificus included in the susceptibility testing, significant differences were observed in MICs
to ampicillin, cefotaxime, ciprofloxacin, imipenem, and tetracycline (P < 0.0001), among which
impenem was the only one that V. vulnificus had higher mean log2MIC value (Table 3-3).
According to breakpoints recommended by the CLSI M45-A document (Clinical and
Laboratory Standards Institute, 2006b), the only non-susceptible isolates among the 319 Vibrio
tested were 95 (29.8%) and 41 (12.9%) isolates, possessing ampicillin MICs in the resistant and
intermediate categories, respectively. These isolates were all V. parahaemolyticus, resulting in
the overall ampicillin resistance and intermediate rates among the 168 V. parahaemolyticus
isolates tested to be 56.5% and 24.4%, respectively (Table 3-4), i.e., 81% of the V.
parahaemolyticus tested had an MIC ≥ 16 µg/ml. The 151 V. vulnificus isolates included in the
susceptibility testing, on the other hand, were all susceptible to ampicillin. The distribution of
ampicillin-resistant V. parahaemolyticus in the oyster collecting sites indicated that restaurant A
had the highest ampicillin resistance and intermediate combined rate (90.9%), followed closely
by restaurant B (90%), the Gulf (77.5%), the grocery store (74%), and restaurant C (50%).
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Table 3 - 3 Antimicrobial susceptibility testing ranges, breakpoints, and MIC distribution for 319 Vibrio parahaemolyticus and Vibrio
vulnificus isolates for eight antimicrobials tested
MIC (g/ml) distribution forb
Breakpoint (g/ml)a
Test range
Antimicrobial
agent
(g/ml)
S
I
R
V. parahaemolyticus (n =168)
V. vulnificus (n =151)
b
MIC50 MIC90 Range
Mean
MIC50 MIC90 Range
Meanb
Ampicillin
0.03-64
≤8
16
≥32
32
32
0.5-64
4.25c
1
1
0.06-8
-0.20 c
Cefotaxime

0.03-64

≤8

16-32

≥64

0.25

0.5

≤0.03-4 -1.85 c

0.25

0.25

≤0.03-2

-2.27 c

Ceftazidime

0.03-64

≤8

16

≥32

0.25

0.5

≤0.03-4 -2.13

0.25

0.5

≤0.03-1

-2.17

Chloramphenicol 1-1024

≤8

16

≥32

1

1

0.06-8

1

1

0.06-8

-0.50

Ciprofloxacin

0.03-64

≤1

2

≥4

0.125

0.5

≤0.03-1 -3.28 c

≤0.03

0.06

≤0.03-0.25

-5.39 c

Gentamicin

0.06-64

≤4

8

≥16

0.5

2

0.125-2

0.5

1

≤0.03-2

-0.57

Imipenem

0.03-64

≤4

8

≥16

≤0.03

0.06

≤0.03-2 -5.29 c

0.125

0.25

≤0.03-0.5

-3.28 c

Tetracycline

0.03-64

≤4

8

≥16

0.5

1

0.06-2

0.25

0.5

0.06-2

-2.21 c

a

-0.75

-0.49

-1.14 c

Breakpoints recommended by the Clinical and Laboratory Standards Institute in M45-A (Clinical and Laboratory Standards Institute,
2006b). S, I, and R stand for susceptible, intermediate, and resistant, respectively.
b
Mean MIC values were expressed in log2 scale. When MIC was ≤0.03 g/ml, a -6 value was used as the value for mean calculation.
c
Indicates significantly different mean MIC values (in log2 scale) between V. parahaemolyticus and V. vulnificus (P < 0.05).

40

However, except for that of restaurant C, all other ampicillin resistance and intermediate
combined rates were not statistically significant (Table 3-4).
For the ten reference strains included in the susceptibility testing, similar to our oyster
isolates, these strains were susceptible to the majority of antimicrobials tested except that
ampicillin resistance was observed in 3 out of 6 V. parahaemolyticus strains and one additional
V. parahaemolyticus was intermediate to ampicillin.

Table 3 - 4 The presence of ampicillin-resistant and intermediate Vibrio parahaemolyticus
isolates from Louisiana Gulf and retail oysters among 168 Vibrio parahaemolyticus isolates
included in the susceptibility testing
No. (%a) of V. parahaemolyticusb
Site
R
I
R+Ic
Gulf
18 (45)
13 (32.5)
31 (77.5)A
Grocery Store

25 (54.3)

9 (19.6)

34 (73.9)A

Restaurant A

29 (65.9)

11 (25)

40 (90.9)A

Restaurant B

21 (70)

6 (20)

27 (90)A

Restaurant C

2 (25)

2 (25)

4 (50)B

95 (56.5)

41 (24.4)

136 (81)

Total
a

Denominators indicate numbers of V. parahaemolyticus recovered from oyster samples
collected in that particular sampling site and were included for susceptibility testing
b
R and I stand for resistant and intermediate to ampicillin, respectively.
C
Percentages in the same column followed by different letters are significantly different (P <
0.05).

Discussion
This study represents the first report on both prevalence and antimicrobial susceptibility
of V. parahaemolyticus and V. vulnificus in Louisiana oysters, from the Gulf harvesting sites and
consumer ready, since 1998. The study demonstrated that these two Vibrio spp. may be
frequently isolated from oysters harvested from the Louisiana Gulf Coast (80%) and from retail
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outlets (89.2%), particularly during spring to summer (February to June) for V. parahaemolyticus
and summer months (June to September) for V. vulnificus, when a 100% detection rate was
recorded at some sampling sites. This observation is supported by previous survey studies
indicating generally high prevalence and density of these Vibrio spp. in the Gulf Coast oysters
and waters (Cook et al., 2002a; Cook et al., 2002b; DePaola et al., 1990; DePaola et al., 2003),
and correlates well with human Vibrio infections reported to CDC through the Cholera and other
Vibrio Illness Surveillance (COVIS) System that began in Gulf Coast states (Alabama, Florida,
Louisiana, Mississippi, and Texas) in 1988 (Centers for Disease Control and Prevention, 2005c)
and through FoodNet.
The prevalence rates (50%-60%) of individual Vibrio spp. observed in this study for
either Gulf Coast or retail oyster samples combined, however, were lower than those reported by
other investigators. In a comprehensive national survey of these two Vibrio spp. in U.S. retail
shell oysters from June 1998 to July 1999, Cook et al. reported that oysters from the Gulf Coast
consistently had the highest numbers of both V. parahaemolyticus and V. vulnificus year-round,
and prevalence rates of 97.4% and 96.2% were observed for V. parahaemolyticus and V.
vulnificus, respectively, among 80 retail oyster samples harvested from Louisiana (Cook et al.,
2002b). Another study conducted in 1999 and 2000 by the same group, examining V.
parahaemolyticus in Atlantic and Gulf Coast oysters at harvest, reported the highest detection
rate (82%) for the Gulf Coast samples and the lowest (34.6%) for the North Atlantic coast
samples (Cook et al., 2002a). A third study testing 156 Alabama oysters during the same period
of time for V. parahaemolyticus reported the detection of this organism in all samples with the
25 g enrichments (DePaola et al., 2003). Several reasons may account for differences in
prevalence rates between the present study and others. First, since the main aim of our study was
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to examine the antimicrobial susceptibility of the two vibrios instead of quantifying the levels of
their presence in the oysters, our methodology was focused on isolation rather than enumeration.
Therefore, we picked 5 to 10 presumptive Vibrio colonies from the direct plating or enrichment
plates, instead of up to 48 colonies as recommended for quantitative direct-plating (DePaola et
al., 2003). Second, oysters sold at retail outlets, although harvested in the same region as the
Gulf, may have gone through post-harvest treatments, resulting in significant reduction of the
prevalence of Vibrio spp., but that information was not made available for the present study.
Last, all the studies mentioned above were conducted in or before 2000, and the Louisiana Gulf
Coast environment may have since changed, particularly in light of the two hurricanes, Katrina
and Rita, which made landfalls in August and September 2005, respectively. These storms may
have had an effect on the ecology of Vibrio spp. in oysters harvested from the Louisiana Gulf
Coast.
The seasonal distribution of V. parahaemolyticus and V. vulnificus in the coastal waters and
oysters, characterized by maximum population abundance during the summer months and
subsequent decline to undetectable levels during the cold winter months, has been well
documented by microbiological analysis and supported by epidemiological data of human Vibrio
infections (Centers for Disease Control and Prevention, 2005c; Cook et al., 2002b; DePaola et
al., 2003). Much of this seasonal distribution is attributable to the positive correlation between
Vibrio density and water temperature (DePaola et al., 2003; Pfeffer et al., 2003; Randa et al.,
2004). In the present study, a similar seasonal trend in the prevalence rates of both Vibrio spp.
was observed. Interestingly, our data indicated a marked difference in the seasonal distribution of
individual Vibrio populations, with the highest prevalence rates for V. parahaemolyticus falling
between February and June, whereas V. vulnificus from June to September, possibly suggesting
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that V. parahaemolyticus strains are more cold tolerant than V. vulnificus strains. However,
further characterizations of these Vibrio populations are needed to explain this observation.
Among 252 V. parahaemolyticus isolated and identified in this study, none possessed Tdh
or Trh, thus were not considered to be pathogenic. Previous studies reported that the prevalence
of pathogenic V. parahaemolyticus in the U.S. is low, ranging from 0-6% (Cook et al., 2002a;
Cook et al., 2002b; DePaola et al., 1990); however, a recent study found a much greater rate of
detection (21.8%) of pathogenic V. parahaemolyticus isolates when many more colonies were
tested for pathogenicity, particularly during cold months (DePaola et al., 2003). Similar to
previous studies, the present study did not conduct extensive examination of pathogenic V.
parahaemolyticus, so the zero prevalence of pathogenic V. parahaemolyticus in the Louisiana
oyster samples reported in this study should be interpreted with caution.
In 2005, according to CDC, COVIS received reports of 578 Vibrio isolates from 546
patients (Centers for Disease Control and Prevention, 2005c). Among 218 patients (40%)
infected with V. parahaemolyticus, 23% were hospitalized and 1% died. On the other hand, V.
vulnificus was isolated from 121 (22%) patients; 90% were hospitalized and 26% died (Centers
for Disease Control and Prevention, 2005c). Despite their public health significance, strains of V.
parahaemolyticus and V. vulnificus were not extensively monitored for antimicrobial resistance,
in contrast to enteric pathogens such as Salmonella or Campylobacter. Aquatic bacteria
including V. parahaemolyticus and V. vulnificus live in the coastal and estuarine waters, an open
area particularly subject to environmental contaminations by agricultural runoff or waste water
treatment plants, which may contain various levels of antimicrobials and heavy metals, and act as
selective pressure for antimicrobial-resistant aquatic bacteria (Gordon et al., 2007; Stepanauskas
et al., 2006).
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Prior to May 2006, no standardized susceptibility testing method was available for noncholera Vibrio spp. Because of this, it was difficult to compare data from different laboratories
due to variables involved in the testing. CLSI recently published the M45-A document which
presented the most current information for drug selection, interpretation, and quality control for
MIC testing of infrequently isolated or fastidious bacteria, including non-Cholera Vibrio spp.
(Clinical and Laboratory Standards Institute, 2006b; Jorgensen & Hindler, 2007). The present
study closely followed these guidelines for MIC testing using broth microdilution. All eight
antimicrobials tested in the present study were in accordance with the guidelines of the M45-A
document and represent antimicrobials agents that may be used in the treatment of non-Cholera
Vibrio spp. infections, particularly tetracycline, cefotaxime, ceftazidime, and fluoroquinolones.
Our findings indicated that these first-line drugs remained highly effective against both V.
parahaemolyticus and V. vulnificus; however, the high prevalence of ampicillin-resistant V.
parahaemolyticus suggested that ampicillin should not be used empirically to treat V.
parahaemolyticus infection. This is in contrast to recommendations posted by CDC (Centers for
Disease Control and Prevention, 2005d). Interestingly, ampicillin resistance in V.
parahaemolyticus is not a new phenomenon. A study in 1978 in the U.S. reported that over 90%
of 160 V. parahaemolyticus was resistant to ampicillin, and exhibited β-lactamase activity
(Joseph et al., 1978). Another study conducted in Italy in 2001 also reported unexpectedly high
frequency (80%) of ampicillin resistance in eight V. parahaemolyticus and six V. vulnificus,
mostly attributable to the production of β-lactamase (Zanetti et al., 2001). A recent report in the
Philippines and Thailand found twelve out of fourteen V. parahaemolyticus were resistant to
ampicillin (Maluping et al., 2005). Similarly, a study in India reported 100% ampicillin
resistance among seven V. vulnificus and five V. parahaemolyticus tested by the disk diffusion
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method (Vaseeharan et al., 2005). More recently, a study in Australia reported an ampicillin
resistance rate of 40% for Vibrio spp., however, only one V. parahaemolyticus and no V.
vulnificus were included in that study (Akinbowale et al., 2006). The findings in the present
study are in agreement with results from these earlier studies, which found high prevalence of
ampicillin resistance in V. parahaemolyticus. Interestingly, none of the V. vulnificus isolates
tested for antimicrobial susceptibility in this study showed ampicillin resistance.
Our examination of the prevalence and antimicrobial susceptibility of V. parahaemolyticus
and V. vulnificus also revealed discernable differences between these two species, e.g. the higher
prevalence of V. parahaemolyticus in colder months, the generally reduced susceptibility of V.
parahaemolyticus to antimicrobials, and the compromised ability of V. vulnificus to grow
directly on TCBS agar, suggesting different microbial physiology may play a role. Further
studies are needed to better explain these phenomena. Those physiological differences may
provide a basis to develop better selective and differential media for isolating V.
parahaemolyticus and V. vulnificus, which can dramatically reduce the number of colonies
needed to be tested by molecular confirmation methods such as probe hybridization or PCR.
Conclusion
Our findings demonstrated the prevalence of V. parahaemolyticus and V. vulnificus in
oysters from the Louisiana Gulf and at retail outlets, a point of contact closest to human
consumption. These results illustrated the need for appropriate food safety practices when
consuming these products. Part of the food safety program could be a national oyster
surveillance program at the retail level as no such program currently exists. Moreover, the
observed high percentage of ampicillin-resistant V. parahaemolyticus isolates suggests a
potential for low efficiency of ampicillin in empirical treatment of infections caused by this
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organism. Continued monitoring of both the prevalence and antimicrobial susceptibility profile is
needed to better ensure oyster safety; particularly the retail survey could be expanded to the
national level.
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CHAPTER 4: GENOTYPIC CHARACTERIZATION OF VIBRIO VULNIFICUS ISOLATES
FROM LOUISIANA GULF AND RETAIL RAW OYSTERS
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Part I: Characterization of Clinical and Environmental Types of Vibrio vulnificus Isolates from
Louisiana Oysters
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Introduction
Vibrio vulnificus is a Gram-negative halophilic bacterium that inhabits warm coastal and
estuarine waters worldwide, and the numbers are especially high in filter-feeding bivalve
mollusks such as oysters (Oliver, 2006; Strom & Paranjpye, 2000). Three types of human
illnesses can result from contact with V. vulnificus. Ingestion of the organism in raw or
undercooked oysters can rapidly lead to primary septicemia, a severe and life-threatening illness
characterized by fever, nausea, hypotension, and secondary blistering skin lesions (Blake et al.,
1979; Morris, 1988). When persons with preexisting wounds come into direct contact with
seawaters containing V. vulnificus, potentially fatal wound infections may occur (Tacket et al.,
1984). Much less frequently, V. vulnificus causes gastroenteritis following raw oyster
consumption (Strom & Paranjpye, 2000). While no fatality has been reported from V. vulnificus
gastroenteritis, the reported case-fatality rate for primary septicemia and wound infection
combined is around 30%, responsible for approximately 30 deaths annually in the United States
(Cholera and Other Vibrio Illness Surveillance, 2009).
As an opportunistic human pathogen, V. vulnificus causes fatal illness predominantly in
at-risk groups, which include people with immunocompromising conditions, diabetes, and
elevated serum iron concentrations due to chronic liver disease or alcohol abuse (Strom &
Paranjpye, 2000). Besides host susceptibility, epidemiological data also suggest that only a small
percentage of V. vulnificus strains in oysters are virulent (Cholera and Other Vibrio Illness
Surveillance, 2009; Jackson et al., 1997; Jones & Oliver, 2009; Warner & Oliver, 2008a)
Several virulence factors have been identified in V. vulnificus as reviewed previously
(Gulig et al., 2005; Jones & Oliver, 2009). The expression of a capsular polysaccharide (CPS) is
considered a major virulence factor for V. vulnificus (Chatzidaki-Livanis et al., 2006b; Simpson
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et al., 1987). However, both clinical and environmental isolates are generally encapsulated
(Wright et al., 1996). The frequencies of occurrence of other putative virulence factors, including
lipopolysaccharide (McPherson et al., 1991), flagella (Kim & Rhee, 2003), cytolysin (Gray &
Kreger, 1985), and metalloprotease (Kothary & Kreger, 1987) did not differ between
environmental and clinical V. vulnificus isolates as examined by multiple studies (DePaola et al.,
2003; Gulig et al., 2005; Stelma et al., 1992). Using animal models, studies found that both
clinical and environmental V. vulnificus isolates were virulent to mice (DePaola et al., 2003;
Starks et al., 2000; Stelma et al., 1992; Tison & Kelly, 1986); although one study found that
higher bacterial inoculum was required for environmental isolates to generate identical frequency
and magnitude of infection as clinical ones (Starks et al., 2000). Therefore, there lacks a unique
virulence marker that can be used to screen for virulent V. vulnificus isolates from oysters. One
exception was the siderophores production which was found to differ between a virulent and
weakly virulent V. vulnificus strain (Simpson & Oliver, 1983). Another study also reported a
good correlation between clinical-type V. vulnificus isolates in shellfish and the detection of a
vulnibactin-encoding viuB gene (Panicker et al., 2004b), one of the siderophore genes involved
in iron acquisition (Litwin et al., 1996). However, because the reverse primer used in that study
extended to the viuB downstream intergenic region, technically, the target detected was a viuBassociated fragment, not viuB per se.
Given the lack of unique virulence markers, bacterial genotyping methods have been
used recently to associate certain V. vulnificus genotypes with clinical or environmental type
strains (Chatzidaki-Livanis et al., 2006a; Gordon et al., 2008; Nilsson et al., 2003; Rosche et al.,
2005; Vickery et al., 2007; Warner & Oliver, 2008a; Warner & Oliver, 1999). Firstly, using
random amplified polymorphic DNA (RAPD), a virulence-correlated gene (vcg) was identified
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in V. vulnificus (Warner & Oliver, 1999). Among 55 randomly selected V. vulnificus, 90% of
clinical isolates possessed the vcgC sequence variant and 93% of environmental isolates had the
vcgE sequence variant (Rosche et al., 2005). Secondly, the polymorphic regions (17 bp) of the V.
vulnificus 16S rRNA gene have been explored to differentiate between clinical and
environmental strains (Nilsson et al., 2003; Vickery et al., 2007). Using restriction fragment
length polymorphism (RFLP), a study found that the majority (31 out of 33) of nonclinical V.
vulnificus isolates had 16S rRNA type A, whereas a significant percentage (24 out of 34) of
clinical isolates belonged to 16S rRNA type B (Nilsson et al., 2003). Real-time PCR assays have
since been designed to differentiate the two16S rRNA genotypes (Gordon et al., 2008; Vickery
et al., 2007). Lastly, genetic variations in the V. vulnificus CPS operon have been characterized
and two distinct genotypes termed CPS allele 1 and 2 were identified (Chatzidaki-Livanis et al.,
2006b). A follow-up study analyzing 68 clinical and environmental V. vulnificus isolates
indicated a significant association between clinical isolates and CPS allele 1 whereas
environmental isolates and CPS allele 2 (Chatzidaki-Livanis et al., 2006a). Additionally, that
study also independently evaluated the use of vcg and 16S RNA to differentiate clinical and
environmental types of V. vulnificus isolates. Although significant associations of distinct
genotypes with clinical isolates were confirmed, greater diversity (i.e., lower percentages of
association) than those previously reported was also observed (Chatzidaki-Livanis et al., 2006a).
Therefore, more independent studies are needed to evaluate the usefulness of these biomarkers to
predict clinically important V. vulnificus isolates from environmental sources such as oysters.
We previously recovered 349 V. vulnificus isolates from Louisiana oysters (Han et al.,
2007). The objectives of this study were to determine the distribution of different genotypes
among these V. vulnificus isolates by analyzing the genetic variations in vcg, 16S rRNA, and
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CPS, and the presence/absence of the viuB-associated fragment, and to identify environmental
factors associated with an increased prevalence of clinical-type V. vulnificus isolates in oysters.
Materials and Methods
Bacterial Strains and Culture Conditions. V. vulnificus strains (n = 356) used in this
study included 7 reference strains (Table 4-1) and 349 isolates previously recovered from
Louisiana Gulf and retail oysters (Han et al., 2007). The V. vulnificus isolates from oysters were
recovered using methods described in the Food and Drug Administration Bacteriological
Analytical Manual and PCR was used for confirmation and speciation (Han et al., 2007). The
cultures were stored in Luria-Bertani broth (BD Diagnostic Systems, Sparks, MD) containing
30% glycerol at -80oC. V. vulnificus strains were routinely cultured on trypticase soy agar (BD
Diagnostic Systems) supplemented with 2% NaCl and incubated at 35oC for 24 h.

Table 4 - 1 Vibrio vulnificus reference strains used in this study, their source of isolation, and
genotypic characteristics based on the virulence-correlated gene (vcg), 16S rRNA, capsular
polysaccharide operon (CPS), and the vulnibactin gene (viuB)-associated fragment
V. vulnificus straina Source of isolation
Characteristicsb
16S rRNA
CPS
vcg
viuB
C
E
A
B
1
2
Clinical strains (n = 5)
ATCC 27562
Blood, Florida
+
+
+
+
ATCC 29306
Corneal ulcer, Virginia +
+
+
+
ATCC 33815
Leg ulcer, Wisconsin
+
+
+
+
ATCC 33816
Blood, Alaska
+
+
+
+
1007
Blood, Louisiana
+
+
+
+
Environmental strains (n = 2)
515-4C2
Oyster, California
+
+
+
WR1
Sea water, Washington +
+
a
ATCC, American Type Culture Collection, Manassas, VA.
b
The following genotypes denote clinical-type V. vulnificus: vcgC, 16S rRNA type B, CPS allele
1, and the presence of viuB.
“+” stands for amplificaition of the gene, “-” stands for no amplification of the gene.
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Multilocus PCR Assays. Primer sets used for each locus are listed in Table 4-2. For vcg,
two pairs of primers (a common reverse primer) previously published were utilized, one
targeting the clinical-type V. vulnificus strains and the other one amplifying environmental-type
strains (Rosche et al., 2005). For 16S rRNA, a Taqman real-time PCR assay designed previously
was adopted (Vickery et al., 2007). For CPS, two pairs of primers were designed using the
Primer3 software (http://frodo.wi.mit.edu/), one targeting the hypothetical protein 1 (HP1) in V.
vulnificus MO6-24/O (CPS allele 1) and the other one amplifying the hypothetical protein 2
(HP2) in V. vulnificus YJ106/O (CPS allele 2) (Chatzidaki-Livanis et al., 2006b). For viuBassociated fragment, one pair of primers was used which targeted the viuB gene and downstream
intergenic region, and the amplification of this fragment indicated clinically important V.
vulnificus strains (Panicker et al., 2004a; Panicker et al., 2004b).
Chromosomal DNAs of the V. vulnificus strains were prepared by using a UltraClean
DNA isolation kit (MO BIO Laboratories, Carlsbad, CA). PCR or real-time PCR conditions for
vcg, 16S rRNA, and the viuB fragment followed previously described protocols (Panicker et al.,
2004b; Rosche et al., 2005; Vickery et al., 2007). For CPS, each PCR mix in a total volume of
25 µl consisted of the following: 1 × PCR buffer, 0.2 mM of each deoxynucleotide triphosphate,
1.5 mM of MgCl2, 0.5 unit of Go Taq Hot Start Polymerase (Promega, Madison, WI), 0.2 µM of
each primer (Invitrogen, Carlsbad, CA), and 1 µl of chromosomal DNA template. The PCR
reaction was conducted using 95°C for 5 min followed by 30 cycles of denaturation at 94°C for 1
min, primer annealing at 50°C for 1 min, extension at 72°C for 1 min, and a final extension at
72°C for 7 min in a Bio-Rad C1000 Thermal Cycler (Hercules, CA). PCR products were
analyzed by electrophoresis on 1.5% agarose gel containing ethidium bromide, and visualized
under UV light, and documented by a Gel Doc XR system (Bio-Rad).
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Target
locus
vcg

Genotype
C
E

16S rRNA

Common
A
B

CPS

1
2

Table 4 - 2 PCR primers used to characterize Vibrio vulnificus genotypes
Primer name
Position
GenBank
Sequence (5-3)b
accession no.
P1
AGCTGCCGATAGCGATCT
AY626575
156-173
P3
CGCTTAGGATGATCGGTG
416-433
P2
CTCAATTGACAATGATCT
AY626579
156-173
P3
CGCTTAGGATGATCGGTG
416-433
Vvu16S51-F
CAAGTCGAGCGGCAGCA
X76333 and 51-67
X76334
Vvu16S221-R TCCTGACGCGAGAGGCC
205-221
Vvu16SA-P
6FAM-TGATAGCTTCGGCTCAAX76333
173-189
MGBNFQ
Vvu16SB-P
TET-CCCGTAGGCATCATGCX76334
185-170
MGBNFQ
HP1F
TTTGGGATTTGAAAGGCTTG
DQ360502
2156-2175
HP1R
GTGCCTTTGCGAATTTTGAT
2478-2497
HP2F
TTCCATCAAACATCGCAGAA
NC_005139 125-144
HP2R
CTTTTGTCCGGCTTCTATCG
(VV0338)
257-276
F-viuB
GGTTGGGCACTAAAGGCAGATATA U32676
1729-1752

Amplicon
size (bp)c
278
278

Reference
(Rosche
et
al.,
2005)

171

(Vickery
et
al.,
2007)

342

This
study

152

(Panicker
et
al.,
R-viuB
CGGCAGTGGACTAATACGCAGC
2212-2233
2004a)
a
The following genotypes denote clinical-type V. vulnificus: vcgC, 16S rRNA type B, CPS allele 1, and the presence of viuBassociated fragment.
b
MGBNFQ is minor groove binding non-fluorescent quencher.
c
Differences in amplicon sizes were noted from those originally published after reanalysis of the sequences and primer locations.

viuB
fragment

clinical

a
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Statistical Analysis. The distributions of different genotypes among V. vulnificus oyster
isolates were sorted by the target locus and the month of isolation and analyzed by using oneway analysis of variance (ANOVA) followed by post-hoc multiple comparisons using the Least
Significant Difference (LSD) test (SAS for Windows, version 9; SAS Institute Inc., Cary, NC).
Additionally, differences in the presence of the viuB-associated fragment among clinical-type
(harboring vcgC, 16S rRNA B, CPS allele 1, and the viuB fragment) and environmental-type
(being vcgE, 16S rRNA A, CPS allele 2, and lack the viuB fragment) V. vulnificus isolates as
characterized by different markers (vcg, 16S rRNA, and CPS) were compared by using the Chisquare test. Differences between the mean values were considered significant when P < 0.05.
Results
Distribution of V. vulnificus Genotypic Profiles. Genotypic profiles of the seven V.
vulnificus reference strains are shown in Table 4-1. V. vulnificus genotypes were designated
using a combination of the strains’ vcg type, 16S rRNA type, and CPS allele type following that
order. Among the five V. vulnificus clinical strains, two (ATCC 27562 and ATCC 29306) had
genotype EA2, and the rest (ATCC 33815, ATCC 33816, and 1007) CB1. For the two
environmental strains, 515-4C2 possessed genotype EA2 whereas WR1 had genotype EANone
since no amplification was obtained using either CPS allele 1 or 2 primer sets (Table 4-1).
Table 4-3 shows the distribution of genotypic profiles among 349 V. vulnificus oyster
isolates. Based on the vcg genotypic analysis, the majority (59%) of V. vulnificus oyster isolates
belonged to environmental-type strains (genotype vcgE), and the remainders (41%) were vcgC
genotype which was associated with clinical-type strains. Similarly, there was also a higher
percentage of V. vulnificus oyster isolates possessing environmental-type genotypes than that of
clinical-type ones based on the analysis of the 16S rRNA and CPS loci (Table 4-3). For 16S
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rRNA, there was a small proportion (8%) of the oyster isolates harbored both A and B
genotypes, making it difficult to designate them as clinical- or environmental-type strains (Table
4-3). For CPS, the absence of both allele 1 and 2 indicated that the strain was not encapsulated,
i.e., an environmental-type strain. Therefore, environmental-type strains were 72.5% based on
the CPS analysis, much higher than clinical-type strains (27.5%).

Table 4 - 3 Distributions of genotypic profiles among 349 Vibrio vulnificus oyster isolates based
on genotypic characteristics of three loci (vcg, 16S rRNA, and CPS)
Target locus Clinical-type
Environmental-type
Atypicala
Genotype
No. (%)
Genotype
No. (%)
Genotype
No. (%)
C
143 (41)
E
206 (59)
ND
vcg
16S rRNA
B
141 (40.4) A
180 (51.6) AB
28 (8)
CPS
1
96 (27.5)
2
180 (51.6) ND
None
73 (20.9)
Subtotal
253 (72.5)
All three loci CB1
74 (21.2)
EA2
130 (37.2) CA1
1 (0.3)
EANone
31 (8.9)
CA2
3 (0.9)
Subtotal
161 (46.1) CAB2
1 (0.3)
CABNone 1 (0.3)
CB2
25 (7.2)
CBNone
38 (10.9)
EA1
15 (4.3)
EAB1
6 (1.7)
EAB2
18 (5.2)
EABNone 2 (0.6)
EB2
3 (0.9)
EBNone
1 (0.3)
Subtotal
114 (32.7)
a
ND means not detected.

When combining the three loci, the prevalence of environmental-type V. vulnificus strains
among the 349 oyster isolates was 46.1% compared to 21.2% for clinical-type strains (Table 43). A notable percentage (32.7%) of isolates was atypical with various genotypic combinations
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of the three loci (Table 4-3). Major atypical genotypes include CBNone (38; 10.9%), CB2 (25;
7.2%), EAB2 (18; 5.2%), and EA1 (15; 4.3%).
Prevalence of the viuB-associated Fragment. The presence of the viuB fragment among
the seven V. vulnificus reference strains is also shown in Table 4-1. All five clinical strains
possessed the viuB-associated fragment, whereas neither of the two environmental V. vulnificus
strains was positive for this gene, indicating a good correlation between the presence of the viuB
fragment and the clinical source of the strains as well as the absence of this gene and the
environmental source of the strains.
Among 349 V. vulnificus oyster isolates, the majority (59%) showed no amplification of
the viuB fragment. The association between environmental and clinical genotypes based on
analysis of each of the three loci (vcg, 16S rRNA, and CPS) and the presence/absence of the viuB
fragment is presented in Table 4-4. Based on either vcg or 16S rRNA analysis, over 75% of
isolates assigned to the clinical-type V. vulnificus strains had the viuB fragment, whereas
between 83-85% of the environmental-type strains lacked this fragment. For isolates assigned to
be clinical-type strains based on the CPS analysis, 63.5% of them were viuB-associated fragment
positive, while only 32.4% of environmental-type isolates based on CPS were viuB-associated
fragment positive (Table 4-4). Statistical analysis indicated significantly higher percentages of
clinical-type strains than environmental ones possessed the viuB fragment regardless of which
genotyping analysis was used to assign the clinical- or environmental-type strains (P < 0.0001).
Prediction of Clinically Important V. vulnificus. Predictions were made using various
combinations of the four biomarkers: vcg type, 16S rRNA type, CPS allele type, and the
presence/absence of the viuB-associated fragment. When all four biomarkers were used, three out
of five V. vulnificus reference strains from clinical sources were shown to be clinically important
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because of having CA1 genotype and possessing viuB-associated fragment, whereas none of the
two environmental strains was presumed to be clinically important due to possessing EA2 or
EAnone genotype and lacking the viuB fragment.

Table 4 - 4 Associations between environmental and clinical Vibrio vulnificus genotypes based
on analysis of each of the three loci (vcg, 16S rRNA, and CPS) and the presence/absence of the
viuB-associated fragment among 349 V. vulnificus oyster isolates
Target
Number (percentage) of V. vulnificus isolates with the presence or absence of the viuBlocusa
associated fragment among all isolates of
Clinical-type
Environmental-type
Genotype No. Present
Absent
Genotype No. Present
Absent
C
143 108 (75.5) 35 (24.5)
E
206 35 (17)
171 (83)
vcg
16S rRNA B
141 107 (75.9) 34 (24.1)
A
180 27 (15)
153 (85)
CPS
1
96
61 (63.5)
35 (36.5)
2
180 49 (27.2)
131 (72.8)
None
73
33 (45.2)
40 (54.8)
Subtotal
253 82 (32.4)
171 (67.6)
a
Due to the presence of atypical isolates based on the 16S rRNA gene analysis, the total number
of isolates did not add up to 349 for the 16S rRNA row.

Table 4-5 shows predictions of clinically important V. vulnificus isolates from the oyster
samples based on various combinations of the biomarkers used. When using all four biomarkers,
16.3% (57/349) of isolates were predicted to be clinically important due to harboring vcgC, 16S
rRNA B, CPS allele 1, and the viuB fragment. When three biomarkers were used, the predicted
percentages of clinical-type V. vulnificus strains ranged between 16.3% and 30.7%. When only
two biomarkers were used, the range became 17.5-39.3% for clinically important V. vulnificus
strains. Regardless of two or three biomarkers were used, combinations including vcg and 16S
rRNA gave higher percentages of clinically important V. vulnificus isolates whereas
combinations including CPS gave lower percentages. Furthermore, agreements in assigning
clinical or environmental type V. vulnificus strains based on all the biomarkers used in each
combination are presented in Table 4-5. Not surprisingly, the agreement was the lowest when all
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four biomarkers were used (55.3%), and among combinations involving two biomarkers, the
highest agreement was found in the vcg/16S rRNA combination (89.7%) whereas the lowest one
CPS/viuB (66.5%). When three markers were used, the highest agreement was found for vcg/16S
rRNA/viuB (73.6%) and the lowest for 16S rRNA/CPS/viuB (56.2%).

Table 4 - 5 Predictions of clinically important Vibrio vulnificus isolates from Louisiana oysters
based on various combinations of the four biomarkers used in this study
Biomarker combinationa Clinical-type
Environmental-type
Agreement
b
(%)
Genotype No. (%)
Genotype
No. (%)
vcg/16S rRNA/CPS/viuB CB1Yes 57 (16.3)
EA2No or EANoneNo 136 (39)
193 (55.3)
vcg/16S rRNA/CPS
CB1
74 (21.2)
EA2 or EANone
161 (46.1) 235 (67.3)
vcg/16S rRNA/viuB
CBYes
107 (30.7) EANo
150 (43)
257 (73.6)
vcg/CPS/viuB
C1Yes
58 (16.6)
E2No or ENoneNo
153 (43.8) 211 (60.5)
16S rRNA/CPS/viuB
B1Yes
57 (16.3)
A2No or ANoneNo
139 (39.8) 196 (56.2)
vcg/16S rRNA
CB
137 (39.3) EA
176 (50.4) 313 (89.7)
vcg/CPS
C1
75 (21.5)
E2 or ENone
185 (53)
260 (74.5)
vcg/viuB
CYes
108 (30.9) ENo
171 (49)
279 (80)
16S rRNA/CPS
B1
74 (21.2)
A2 or ANone
164 (47)
238 (68.2)
16S rRNA/viuB
BYes
107 (30.7) ANo
153 (43.8) 260 (74.5)
CPS/viuB
1Yes
61
2No or NoneNo
171 (49)
232 (66.5)
(17.5)
a
Due to the presence of atypical genotypes, the total number of isolates did not add up to be 349.
b
Percent agreement was calculated by using the total number of isolates assigned to either
clinical or environmental-type V. vulnificus strains by all the biomarkers used in each
combination divided by 349.
Seasonal Distribution of Clinical-type V. vulnificus. Figure 4-1 presents the ratios of
clinical-type and environmental-type Vibrio vulnificus oyster isolates by the month of isolation.
An apparent seasonal pattern where warmer months were associated with more clinical-type V.
vulnificus oyster isolates was observed when analyzing using vcg, 16S rRNA, CPS, and the viuBassociated fragment individually (Fig. A-D). A combination of the four markers analysis also
indicated a similar seasonal distribution (Fig. E), and clinical-type strains had the highest
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percentage in September followed by August, July, and June, whereas absent from May and
April isolates (P < 0.05).

Figure 4 - 1 Ratios of clinical-type and environmental-type of Vibrio vulnificus oyster isolates by
the month of isolation when analyzed by vcg (A), 16S rRNA (B), CPS (C), viuB-associated
fragment (D), and a combination of all four markers (E).
The solid bars at the bottom indicate percentages of clinical-type strains (vcgC, 16S rRNA type
B, CPS allele 1, and the presence of viuB fragment) and the croass-hatch bars indicate
percentages of environmental-type strains. Due to the presence of strains with atypical genotypes
by 16S rRNA and combinations of all four biomarkers, the total percentages for some months
did not add up to be 100% in B and E.
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Discussion
The apparent discrepancy between human exposure to V. vulnificus through oyster
consumption and the annual number of illness/deaths resulted have prompted many investigators
to examine the virulence potential of V. vulnificus isolates from oysters and to investigate tools
that could be used to differentiate clinical-type V. vulnificus strains from environmental-type
ones (Aznar et al., 1994; DePaola et al., 2003; Gordon et al., 2008; Jones & Oliver, 2009;
Nilsson et al., 2003; Panicker et al., 2004b; Rosche et al., 2005; Sanjuan et al., 2009; Vickery et
al., 2007; Warner & Oliver, 2008b; Warner & Oliver, 1999). In the present study, we evaluated
356 V. vulnificus strains including 7 reference strains and 349 oyster isolates using four
biomarkers, vcg, 16S rRNA, CPS, and viuB. This is the first study that combinations of these
four biomarkers were used to independently evaluate their usefulness in predicting clinically
important V. vulnificus isolates from oysters.
Genotypic analysis of three biomarkers (vcg, 16S rRNA, and CPS) indicated that the
majority of 349 V. vulnificus oyster isolates belonged to environmental-type strains, i.e., vcgE,
16S rRNA type A, and capsule allele 2 or absent, although the actual percentages of
environmental-type strains differed dependent upon the biomarkers examined, ranging from
51.6% for 16S rRNA (type A) and 72.5% for the capsular polysaccharide operon (allele 2 or
absent). Very few studies have examined V. vulnificus populations from natural oyster or
seawater by using these markers. One study characterized vcg genotypes among V. vulnificus
oyster and seawater isolates recovered from the eastern coast of North Carolina and found that
84.4% of the 880 oyster isolates had the vcgE type, whereas an almost equal distribution of the
two vcg genotypes (46.9% vcgE versus 53.1% vcgC) was found among 292 seawater isolates
(Warner & Oliver, 2008a). Another study using SYBR-based real-time PCR to detect and
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differentiate 16S rRNA A and B types showed that the ratio of A: B was 5:8 (A type 38.5%; n =
26) from oysters in poor water quality while for oysters in good water quality, the ratio was 10:1
(A type 90.9%; n = 22) (Gordon et al., 2008). In our study, the percentages of oyster isolates
possessing vcgE and 16S rRNA A genotypes were 59% and 51.6%, respectively, which may be
partly explained by the different geographical regions and seasons involved in sampling. On the
other hand, when using the three biomarkers to analyze seven reference strains with known
source of isolation in this study, two out of five clinical strains showed environmental-type
characteristics (vcgE, 16S rRNA type A, and CPS allele 2) by all three markers (Table 4-1). This
finding is not surprising as indicated by multiple previous studies using larger collections of V.
vulnificus strains, although significant associations between clinical strains and vcgC, 16S rRNA
type B, or CPS allele 1 were observed, small percentages of clinical isolates did fall into the
opposite genotypes, i.e., EA2 (Chatzidaki-Livanis et al., 2006a; Nilsson et al., 2003; Rosche et
al., 2005). Such findings highlight the drawbacks associated with assigning clinical or
environmental-type V. vulnificus strains based on genotyping studies, rather than based on the
presence or absence of a unique virulence marker.
Interestingly, analyzing the 349 oyster isolates by 16S rRNA real-time PCR indicated
approximately 8% of the isolates had both A and B types, which confirmed findings from
previous studies that the two 16S rRNA sequence variants could be present simultaneously
within a single V. vulnificus strain (Chatzidaki-Livanis et al., 2006b; Vickery et al., 2007). Type
AB strains have been sequenced previously and data suggested that in the genome of most
strains, there were more copies of the type A gene present than that of type B (Vickery et al.,
2007). Nonetheless, the presence of 16S rRNA AB type made it difficult to designate those
strains as either clinical- or environmental-type strains, which was not a desirable feature when
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genotyping was conducted primarily to differentiate clinical-type V. vulnificus strains from
environmental-type ones.
In contrast to the above mentioned three biomarkers, especially vcg and 16S rRNA, viuB
has not been used widely to differentiate clinical and environmental-type V. vulnificus strains.
Among the seven reference strains used in the study, a 100% correlation between the presence or
absence of the viuB-associated fragment with strains from clinical or environmental sources,
respectively was found, similar to those reported previously (Panicker et al., 2004b). Such
findings suggested that the viuB fragment could be used as a promising biomarker to identify V.
vulnificus environmental or food isolates with clinical potentials, although further studies
examining a large collection of V. vulnificus strains with known clinical or environmental
sources coupled with mouse bioassays would be necessary to confirm this possibility.
Among the 349 V. vulnificus oyster isolates examined in this study, approximately 41%
showed amplification of the viuB fragment. A previous study examining the prevalence of viuB
among natural oyster samples reported 5 out of 33 (15%) V. vulnificus-positive oyster samples
contained viuB (Panicker et al., 2004b). Again, different regions and seasons of oyster sample
collection may explain the difference in the prevalence of viuB fragment observed. It is
noteworthy that when combining viuB analysis with three marker genotyping data, our data
showed that over 75% of clinical-type strains assigned by vcg and 16S rRNA possessed the viuBassociated fragment whereas approximately 83% of environmental-type strains lacked this
fragment (Table 4-4). Such significant association (P < 0.0001) further suggested the potential
usefulness of the viuB-associated fragment as a biomarker for identifying clinical-type V.
vulnificus strains.
Based on the agreement analysis, among the four biomarkers used in this study, the best
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agreement was found between vcg and 16S rRNA (Table 4-5). Additionally, our data indicated
that CPS tended to give lower estimate of potentially clinical important V. vulnificus strains
compared to vcg, 16S rRNA, or viuB. However, findings based on a single study are not
conclusive and future studies involving a large collection of V. vulnificus strains would be
needed to better assess the usefulness of these biomarkers in predicting clinically important V.
vulnificus strains from oysters or the environment. Nonetheless, the fact that there were many
atypical strains when combinations of biomarkers were used suggest that fundamentally it is
difficult to appropriately assign clinical or environmental types to these V. vulnificus strains.
Interestingly, a seasonal presence of clinical-type V. vulnificus among oyster isolates was
observed, corroborating findings from previous studies (Panicker et al., 2004b; Warner & Oliver,
2008a). Such finding is alarming, as it is well established that V. vulnificus resides in high
numbers (103 to 104 per gram) in oysters during summer months and temperature is a major
parameter that strongly correlates with V. vulnificus density (Randa et al., 2004; Wright et al.,
1996). Therefore, future control measures need to target more specifically on seasons that tend to
accumulate high-density clinical-type V. vulnificus.
Finally, besides markers examined in this study, other markers such as vvhA (encodes V.
vunificus hemolysin) has been used for the similar purpose. In a very recent study evaluating
multiple genotypic (ribotyping, DNA polymorphism at vcg, 16S rRNA, and vvhA) and
phenotypic (API 20E, API 20 NE, and BIOLOG) methods to distinguish clinical from
environmental V. vulnificus strains, the authors concluded that profile 1 strains were vcgC, 16S
rRNA B, and vvhA type 1, and included most (75%) of the biotype 1 human septicemic isolates
from blood (Sanjuan et al., 2009). In contrast to our findings, 75% of oyster isolates also
belonged to profile 1, suggesting of clinical-type strains. It is noteworthy that the isolates used in
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that study were collected from multiple continents over extended time periods, and may not
represent isolates typical in the United States Gulf region. Our findings, although supported the
usefulness of utilizing biomarkers in characterizing V. vulnificus strains, also highlighted the
drawbacks of using biomarker genotypes to predict V. vulnificus strain virulence and called for
more virulence mechanism studies to identify unique virulence markers in this organism to be
used as unequivocal ways to screen for virulent V. vulnificus strains from oysters or the
environment.
Conclusion
In this study, we used multiple biomarkers to characterize 349 V. vulnificus oyster
isolates previously isolated from Louisiana oysters. The majority of V. vulnificus isolates were of
environmental type, and there existed a seasonal variation in the V. vulnificus genotypes
identified, which may have important implications for future control measures. Among the
biomarkers used, vcg and 16S rRNA had the best agreement, whereas using all four biomarkers
was the most discriminatory typing method. However, predicting V. vulnificus strain virulence
using biomarker genotyping had drawbacks and unique virulence markers in this organism
would be necessary to facilitate future screening of virulent V. vulnificus strains from oysters or
the environment.
References
Aznar, R., Ludwig, W., Amann, R. I. & Schleifer, K. H. (1994). Sequence determination of
rRNA genes of pathogenic Vibrio species and whole-cell identification of Vibrio vulnificus with
rRNA-targeted oligonucleotide probes. Int J Syst Bacteriol 44, 330-337.
Blake, P. A., Merson, M. H., Weaver, R. E., Hollis, D. G. & Heublein, P. C. (1979). Disease
caused by a marine Vibrio. Clinical characteristics and epidemiology. N Engl J Med 300, 1-5.
Chatzidaki-Livanis, M., Hubbard, M. A., Gordon, K., Harwood, V. J. & Wright, A. C.
(2006a). Genetic distinctions among clinical and environmental strains of Vibrio vulnificus. Appl
Environ Microbiol 72, 6136-6141.

69

Chatzidaki-Livanis, M., Jones, M. K. & Wright, A. C. (2006b). Genetic variation in the
Vibrio vulnificus group 1 capsular polysaccharide operon. Journal of bacteriology 188, 19871998.
Cholera and Other Vibrio Illness Surveillance (2009).Summary of human Vibrio isolates
reported
to
CDC
2007.
Available
at
http://www.cdc.gov/nationalsurveillance/PDFs/CSTEVibrio2007.pdf. Accessed on April 28,
2010.
DePaola, A., Nordstrom, J. L., Dalsgaard, A., Forslund, A., Oliver, J., Bates, T., Bourdage,
K. L. & Gulig, P. A. (2003). Analysis of Vibrio vulnificus from market oysters and septicemia
cases for virulence markers. Appl Environ Microbiol 69, 4006-4011.
Gordon, K. V., Vickery, M. C., DePaola, A., Staley, C. & Harwood, V. J. (2008). Real-time
PCR assays for quantification and differentiation of Vibrio vulnificus strains in oysters and water.
Appl Environ Microbiol 74, 1704-1709.
Gray, L. D. & Kreger, A. S. (1985). Purification and characterization of an extracellular
cytolysin produced by Vibrio vulnificus. Infect Immun 48, 62-72.
Gulig, P. A., Bourdage, K. L. & Starks, A. M. (2005). Molecular Pathogenesis of Vibrio
vulnificus. Journal of microbiology (Seoul, Korea) 43 Spec No, 118-131.
Han, F., Walker, R. D., Janes, M. E., Prinyawiwatkul, W. & Ge, B. (2007). Antimicrobial
susceptibilities of Vibrio parahaemolyticus and Vibrio vulnificus isolates from Louisiana Gulf
and retail raw oysters. Appl Environ Microbiol 73, 7096-7098.
Jackson, J. K., Murphree, R. L. & Tamplin, M. L. (1997). Evidence that mortality from
Vibrio vulnificus infection results from single strains among heterogeneous populations in
shellfish. J Clin Microbiol 35, 2098-2101.
Jones, M. K. & Oliver, J. D. (2009). Vibrio vulnificus: disease and pathogenesis. Infect Immun
77, 1723-1733.
Kim, Y. R. & Rhee, J. H. (2003). Flagellar basal body flg operon as a virulence determinant of
Vibrio vulnificus. Biochem Biophys Res Commun 304, 405-410.
Kothary, M. H. & Kreger, A. S. (1987). Purification and characterization of an elastolytic
protease of Vibrio vulnificus. Journal of general microbiology 133, 1783-1791.
Litwin, C. M., Rayback, T. W. & Skinner, J. (1996). Role of catechol siderophore synthesis in
Vibrio vulnificus virulence. Infect Immun 64, 2834-2838.
McPherson, V. L., Watts, J. A., Simpson, L. M. & Oliver, J. D. (1991). Physiological effects
of the lipopolysaccharide of Vibrio vulnificus on mice and rats. Microbios 67, 141-149.

70

Morris, J. G., Jr. (1988). Vibrio vulnificus--a new monster of the deep? Ann Intern Med 109,
261-263.
Nilsson, W. B., Paranjype, R. N., DePaola, A. & Strom, M. S. (2003). Sequence
polymorphism of the 16S rRNA gene of Vibrio vulnificus is a possible indicator of strain
virulence. J Clin Microbiol 41, 442-446.
Oliver, J. D. (2006). Vibrio vulnificus, p. 349-366. Edited by F. L. Thompson, B. Austin, and J.
Swings (ed.), The biology of vibrios. Washitonton, DC: ASM press.
Panicker, G., Call, D. R., Krug, M. J. & Bej, A. K. (2004a). Detection of pathogenic Vibrio
spp. in shellfish by using multiplex PCR and DNA microarrays. Appl Environ Microbiol 70,
7436-7444.
Panicker, G., Vickery, M. C. & Bej, A. K. (2004b). Multiplex PCR detection of clinical and
environmental strains of Vibrio vulnificus in shellfish. Can J Microbiol 50, 911-922.
Randa, M. A., Polz, M. F. & Lim, E. (2004). Effects of temperature and salinity on Vibrio
vulnificus population dynamics as assessed by quantitative PCR. Appl Environ Microbiol 70,
5469-5476.
Rosche, T. M., Yano, Y. & Oliver, J. D. (2005). A rapid and simple PCR analysis indicates
there are two subgroups of Vibrio vulnificus which correlate with clinical or environmental
isolation. Microbiol Immunol 49, 381-389.
Sanjuan, E., Fouz, B., Oliver, J. D. & Amaro, C. (2009). Evaluation of genotypic and
phenotypic methods to distinguish clinical from environmental Vibrio vulnificus strains. Appl
Environ Microbiol 75, 1604-1613.
Simpson, L. M. & Oliver, J. D. (1983). Siderophore production by Vibrio vulnificus. Infect
Immun 41, 644-649.
Simpson, L. M., White, V. K., Zane, S. F. & Oliver, J. D. (1987). Correlation between
virulence and colony morphology in Vibrio vulnificus. Infect Immun 55, 269-272.
Starks, A. M., Schoeb, T. R., Tamplin, M. L., Parveen, S., Doyle, T. J., Bomeisl, P. E.,
Escudero, G. M. & Gulig, P. A. (2000). Pathogenesis of infection by clinical and environmental
strains of Vibrio vulnificus in iron-dextran-treated mice. Infect Immun 68, 5785-5793.
Stelma, G. N., Jr., Reyes, A. L., Peeler, J. T., Johnson, C. H. & Spaulding, P. L. (1992).
Virulence characteristics of clinical and environmental isolates of Vibrio vulnificus. Appl
Environ Microbiol 58, 2776-2782.
Strom, M. S. & Paranjpye, R. N. (2000). Epidemiology and pathogenesis of Vibrio vulnificus.
Microbes Infect 2, 177-188.

71

Tacket, C. O., Barrett, T. J., Mann, J. M., Roberts, M. A. & Blake, P. A. (1984). Wound
infections caused by Vibrio vulnificus, a marine vibrio, in inland areas of the United States. J
Clin Microbiol 19, 197-199.
Tison, D. L. & Kelly, M. T. (1986). Virulence of Vibrio vulnificus strains from marine
environments. Appl Environ Microbiol 51, 1004-1006.
Vickery, M. C., Nilsson, W. B., Strom, M. S., Nordstrom, J. L. & DePaola, A. (2007). A realtime PCR assay for the rapid determination of 16S rRNA genotype in Vibrio vulnificus. J
Microbiol Methods 68, 376-384.
Warner, E. & Oliver, J. D. (2008a). Population structures of two genotypes of Vibrio vulnificus
in oysters (Crassostrea virginica) and seawater. Appl Environ Microbiol 74, 80-85.
Warner, E. B. & Oliver, J. D. (2008b). Multiplex PCR assay for detection and simultaneous
differentiation of genotypes of Vibrio vulnificus biotype 1. Foodborne Pathog Dis 5, 691-693.
Warner, J. M. & Oliver, J. D. (1999). Randomly amplified polymorphic DNA analysis of
clinical and environmental isolates of Vibrio vulnificus and other vibrio species. Appl Environ
Microbiol 65, 1141-1144.
Wright, A. C., Hill, R. T., Johnson, J. A., Roghman, M. C., Colwell, R. R. & Morris, J. G.,
Jr. (1996). Distribution of Vibrio vulnificus in the Chesapeake Bay. Appl Environ Microbiol 62,
717-724.

72

Part II: Multiplex PCR Assays for Simultaneous Detection and Characterization of Vibrio
vulnificus Strains

Reprint by permission of “Letters in Applied Microbiology” (see appendix for permission from
publisher)
Citation: Han, F. and B. Ge. 2010. Multiplex PCR assays for simultaneous detection and
characterization of Vibrio vulnificus strains. Letters in Applied Microbiology (in press)

73

Introduction
Vibrio vulnificus, a Gram-negative halophilic bacterium, is a natural inhabitant of the
estuarine and coastal waters worldwide (Oliver, 2006). This organism is capable of causing fatal
illness such as primary septicemia and wound infection, especially among immunocompromised
persons and those with increased serum iron level due to diabetes or chronic liver disease (Strom
& Paranjpye, 2000). In the United States, V. vulnificus is responsible for over 95% of seafoodrelated deaths (Oliver, 2006). One major source of V. vulnificus infection is the consumption of
raw or undercooked seafood, particularly oysters (Cholera and Other Vibrio Illness Surveillance,
2009). To better control V. vulnificus risks in oysters, rapid and specific detection methods are
imperative, especially if information on the virulence potential of the strain could be obtained
simultaneously.
A number of molecular-based detection methods, primarily PCR and real-time PCR
targeting the V. vulnificus cytolysin/hemolysin gene (vvhA) have been descried (Coleman et al.,
1996; Hill et al., 1991; Panicker & Bej, 2005; Wright et al., 2007). Although widely used and
highly specific to V. vulnificus, this species-specific gene is not capable of predicating the
virulence potential of V. vulnificus strains. Given that unique virulence markers, which present
exclusively in virulent V. vulnificus strains have not been identified (Han et al., 2009), alternative
strategies are sought. Recently, several biomarkers have been explored to differentiate virulent(i.e., clinical-) from non-virulent- (i.e., environmental-) type V. vulnificus strains with varied
degree of success. The first biomarker is the virulence-correlated gene (vcg), which was
identified using randomly amplified polymorphic DNA (Warner & Oliver, 1999). A follow-up
study showed that 90% of clinical strains had the vcgC sequence variant whereas 93% of
environmental isolates possessed the vcgE sequence variant (Rosche et al., 2005). Secondly,
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polymorphism in 17 nucleotides of the V. vulnificus 16S rRNA gene was used to differentiate
clinical- from environmental-type strains using restriction fragment length polymorphism
(Nilsson et al., 2003). By real-time PCR, the majority of clinical isolates were determined to be
16S rRNA type B, while most environmental strains belonged to 16S rRNA type A (Gordon et
al., 2008; Vickery et al., 2007). Thirdly, the capsular polysaccharide (CPS) operon was
examined and significant associations were identified between clinical isolates and CPS allele 1,
as well as between environmental isolates and CPS allele 2 (Chatzidaki-Livanis et al., 2006a;
Chatzidaki-Livanis et al., 2006b). Therefore, it now seems technically feasible to design
molecular detection assays that specifically target polymorphic regions of these biomarkers to
differentiate virulent- from non-virulent-type V. vulnificus strains.
In most studies using biomarkers to differentiate V. vulnificus strains, single PCR or realtime PCR assays have been used. Frequently, two PCR reactions were needed for one biomarker
and a high-fidelity DNA polymerase was required (Chatzidaki-Livanis et al., 2006a; Rosche et
al., 2005; Sanjuan et al., 2009), rending the process both labor-intensive and costly. In addition,
species detection and strain characterization were commonly done in sequential steps, rather than
simultaneously. Recently, a multiplex PCR assay was developed which targeted vcgC, vcgE, and
vvhA, that allowed for both species-level identification and determination of the vcg genotype
(Warner & Oliver, 2008b). Nonetheless, only one biomarker was targeted in this multiplex PCR
and several studies have pointed out the benefit of using multiple biomarkers in characterizing V.
vulnificus strains (Han et al., 2009; Sanjuan et al., 2009).
The objective of this study was to develop multiplex PCR assays that targeted vvhA and a
combination of several potential virulence biomarkers (vcg, 16S rRNA, and CPS) to
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simultaneously detect and characterize V. vulnificus strains, either virulent type or non-virulent
type.
Materials and Methods
Bacterial Strains and Culture Conditions. V. vulnificus strains (n = 90) used in this
study included 10 reference strains (Table 4-6) and 80 isolates (Table 4-7) previously recovered
from Louisiana Gulf and retail oysters (Han et al., 2007). The strains were confirmed using the
vvhA-PCR (Kaysner & DePaola, 2001) and characterized by single PCR or real-time PCR for the
three biomarkers, vcg, 16S rRNA, and CPS (Han et al., 2009). The cultures were stored in LuriaBertani broth (BD Diagnostic Systems, Sparks, MD) containing 30% glycerol at -80oC. V.
vulnificus strains were routinely cultured on trypticase soy agar (BD Diagnostic Systems)
supplemented with 2% NaCl and incubated at 35oC for 24 h.
Multiplex PCR Assays. PCR primers used for each biomarker are listed in Table 4-8.
Two pairs of multiplex PCR assays were developed, with one pair targeted four genes (vcg, 16S
rRNA, CPS and vvhA) and the other pair three genes (vcg, 16S rRNA, and vvhA). For virulenttype V. vulnificus assays, a combination of vcgC, 16S rRNA type B, CPS allele 1, and vvhA was
used, whereas for non-virulent-type assays, a combination of vcgE, 16S rRNA type A, CPS allele
2, and vvhA was used. Two sets of vcgC primers were used, one in the 4-target virulent-type
multiplex PCR and the other one in 3-target virulent-type multiplex PCR, amplifying PCR bands
of 99 bp and 278 bp, respectively (Table 4-8).
V. vulnificus genomic DNAs were prepared by using an UltraClean Microbial DNA
Isolation kit (MO BIO Laboratories, Carlsbad, CA). Each prototype PCR mix in a total volume
of 25 µl consisted of the following: 1 × PCR buffer, 0.2 mM of each deoxynucleotide
triphosphate (dNTP), 1.5 mM of MgCl2, 0.5 U of GoTaq Hot Start polymerase (Promega,
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Madison, WI), 0.2 µM of each primer (Invitrogen, Carlsbad, CA), and 1 µl of genomic DNA
template. The PCR reaction was conducted using 95°C for 5 min followed by 30 cycles of
denaturation at 94°C for 1 min, primer annealing at 50°C for 1 min, extension at 72°C for 1 min,
and a final extension at 72°C for 7 min in a Bio-Rad C1000 Thermal Cycler (Hercules, CA).
PCR products were analyzed by electrophoresis on 1.5% agarose gel containing ethidium
bromide, visualized under UV light, and documented by a Gel Doc XR system (Bio-Rad).
Optimization of Multiplex PCR Assays. Annealing temperature (50 to 70oC in 2oC
increments) and primer concentration (0.1 to 0.8 M in 0.1 M increments and one pair at a time)
were optimized. Annealing temperature was decreased when the bands intensity was too low,
and increased when it was too high. In contrast, primer concentration was increased when the
corresponding band intensity was too low, and decreased it was too high. V. vulnificus ATCC
33815 was used for optimizing the 4-target or 3-target virulent-type multiplex PCR assays
whereas V. vulnificus 515-4C2 for non-virulent-type assays. Each optimization experiment was
repeated twice.
Specificity of Multiplex PCR Assays. Ten V. vulnificus reference strains and eighty V.
vulnificus oyster isolates with known strain characteristics for the three biomarker genes (Han et
al., 2009) were used. False positive and false negative rates, if any, were calculated by using the
numbers of false positive or false negative strains divided by respective negative or positive
strains included in the testing.
Results
Effect of Annealing Temperature on Multiplex PCR. To allow for high-efficiency
PCR amplifications of all of the target genes, the annealing temperature was optimized in 2oC
increments and repeated twice.
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Table 4 - 6 Ten Vibrio vulnificus reference strains used for multiplex PCR
Source and origin
Characteristics of
Multiplex PCR results
V. vulnificus
target geneb
strain IDa
virulent-type
non-virulent-type
16S
CPS vcgC 16S B CPS 1 vvhA vcgE 16S A CPS 2 vvhA
vcg
ATCC 27562 Blood, Florida
E
A
2
+
+
+
+
+
ATCC 29306 Corneal ulcer, Virginia
E
A
2
+
+
+
+
+
ATCC 33815 Leg ulcer, Wisconsin
C
B
1
+
+
+
+
+
ATCC 33816 Blood, Alaska
C
B
1
+
+
+
+
+
1003
Wound, Louisiana
C
B
1
+
+
+
+
+
1004
Stool, Louisiana
C
B
1
+
+
+
+
+
1006
Blood, Louisiana
C
B
2
+
+
+
+
+
1007
Blood, Louisiana
C
B
1
+
+
+
+
+
WR1
Seawater, Washington
E
A
none
+
+
+
+
515-4C2
Oyster, California
E
A
2
+
+
+
+
+
a
ATCC, American Type Culture Collection, Manassas, VA.
b
Obtained using single PCR methods described in our previous study (Han et al., 2009). The 16S was a short form of 16S rRNA.
“+” stands for amplificaition of the gene, “-” stands for no amplification of the gene.
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Table 4 - 7 Vibrio vulnificus oyster isolates used in the specificity test of multiplex PCR
No.
Characteristics of target
Multiplex PCR results
V. vulnificus strain type and IDa
genea
virulent-type
non-virulent-type
16S
CPS
vcg
vcgC 16S B CPS 1 vvhA vcgE 16S A CPS 2 vvhA
Virulent-type
19
C
B
1
+
+
+
+
+
V332, V358, V360, V363, V388,
C
B
1
+
+
+
+
+
V419, V443, V444, V469, V499,
V501, V504, V513, V534, V544,
V545, V560, V601, V616
Non-virulent-type
34
E
A
2 or none
+
+
+
varies
+
V209, V213, V225, V240, V242, 24
E
A
2
+
+
+
+
+
V248, V252, V261, V280, V292,
V324, V327, V333, V350, V372,
V381, V383, V392, V416, V471,
V484, V546, V574, V631
V223, V238, V260, V274, V299, 10
E
A
None
+
+
+
+
V304, V308, V354, V364, V477
Atypical
27
varies
varies
V246
1
C
A
1
+
+
+
+
+
V241, V457
2
C
A
2
+
+
+
+
+
V214
1
C
AB
2
+
+
+
+
+
+
V414
1
C
AB
None
+
+
+
+
+
V371, V385, V389, V447
4
C
B
2
+
+
+
+
+
V377, V465, V552, V576
4
C
B
None
+
+
+
+
V239, V297, V387, V438, V490
5
E
A
1
+
+
+
+
+
V337, V598
2
E
AB
1
+
+
+
+
+
+
V328, V584
2
E
AB
2
+
+
+
+
+
+
V470, V474
2
E
AB
None
+
+
+
+
+
V432, V433
2
E
B
2
+
+
+
+
+
V606
1
E
B
None
+
+
+
+
a
Obtained using single PCR methods described in our previous study (Han et al., 2009). The 16S was a short form of 16S rRNA.
“+” stands for amplificaition of the gene, “-” stands for no amplification of the gene.
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Table 4 - 8 Multiplex PCR primers to simultaneously detect and characterize Vibrio vulnificus strains
Target
Primer
Sequence (5′-3′)
GenBank
Position
Amplicon
Reference
gene
name
accession no.
size (bp)
Vvh-785F
CCGCGGTACAGGTTGGCGCA
M34670
785-804
519
(Kaysner
&
vvhA
DePaola, 2001)
Vvh-1303R CGCCACCCACTTTCGGGCC
1285-1303
b
a
Virulent
vcgC F
AGCTGCCGATAGCGATCT
AY626575
156-173
99
(Warner
&
vcgC
Oliver, 2008b)
vcgC R
TGAGCTAACGCGAGTAGTGAG
234-254
P1
AGCTGCCGATAGCGATCT
156-173
278
(Rosche et al.,
2005)
P3
CGCTTAGGATGATCGGTG
416-433
16S B
B F1
GCCTACGGGCCAAAGAGG
X76334
177-194
839
(Warner
&
Oliver,
2008a)
B R1
CCTGCGTCTCCGCTGGCT
998-1015
CPS 1
HP1F
TTTGGGATTTGAAAGGCTTG
DQ360502
2156-2175 342
(Han et al.,
2009)
HP1R
GTGCCTTTGCGAATTTTGAT
2478-2497
NonP2
CTCAATTGACAATGATCT
AY626579
156-173
278
(Rosche et al.,
vcgE
virulent
2005)
P3
CGCTTAGGATGATCGGTG
416-433
16S A
A F2
AGCTTCGGCTCAAAGAGG
X76333
177-194
839
This study
A R2
CCAGCGTCTCCGCTAGAT
998-1015
CPS 2
HP2F
TTCCATCAAACATCGCAGAA
NC_005139 125-144
152
(Han et al.,
(VV0338)
2009)
HP2R
CTTTTGTCCGGCTTCTATCG
257-276
a
Two sets of vcgC primers were used in this study, i.e., vcgC F/vcgC R and P1/P3 for the 4-target and 3-target virulent-type multiplex
PCR, respectively.
b
In the original paper, 97 bp was used.
Assay
type
Both
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The optimized annealing temperature for 4-target multiplex PCR assays was 56oC for
virulent-type V. vulnificus and 50oC for non-virulent-type V. vulnificus. After excluding CPS, the
optimized annealing temperature for 3-target multiplex PCR assays was 60oC for virulent-type V.
vulnificus and 50oC for non-virulent-type V. vulnificus.

Figure 4 - 2 An agarose gel showing multiplex PCR amplification products using typical
virulent- and non-virulent-type Vibrio vulnificus strains.
Lanes 1, 10, 19: molecular weight marker (New England Biolabs, Ipswich, MA); lanes 2-5,
obtained using 3-target multiplex PCR (60oC annealing temperature) for virulent-type V.
vulnificus; lanes 6-9, using 3-target multiplex PCR (50oC annealing temperature) for nonvirulent-type V. vulnificus; lanes 11-14, using 4-target multiplex PCR (56oC annealing
temperature) for virulent-type V. vulnificus; lanes 15-18, using 4-target multiplex PCR (50oC
annealing temperature) for non-virulent-type V. vulnificus. DNA templates used for multiplex
PCR amplifications: V. vulnificus ATCC 33815 (vcgC, 16S rRNA B type, CPS allele 1, and vvhA
+) in lanes 2, 6, 11, 15; V. vulnificus 515-4C2 (vcgE, 16S rRNA A type, CPS allele 2, and vvhA
+) in lanes 3, 7, 12, 16; V. vulnificus V223 (vcgE, 16S rRNA A type, CPS none, and vvhA +) in
lanes 4, 8, 13, 17; negative control in lanes 5, 9, 14, 18. Target gene amplification products as
shown in the descending order by size in the 3-target multiplex PCR pair are: 16S rRNA B type
(839 bp), vvhA (519 bp), and vcgC (278 bp) for virulent-type V. vulnificus, and 16S rRNA A type
(839 bp), vvhA (519 bp), and vcgE (278 bp) for non-virulent-type V. vulnificus. In the 4-target
multiplex PCR pair, the amplicon sizes are: 16S rRNA B type (839 bp), vvhA (519 bp), CPS
allele 1 (342 bp), and vcgC (99 bp) for the multiplex PCR assays for virulent-type V. vulnificus,
and 16S rRNA A type (839 bp), vvhA (519 bp), vcgE (278 bp), and CPS allele 2 (152 bp) for the
multiplex PCR assays for non-virulent-type V. vulnificus.
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Effect of Primer Concentration on Multiplex PCR. In order to amplify all of the target
genes with equal efficiency, i.e., same band intensity, the concentrations of individual primer
pairs were optimized. The optimized primer concentrations for the 4-target virulent-type
multiplex PCR were: 0.3 M of vcgC primers (vcgC F/vcgC R), 0.2 M of 16S rRNA type B
primers (B F1/B R1), 0.7 M of CPS allele 1 primers (HP1F/HP1R), and 0.1 M of vvhA
primers (Vvh-785F/Vvh-1303R). For the 4-target non-virulent-type assay, the optimized primer
concentrations were: 0.3 M of vcgE primers (P2/P3), 0.3 M of 16S rRNA type A primers (A
F2/A R2), 0.2 M of CPS allele 2 primers (HP2F/HP2R), and 0.1 M of vvhA primers (Vvh785F/Vvh-1303R) (data not shown). After excluding CPS, the optimum primer concentrations
remained the same as in the corresponding 4-target multiplex PCR pair.
Specificity of Multiplex PCR Assays. Among 10 V. vulnificus reference strains and 80
oyster isolates (Tables 4-6 & 4-7), false-positive or false-negative multiplex PCR results were
not observed for any of the four target genes, i.e., 100% match with known strain characteristics
obtained previously using single PCR or real-time PCR assay (Han et al., 2009). Figure 4-2
shows a representative gel of multiplex PCR amplification products using typical virulent- and
non-virulent-type V. vulnificus strains.
Discussion
In order to simultaneously detect and differentiate V. vulnificus strains, we combined the
species-specific vvhA gene with three V. vulnificus potential virulence biomarkers (vcg, 16S
rRNA, and CPS) in two pairs of multiplex PCR assays. The first multiplex PCR pair amplified
all of the four target genes whereas the second pair amplified three genes except for CPS. For
each multiplex pair, one assay was designed for virulent-type V. vulnificus strains while the other
one for non-virulent-type V. vulnificus strains. Although these biomarkers have been used
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previously in single PCR or real-time PCR format to distinguish between clinical- (i.e., virulent-)
and environmental- (i.e., non-virulent) type V. vulnificus strains (Chatzidaki-Livanis et al., 2006a;
Gordon et al., 2008; Rosche et al., 2005; Vickery et al., 2007), this is the first study that
designed assays targeting multiple V. vulnificus biomarkers and vvhA to detect and characterize
either virulent-type or non-virulent-type V. vulnificus strains.
The vvhA gene was included as a species control so that only V. vulnificus strains were
detected and characterized by these multiplex PCR assays. Additionally, BLAST searches
(http://www.ncbi.nih.gov/BLAST) indicated both vcg and CPS are highly specific to V.
vulnificus. Therefore, we did not include non-V. vulnificus strains in the specificity
testing.Application of these multiplex PCR assays in 10 V. vulnificus reference strains and 80
V.vulnificus oyster isolates suggested that the assays were highly specific and accurate, with
results matching exactly with those obtained previously by using single PCR or real-time PCR
(Han et al., 2009). Therefore, by running one multiplex PCR reaction, e.g., the 4-target virulenttype assay, information on the strain genus/species and the presence or absence of the vcgC
sequence variant, 16S rRNA type B, and CPS allele 1 would be obtained simultaneously.
Similarly, the 4-target non-virulent-type assay would specifically characterize the strain
genus/species and the presence or absence of the vcgE sequence variant, 16S rRNA type A, and
CPS allele 2.
In addition, results for some biomarkers from the paired multiplex PCR assays agreed
well with each other, e.g., a strain positive for vcgC by using the virulent-type multiplex PCR
assay would show negative amplification for vcgE by using the non-virulent-type assay, and vice
versa. This mutual exclusivity of vcgC and vcgE sequence variants in V. vulnificus agreed with
several previous studies (Chatzidaki-Livanis et al., 2006a; Drake et al., 2010; Han et al., 2009;
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Rosche et al., 2005; Sanjuan et al., 2009). However, another study (Warner & Oliver, 2008a)
reported the isolation of V. vulnificus strains from oyster and water that amplified both vcgC and
vcgE sequences. For 16S rRNA types, the majority of V. vulnificus strains were mutually
exclusive, reflected by the amplification of either 16S rRNA B type in the virulent-type
multiplex PCR assay or A type in the non-virulent-type assay. Occasionally, strains amplifying
both 16S rRNA A and B types occurred as shown in Table 4-7 under atypical strains. This
phenomenon has been frequently reported in the literature (Chatzidaki-Livanis et al., 2006a;
Drake et al., 2010; Gordon et al., 2008; Han et al., 2009; Sanjuan et al., 2009; Senoh et al.,
2005; Vickery et al., 2007; Warner & Oliver, 2008a), possibly to meet V. vulnificus survival
needs under different environmental conditions. For CPS, there has been no reports of V.
vulnificus strain possessing both allele 1 and 2; however, strains possessing neither allele have
been reported (Chatzidaki-Livanis et al., 2006a; Han et al., 2009). In that scenario, those strains
would be negative for CPS allele 1 by the virulent-type multiplex PCR as well as CPS allele 2
negative by the non-virulent-type assay. Regardless of the strains being virulent-type, nonvirulent-type, or atypical, evaluating 90 V. vulnificus confirmed the accuracy of the multiplex
PCR results when compared with single PCR or real-time PCR results (Tables 4-6 & 4-7),
suggesting reliable multiplex PCR assays.
In the present study, besides a pair of 4-target multiple PCR assays, we also designed a
pair of 3-target multiplex PCR assays which excluded CPS. There are a few explanations.
Firstly, in our previous study, CPS tended to give a low estimate of potentially clinical important
V. vulnificus strains compared to vcg, 16S rRNA, or viuB, and the agreement between CPS and
other biomarkers was poor (Han et al., 2009). Secondly, there was an ambiguity associated with
CPS as mentioned above, i.e., non-virulent-type V. vulnificus strains possessed either CPS allele
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2 or none. Thirdly, CPS has not been used widely as a potential virulence biomarker for V.
vulnificus as vcg or 16S rRNA. Therefore, in parallel to the 4-target multiplex PCR pair, we also
designed the 3-target multiplex PCR pair, which could be used when the determination of CPS
allele types is not desirable.
Practically, when applying these multiplex PCR assays in microbial ecology or
epidemiology studies, it is acceptable to run one multiplex PCR assay, either the virulent-type or
non-virulent type. For the 3-target or 4-target virulent-type multiplex PCR, a typical virulenttype V. vulnificus strain would generate 3 or 4 bands, respectively, whereas a typical non-virulent
strain would generate only one vvhA band (Figure 4-2), and the opposite holds true for nonvirulent-type multiplex PCR assays. However, given the ambiguity associated with 16S rRNA
and CPS mentioned above and the presence of atypical strains, it is preferable that the multiplex
PCR assay pair be performed so that the definite strain characteristics for these biomarkers could
be obtained. On the other hand, for oyster and water monitoring programs, the virulent-type
multiplex PCR would be a preferred assay and the generation of more than one vvhA band would
suggest virulent-type strains and warrant further characterization of strain genotypes.
For the 4-target virulent-type multiplex PCR, the optimized annealing temperature was
56oC since the CPS allele 1 target could not be amplified at annealing temperatures greater than
56oC. In the corresponding 3-target virulent-type multiplex PCR, which excluded CPS, the
optimized annealing temperature was increased to 60oC. For the non-virulent-type multiplex
PCR assays, regardless of the number of targets included, vcgE could not be amplified at
annealing temperatures greater than 50oC, therefore the optimized annealing temperature for was
50oC for both 3-target and 4-target non-virulent-type multiplex PCRs. In a single PCR format,
CPS allele 1 and vcgE could be amplified at >60oC and 56oC, respectively. While in a multiplex
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PCR setting, due to the competition of primers and PCR reagents, several primers such as vcgE
or CPS 1 may not amplify in certain stringent condition (i.e. higher annealing temperature).
Besides the three potential virulence biomarkers used in this study, markers such as viuB
(Han et al., 2009; Panicker et al., 2004a; Panicker et al., 2004b) and vvhA (Sanjuan et al., 2009;
Senoh et al., 2005) have been used to differentiate V. vulnificus strain types. Recently, a
phenotypic trait mannitol fermentation has been reported to correlate with these virulenceassociated genotypic characteristics (Drake et al., 2010). However, none of these biomarkers are
confirmed unique virulent markers for V. vulnificus, and the assignment of strains to virulenttype based on these biomarkers only suggests their potential to cause clinical infections.
Conclusion
The multiplex PCR assays developed in the present study were capable of detecting and
characterizing multiple V. vulnificus potential virulence biomarkers simultaneously. Because of
the multiplex format, these assays obviate the need to run multiple single PCR reactions and the
need for high-fidelity enzyme. The assays would be valuable tools in microbial ecology and
epidemiology studies as well as facilitating regulatory agencies and the oyster industry in
controlling V. vulnificus risks in oysters by specifically detecting virulent-type strains, which has
the potential to cause clinical infections.
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CHAPTER 5: MOLECULAR DETECTION OF VIBRIO VULNIFICUS ISOLATES FROM
LOUISIANA GULF AND RETAIL RAW OYSTERS
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Part I: Evaluation of a Loop-Mediated Isothermal Amplification Assay for Detecting Vibrio
vulnificus in Retail Raw Oysters
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Introduction
First reported in 1979 as a foodborne pathogen associated with raw oysters (Blake et al.,
1979), the Gram-negative, halophilic bacterium Vibrio vulnificus is now recognized as the
leading cause of seafood-related deaths in the United States, responsible for over 95% of such
fatal incidences (Oliver, 2006). V. vulnificus causes three quite different human disease
symptoms, gastroenteritis, primary septicemia, and wound infection. And the mortality rates run
over 50% in primary septicemia and 25% in wound infections, the highest among those caused
by foodborne pathogens (Oliver, 2006). In 2004 and 2005, approximately 200 V. vulnificus
illnesses were reported to the Centers for Disease Control and Prevention (CDC), resulting in
around 60 deaths. The majority of patients with known food histories reported oyster
consumption prior to V. vulnificus infection (Centers for Disease Control and Prevention, 2005).
Moreover, according to a recent CDC’s FoodNet report, the incidence of Vibrio
parahaemolyticus and V. vulnificus infections in the U.S. due to eating raw or undercooked
oysters has shown a sustained increase since 2001, indicating further measures are needed to
prevent human illness caused by these pathogens in oysters (Centers for Disease Control and
Prevention, 2007). In particular, there is a need for rapid, sensitive, specific, and cost-effective
detection assays that can be readily employed in the field to better ensure the safety of oysters
from harvest, post-harvest processing (PHP), to retail.
Currently, the Interstate Shellfish Sanitation Conference (ISSC) recommends that all PHP
oysters contain no more than 30 V. vulnificus colony forming units per gram of oyster (CFU/g)
by the most probable number (MPN) analysis (Food and Drug Administration/National Shellfish
Sanitation Program, 2005). Such traditional microbiological culturing methods followed by
biochemical tests for species identification, however, are labor-intensive and time-consuming
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(Kaysner & DePaola, 2001). Besides, reliable biochemical tests/media for Vibrio species
confirmation are lacking (Warner & Oliver, 2007). DNA probe hybridization has been used in
conjunction with direct plating, offering a more rapid (< 24 h) and specific alternative, but is still
cumbersome (Kaysner & DePaola, 2001; Morris et al., 1987; Wright et al., 1993). The reported
detection limits using DNA probe hybridization fell between 102 and 104 CFU/g (Kaysner &
DePaola, 2001; Morris et al., 1987; Wright et al., 1993). Additionally, specific immunological
tests for V. vulnificus have been developed with a reported detection limit of 2 × 103 cells and a
total detection time of about 2-3 days (Simonson & Siebeling, 1986; Tamplin et al., 1991).
However, the required V. vulnificus-specific antibodies are no longer commercially available.
Molecular-based DNA amplification techniques, e.g., polymerase chain reaction (PCR)
(Arias et al., 1995; Brauns et al., 1991; Coleman et al., 1996; Hill et al., 1991; Lee et al., 2003),
reverse-transcription PCR (Fischer-Le Saux et al., 2002), and real-time PCR in recent years
(Campbell & Wright, 2003; Panicker et al., 2004; Panicker & Bej, 2005; Takahashi et al., 2005;
Wright et al., 2007), have been described for the rapid and sensitive detection of V. vulnificus in
oysters. Primarily targeting the vvhA gene that codes for V. vulnificus cytolysin/hemolysin
(Wright et al., 1985), these assays reached a detection limit of 102 CFU/g oyster without
enrichment by real-time PCR or nested PCR (Arias et al., 1995; Campbell & Wright, 2003;
Panicker et al., 2004), whereas a 24 h enrichment was required to achieve the same level of
sensitivity by PCR (Hill et al., 1991). After 5 h enrichment, a sensitivity of 1 CFU/g was
reported again by real-time PCR (Panicker et al., 2004; Panicker & Bej, 2005). The concerns
associated with these assays include expensive thermal cycling instrument, particularly the high
cost associated with a real-time PCR machine, and the inability to differentiate dead from live
cells.

92

Recently, a novel loop-mediated isothermal amplification (LAMP) technique was
described (Notomi et al., 2000) and has shown promise in both bacterial and viral detections
(Hara-Kudo et al., 2005; Song et al., 2005; Yeh et al., 2006; Yoda et al., 2007). The assay
employs a set of four or six primers that create a target-specific stem-loop DNA structure during
initial amplification steps, and subsequent LAMP auto-cycling is achieve by the stranddisplacing Bst DNA polymerase large fragment (Notomi et al., 2000). Advantages of LAMP
relevant to V. vulnificus detection include: 1) isothermal (60-65oC), no special thermal cycling
instrument is required; 2) rapid, the assay can be completed in 15-60 min (Nagamine et al.,
2002); 3) specific, the assay targets 6-8 regions of the target gene sequence; 4) sensitive,
extremely large amount of DNA can be amplified from a few target cells; 5) detection by the
naked eye due to the formation of large quantities of a by-product, magnesium pyrophosphate,
which turns positive reaction tubes turbid (Mori et al., 2001); 6) direct amplification, there is no
need to denature DNA templates before amplification (Nagamine et al., 2001); and 7) robust,
LAMP is less subjective to inhibition by biological substances (Kaneko et al., 2007).
Given these advantages, we hypothesized that LAMP could potentially be a useful tool
for the field detection of V. vulnificus in oysters and growing waters. The objective of the present
study is to develop a LAMP assay suitable for the rapid and sensitive detection of V. vulnificus in
raw oysters by targeting the vvhA gene.
Materials and Methods
Target and LAMP Primer Design. The V. vulnificus cytolysin/hemolysin gene (vvhA)
(GenBank accession number M34670) was selected as the target for LAMP primer design. A set
of four primers, two outer and two inner, that recognize six distinct regions of the target
sequence (Figure 5-1) was designed using the PrimerExplorer software (V4, Fujitsu Limited,
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Japan; http://primerexplorer.jp/e). Forward inner primer (FIP) consisted of a complementary
sequence of F1 and a sense sequence of F2, without any linker sequence in between. Similarly,
backward inner primer (BIP) was a direct combination of a complementary sequence of B1 and a
sense sequence of B2. The two outer primers, forward outer primer and backward outer primer,
were F3 and B3, respectively (Figure 5-1). These primers were selected based on criteria
described previously by Notomi et al. (Notomi et al., 2000).
Bacterial Strains, Culture Conditions, and DNA Preparation. Bacterial strains used in
this study (Table 5-1) were selected from our culture collection at the Department of Food
Science, Louisiana State University. V. vulnificus 1007, a clinical strain originally isolated by the
Louisiana Department of Health and Hospitals, was used for assay optimization and sensitivity
testing with pure culture and seeded raw oysters. Additional 19 V. vulnificus and 30 non-V.
vulnificus strains were used to evaluate the assay specificity. All Vibrio strains were cultured
using tryptic soy agar (TSA; BD Diagnostic Systems, Sparks, MD) or broth containing 2% NaCl
at 35oC overnight. Non-Vibrio strains were grown on Luria-Bertani agar or blood agar (BD
Diagnostic Systems). In addition, modified cellobiose-polymyxin B-colistin (mCPC) agar as
recommended in Food and Drug Administration’s Bacteriological Analytical Manual (Kaysner
& DePaola, 2001) was used to quantify V. vulnificus levels in seeded oyster samples.
To prepare DNA templates, a single bacterial colony grown on appropriate agar plates
was selected and suspended in 500 µl of TE (10 mM Tris, pH 8.0; 1 mM EDTA). The bacterial
suspension was heated for 10 min at 95oC in a dry heating block and stored at -30oC until use.
PCR. As a comparison, two sets of PCR reactions were performed, using LAMP outer
primers F3/B3, and the widely used Vvh-785F/Vvh-1303R primers specific for the V. vulnificus
vvhA gene (Kaysner & DePaola, 2001).
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Table 5 - 1 Bacterial strains used in this study, their source, and specificity of the Vibrio
vulnificus cytolysin/hemolysin (vvhA) gene amplification by LAMP and PCR
Strain ID, species and groupa
Source and originb
vvhA amplification
LAMP
PCR
V. vulnificus clinical strain (n = 5)
ATCC 27562
Blood, Florida
+
+
ATCC 29306
Corneal ulcer
+
+
ATCC 33815
Leg ulcer, Wisconsin
+
+
ATCC 33816
Blood, Alaska
+
+
1007
Clinical, Louisiana
+
+
V. vulnificus environmental strain (n = 15)
WR1
Sea Water, Washington
+
+
515-4C2
Oyster, California
+
+
541-0-84c
Oyster, Gulf, Louisiana
+
+
0106-0-14
Oyster, Gulf, Louisiana
+
+
V97
Oyster, Gulf, Louisiana
+
+
V156
Oyster, Gulf, Louisiana
+
+
V195
Oyster, Gulf, Louisiana
+
+
V196
Oyster, Retail, Louisiana
+
+
V206
Oyster, Retail, Louisiana
+
+
V240
Oyster, Retail, Louisiana
+
+
V261
Oyster, Retail, Louisiana
+
+
V276
Oyster, Retail, Louisiana
+
+
V314
Oyster, Retail, Louisiana
+
+
V325
Oyster, Retail, Louisiana
+
+
V350
Oyster, Retail, Louisiana
+
+
V. parahaemolyticus O3:K6 group (n = 2)
CT-6636, O3:K6
Clinical, Connecticut
TX-2103, O3:K6
Clinical, Texas
V. parahaemolyticus non-O3:K6 group (some with unknown serotypes, n = 11)
8332924, O1:K56
Oyster, Gulf of Mexico
NY477, O4:K8
Oyster, New York
ATCC 49529, O4:K12
Feces, California
M350A, O5
Oyster, Washington
ATCC 17802
Shirasu food poisoning, Japan
ATCC 27969
Blue crab, Maryland
ATCC 33847
Gastroenteritis, Maryland
916i
Oyster, Gulf, Louisiana
541-0-44c
Oyster, Gulf, Louisiana
V50
Oyster, Retail, Louisiana
V150
Oyster, Retail, Louisiana
-
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Table continued
Other Vibrio spp. (n = 5)
V. alginolyticus ATCC 17749
Spoiled horse mackerel, Japan
V. cholera ATCC 14035; O:1
NCTC, United Kingdom
V. cincinnatiensis ATCC 35912
Blood/cerebrospinal fluid, Ohio
V. harveyi ATCC 35084
Brown shark, Maryland
V. mimicus ATCC 33655
Feces, Tennessee
Non-Vibrio spp. (n = 12)
Campylobacter jejuni 81-176
Human
Enterobacter aerogenes ATCC 13048
Sputum, South Carolina
Enterococcus faecalis ATCC 29212
Urine
Escherichia coli ATCC 25922
Human
Listeria monocytogenes ATCC 13932, 4b Spinal fluid, Germany
Listonella anguillarum ATCC 19264
Ulcerous lesion in cod, UK
Pseudomonas aeruginosa ATCC 27853
Human blood
Salmonella enteria Typhimurium LT2
Unknown
Shigella flexneri ATCC 12022
Unknown
Shigella sonnei ATCC 25931
Human feces, Panama
Staphylococcus aureus ATCC 29213
Wound
Streptococcus pneumoniae ATCC 49619 Sputum, Arizona
a
ATCC, American Type Culture Collection, Manassas, VA.
b
NCTC, the National Collection of Type Cultures, London, United Kingdom.
“+” stands for amplificaition of the gene, “-” stands for no amplification of the gene.

-

-

-

-

The PCR mixture contained 1 × PCR buffer, 0.2 mM of each deoxynucleotide
triphosphate (dNTP), 1.5 mM of MgCl2, 0.5 µM of each primer (synthesized by Invitrogen,
Carlsbad, CA), 0.5 U of Taq DNA polymerase (Applied Biosystems, Foster City, CA), and 2 µl
of DNA template in a total volume of 25 µl. The PCR reaction was conducted using 30 cycles of
denaturation at 94°C for 1 min, primer annealing at 58°C for 1 min, extension at 72°C for 1 min,
and a final extension at 72°C for 7 min in a GeneAmp PCR System 2400 (Applied Biosystems).
Aliquots (10 µl) of PCR products were analyzed by electrophoresis on 2% agarose gel, stained
with ethidium bromide, and visualized under UV light. Gel images were documented by a BioRad Gel Doc XR system (Hercules, CA).
LAMP. The LAMP mixture in 25 μl total volume consisted of the following: 1 × Thermo
buffer (containing 2 mM MgSO4), 6 mM of MgSO4, 0.8 M of betaine (Sigma-Aldrich, St. Louis,
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MO), 1.4 mM of dNTP, 0.2 μM of each outer primer, 1.6 μM of each inner primer, 8 U of Bst
DNA polymerase (New England Biolabs, Ipswich, MA), and 2 µl of DNA template. The LAMP
reaction was carried out at 63oC for 1 h and terminated at 80oC for 2 min in a water bath.
Aliquots (2 µl) of LAMP amplicons were analyzed similarly by gel electrophoresis.
LAMP Specificity and Sensitivity. The 50 bacterial strains in Table 5-1 were used to
determine the LAMP specificity in a blinded manner. DNA templates were made from fresh
overnight bacterial cultures and subjected to both LAMP and PCR amplification. False positive
and false negative rates, if any, were calculated. Specificity tests were repeated twice.
To determine the sensitivity of the optimized LAMP assay, tenfold serial dilutions of an
overnight V. vulnificus 1007 culture were prepared in sterile saline solution, quantified using
standard plate counts on TSA with 2% NaCl, and aliquots (2 µl) were subjected to both LAMP
and PCR amplification. Sensitivity tests were repeated five times and the data were presented as
the lower limits of detection (CFU/reaction).
Detection of V. vulnificus in Seeded Oyster Tissue Homogenate. V. vulnificus strain
1007 was used to evaluate the capability of LAMP to detect the bacterium in oyster tissue
homogenates. All oyster samples (12 oysters per sample) were collected from local seafood
restaurants between February and August 2006, shucked, and homogenized with equal volume of
alkaline peptone water (APW; BD Diagnostic Systems) in a food stomacher (Model 400;
Tekmar Company, Cincinnati, OH). Aliquots of the 1:1 oyster homogenate were tested for the
presence of V. vulnificus by direct plating and enrichment following procedures described in our
previous study (Han et al., 2007), and the remainders were stored at -80oC until use. Only oyster
homogenates that were tested negative for V. vulnificus were used in the following seeded oyster
experiments, which were repeated five times.
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Tenfold serial dilutions of a fresh overnight V. vulnificus 1007 culture were made in
sterile saline, and 1 ml of each dilution was added into 1 ml (i.e., 0.5 g) of thawed oyster tissue
homogenate, resulting in bacterial concentrations ranging from approximately 108 CFU/g to 1
CFU/g of oyster tissue. Negative oyster control sample without inoculation was also included.
For direct detection, the seeded oyster samples were mixed well and aliquots (1 ml) were
centrifuged at 200 g for 5 min to remove oyster tissues. Supernatants were transferred to a fresh
tube, centrifuged at 12,000 g for 10 min and the pellets were resuspended in 200 µl TE. After
heating at 95oC for 10 min to release the DNA, the solution was centrifuged again at 12,000 g for
10 min, and an aliquot (2 µl) of the supernatant was used for both LAMP and PCR amplification.
Alternatively, a dilution step was added right after inoculation by adding 1 ml of the seeded
oyster sample into 50 ml of APW, and processed similarly as above.
For enrichment, 1 ml of each dilution of the overnight V. vulnificus 1007 culture was
added into a flask containing 48 ml of sterile APW and 1 ml (i.e., 0.5 g) of thawed oyster tissue
homogenate, and enriched at 35oC for 5 h. After enrichment, aliquots (1 ml) were taken and
processed similarly as above. The V. vulnificus levels after enrichment were quantified by
standard plate counts on both TSA with 2% NaCl and mCPC agar.
Visualization of LAMP Amplicons by the Naked Eye. To facilitate future field
applications of the LAMP assay, detection of LAMP amplicons was also carried out by
inspection with naked eyes as described by Parida et al. (Parida et al., 2007). Briefly, after
LAMP amplification, each reaction tube was inspected first for white turbidity, then observed
immediately for color change (from orange to green or greenish yellow) after adding 0.5 μl of
SYBR Green I dye (Invitrogen). The SYBR Green I color change was observed under both
natural light and UV.
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Results
Figure 5-1 indicates that six specific locations on the V. vulnificus cytolysin/hemolysin
gene (vvhA) were recognized by the LAMP primers, along with detailed information on each
LAMP primer. The detection of LAMP amplicons was done by conventional gel electrophoresis,
turbidity inspection, and color observation with the aid of SYBR Green I fluorescent dye.

Figure 5 - 1 Partial nucleotide sequence of the cytolysin/hemolysin (vvhA) gene of Vibrio
vulnificus EDL174 (accession number M34670), six target regions, and four primers used in the
LAMP assay.
Underlined sequences are the six target regions. Oligonucleotide sequences in bold and also
listed at the bottom were used as LAMP primers. F3 and B3 are the forward outer primer and
backward outer primer, respectively. FIP and BIP are the forward inner primer and the backward
inner primer, respectively.

Specificity and Sensitivity of the LAMP Assay. Among 50 bacterial strains used to
determine the LAMP specificity, all of the 20 V. vulnificus clinical and environmental strains
generated the typical ladder-like LAMP banding pattern, and none of the 30 non-V. vulnificus
strains were positive for LAMP (Table 5-1, second to the last column). There was no false
positive or false negative reactions detected, indicating the LAMP assay was highly specific.
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Similarly, two sets of PCR assays using both F3/B3 and Vvh-785F/Vvh-1303R did not produce
any false positive or false negative results when testing the 50 bacterial strains (Table 5-1, the
last column).
The sensitivity of the LAMP assay was determined by testing tenfold serial dilutions of V.
vulnificus 1007 and comparing it with that of the two conventional PCRs. LAMP was found to
be 10-fold more sensitive than PCR, with a detection limit of approximately 20 CFU versus 202
CFU for PCR (Figure 5-2, Table 5-2), whereas the two PCR assays using either F3/B3 or Vvh785F/Vvh-1303R primers possessed the same level of sensitivity (data not shown).

Figure 5 - 2 Sensitivity of vvhA LAMP (A) and PCR (B) for detecting Vibrio vulnificus 1007 in
pure cultures.
For PCR products shown here, primers used were F3 and B3, and the expected size was 217 bp.
In both gel, lanes 1-7 are amplicons from serial tenfold dilutions of a bacterial culture (1.01 × 108
CFU/ml). Two μl of boiled bacterial dilutions were added into the reaction tube, resulting in the
total CFU numbers in individual tube for lanes 1-7 were 2.02 × 105, 2.02 × 104, 2.02 × 103, 2.02
× 102, 20.2, 2.02, and 2.02 × 10-1, respectively. Lane 8 is 100 bp molecular weight marker (New
England Biolabs). Negative controls used were water (not shown). In gel A, 2 μl of LAMP
amplicons were loaded per lane, whereas in gel B, 10 μl of PCR amplicons were loaded per lane.
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Table 5 - 2 Comparison of sensitivities of LAMP and PCR in detecting Vibrio vulnificus 1007 in
pure cultures and seeded oyster samples
Cells in the reaction
Detection limit
Samples and preparations
Methods
a
tube (CFU)b
(CFU or CFU/g)
Pure culture
LAMP
20
20
PCR
202
202
Seeded oyster
LAMP
4×108
4×106
PCR
ND
N/A
(no enrichment, no dilution)
Seeded oyster
LAMP
4×107
8×103
(no enrichment, with dilution) PCR
ND
N/A
Seeded oyster
LAMP
7
80
4×105
(5 h enrichment)
PCR
7×103
a
For pure culture, the unit for detection limit was colony forming unit (CFU), whereas the units
for those in seeded oysters were CFU/g of oyster tissue.
b
The formula used to calculate the number of cells in the reaction tubes were: cell concentration
(CFU/ml)×2×10-3 for pure culture, CFU/ml×10-2 for seeded oyster with no enrichment or
dilution, CFU/ml×2×10-4 for seeded oyster with no enrichment but with 1:50 dilution before
detection, CFU/ml after enrichment×10-2 for seeded oysters with 5 h enrichment.
ND means not detected. N/A means not applicable.
LAMP Detection of V. vulnificus in Experimentally Seeded Oysters. When applying
LAMP and PCR for the direct detection of V. vulnificus in experimentally seeded raw oysters
without enrichment, LAMP was able to detect V. vulnificus only at the highest inoculum level
tested, i.e. 4×108 CFU/g. When the seeded oyster samples were diluted 1:50 in APW before
detection, the LAMP detection limit without enrichment increased tenfold to 4×107 CFU/g
(Table 5-2). PCR, however, failed to detect any of the seeded oyster samples without enrichment.
After 5 h enrichment in APW, the LAMP assay was able to detect an initial V. vulnificus
inoculum of 7 CFU/g of oyster tissue, when the actual V. vulnificus level in the enrichment broth
reached approximately 8×103 CFU/ml based on cellobiose-positive colony counts on mCPC agar.
The detection limit of PCR for seeded oyster samples after enrichment was 1,000-fold higher
than that of LAMP, i.e., 7×103 CFU/g in the case of PCR, which had an actual cell concentration
of 4×107 CFU/ml after 5 h enrichment.
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Direct Visualization of LAMP Amplicons by the Naked Eye. Following LAMP
amplification at 63oC for 1 h in a water bath, white turbidity could be observed in LAMPpositive samples with the naked eye (Figure 5-3). After adding 0.5 µl of SYBR Green I
fluorescent dye, the LAMP-positive samples clearly showed color change from original orange
color to green or greenish yellow under normal light, whereas for LAMP-negative samples, the
tubes remained the original orange color of the dye (Figure 5-3A). The color difference was
more obvious when both positive and negative tubes were exposed to UV light, as positive tubes
fluoresced bright green (Figure 5-3B). No turbidity change or color change after adding SYBR
Green I was observed in PCR-positive samples.

A

B

Figure 5 - 3 SYBR Green I fluorescent dye-mediated visualization of LAMP amplification
products by the naked eye under normal light (A) and UV (B).
After 0.5 μl of SYBR Green I was added, positive wells immediately turned green or greenishyellow, whereas negative wells remained the orange color of the dye. This color difference was
more obvious under UV as positive wells fluoresced bright green. Both photos were taken by
John Wozniak of the LSU Agricultural Center.
Discussion
As the cause of over 95% of seafood-related deaths (Oliver, 2006), V. vulnificus presents
an imminent threat to public health as well as the Gulf oyster industry. To meet the regulatory
guideline of less than 30 CFU/g of V. vulnificus in PHP oysters, a rapid, sensitive, specific, and
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cost-effective detection assay is desirable, particularly if the assay has the potential to be applied
in the field. In this study, we applied a novel molecular detection assay, LAMP, for the rapid and
sensitive detection of this pathogen in oyster tissue homogenate by targeting the vvhA gene. In
this initial effort, the LAMP assay was developed and optimized, assay characteristics were
evaluated, and its applicability in oyster samples were tested.
The specificity of the LAMP assay was ensured by designing primers targeting unique
regions of the vvhA gene, and was confirmed by testing 50 V. vulnificus and non-V. vulnificus
strains. This is not surprising since LAMP assays inherently carry a high level of specificity due
to the fact that at least six regions on the target DNA sequence were targeted (Notomi et al.,
2000). Similarly, PCR using two LAMP outer primers also demonstrated high levels of
specificity, further confirming that the region of vvhA used for primer design is unique to V.
vulnificus.
When testing V. vulnificus in pure cultures, the LAMP assay was found to be 10-fold
more sensitive than the two conventional PCRs included for comparison, capable of detecting 20
CFU of V. vulnificus per reaction tube. This greater sensitivity of LAMP compared to PCR has
been reported previously (Hara-Kudo et al., 2005; Hara-Kudo et al., 2007; Yano et al., 2007),
however, PCR was found to be one order more sensitive than LAMP in detecting
Flavobacterium columnare when 40 cycles of PCR reaction was used rather than 30 (Yeh et al.,
2006). In addition, the LAMP sensitivity observed in this study was comparable to previously
reported real-time PCR assays for detecting V. vulnificus, ranging from 6 CFU to 100 CFU
(Campbell & Wright, 2003; Panicker et al., 2004).
In addition to its specificity and sensitivity, LAMP was demonstrated to be a faster assay
than PCR, taking 1 h rather than > 2 h for PCR. Moreover, during LAMP amplification, very
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large amount of amplicons were generated rapidly, which could result in white turbidity as well
as SYBR Green I fluorescent dye color change. PCR, on the other hand, did not generate
sufficient amount of amplicons to be detected by these simple visual observations. According to
Mori et al., LAMP synthesized DNA in the range of 10-20 µg/25 µl reaction mix, whereas DNA
yield by PCR was about 0.2 µg/25 µl (Mori et al., 2001). This discrepancy accounted for the
different reactions observed when adding SYBR Green I dye. This unique yet simple detection
method for LAMP could facilitate future field applications of the assay.
When the optimized LAMP assay was used to detect V. vulnificus in experimentally
seeded Louisiana raw oysters, LAMP was demonstrated to be much less susceptible to certain
inhibitors present in oyster samples, resulting in 1,000 fold greater sensitivity than PCR for
detection following enrichment (Table 5-2). Nonetheless, although an internal amplification
control was not included in our assay development, the inhibitory effects of certain biological
substances in the oyster samples were obvious, as evidenced by much hampered sensitivity
compared to that in pure cultures (Table 5-2). This observation was in contrast to a previous
report that conducted inhibition control study in Alabama oysters and concluded that the oyster
tissue matrix did not affect the sensitivity of a real-time PCR (Panicker & Bej, 2005). This
discrepancy could be due to that oyster samples from different regions were assessed. Diluting
the seeded oyster samples in APW (1:50) before detection was tested, and it lowered the
detection limit by 10-fold. However, as indicated in Table 5-2, the actual number of cells in the
reaction tube after this dilution step was 8×103 compared to 4×106 without dilution, suggesting
that the dilution procedure did greatly reduce the oyster matrix effect.
Our data clearly indicated that when DNA amplification assays such as LAMP were
applied to the detection of Vibrio in oysters, direct detection without enrichment lacked the
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needed sensitivity (30 CFU/g). Based on theoretical calculations, given a LAMP detection limit
of 20 cells/reaction (2 µl) in pure cultures, it needs at least 1×104 CFU/ml bacteria in oyster
homogenate not counting oyster matrix effects. There was also a dilution factor (1:50) to reduce
inhibitor concentrations (1 ml of bacterial suspension into 50 ml APW) and a concentrating
factor (5:1) during sample preparation (1 ml into 200 µl TE). Taken together, a cell concentration
of at least 1×105 CFU/ml (i.e., 1×105 CFU/g) is needed. Therefore, enrichment seems an
inevitable step in terms of V. vulnificus detection in oysters, concurring with findings in the
literature (Panicker et al., 2004; Panicker & Bej, 2005). Very recently, two studies using realtime PCR to detect pathogenic V. parahaemolyticus (Nordstrom et al., 2007) or V. vulnificus
(Wright et al., 2007) also sought to use a combination of MPN enrichment and real-time PCR
approach to achieve the needed sensitivity. In this regard, the LAMP assay could readily pair
with MPN but further evaluation is needed.
During the assay development and application in oyster samples, several simple
centrifugation steps were used to remove oyster liquid and tissue, which were quite efficient and
achieved a detection limit of 7 CFU/g after enrichment. This level of detection was comparable
to that of previously reported assays by real-time PCR (Panicker et al., 2004; Panicker & Bej,
2005), and well met the current ISSC recommended 30 CFU/g guidelines (Food and Drug
Administration/National Shellfish Sanitation Program, 2005). This simple oyster sample
processing method obviated the need for lengthy nucleic acid purification steps, therefore
reducing the cost and turnaround time for detection.
Conclusion
A rapid, specific, and inexpensive LAMP assay for detecting V. vulnificus in raw oysters
was developed and evaluated in this study. The lower limit of detection was 20 CFU of V.
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vulnificus in pure cultures. After 5 h enrichment, the assay was capable of detecting 7 CFU/g V.
vulnificus in experimentally inoculated Louisiana oyster samples. Because of its isothermal
format and unique amplicon detection technique, this rapid and sensitive LAMP assay holds
potential for future field application. Further optimization of the oyster sample processing
procedure and large-scale testing on oyster samples obtained from various regions of the U.S. are
needed to bring this assay a step closer to the field.
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Introduction
Vibrio vulnificus is a Gram-negative, halophilic bacterium that inhabits warm coastal and
estuarine waters throughout the world (Oliver, 2006). Most human infections result from the
consumption of raw or undercooked seafood, particularly oysters (Cholera and Other Vibrio
Illness Surveillance, 2009). V. vulnificus is capable of causing fatal diseases such as primary
septicemia and wound infections, with reported mortality rates over 50% and 25%, respectively
(Oliver, 2006). At-risk groups for fatal V. vulnificus infections include people with
immunocompromising conditions, diabetes, and elevated serum iron concentrations due to
chronic liver disease or alcohol abuse (Strom & Paranjpye, 2000). Annually, there are
approximately 30 V. vulnificus-associated deaths in the United States (Centers for Disease
Control and Prevention, 2010). Therefore, rapid and sensitive detection assays are needed to
facilitate better control of potential V. vulnificus infections from seafood consumption.
Conventional culture-based methods for the detection and quantification of V. vulnificus
include the most probable number (MPN) method and DNA hybridization, which are timeconsuming and labor-intensive (Kaysner & DePaola, 2001; Wright et al., 1993). Molecularbased assays such as PCR and real-time PCR have been widely employed for the rapid, specific,
and sensitive detection and quantification (in the case of real-time PCR) of V. vulnificus
(Campbell & Wright, 2003; Coleman et al., 1996; Hill et al., 1991; Panicker et al., 2004;
Panicker & Bej, 2005; Takahashi et al., 2005; Wright et al., 2007). A previous study reported
that a real-time Taqman PCR assay was able to detect 1 CFU of V. vulnificus per gram of oyster
tissue homogenate after 5 h enrichment (Panicker & Bej, 2005). However, for both PCR and
real-time PCR, a dedicated thermal cycler is needed, which is rather expensive especially for
real-time PCR, and hinders the wide application of such assays.
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A newer DNA amplification technique, loop-mediated isothermal amplification (LAMP)
was developed in 2000 (Notomi et al., 2000). LAMP utilizes four to six primers that specifically
recognize six to eight regions of the target DNA sequence and amplifies millions of DNA copies
under isothermal conditions (60-65oC) within an hour (Notomi et al., 2000). Since its invention,
LAMP has been applied to detect multiple bacterial and viral agents, including those of major
food safety concerns, such as Campylobacter, pathogenic, Escherichia coli, Salmonella,
Staphylococcus aureus, and noroviruses (Goto et al., 2007; Hara-Kudo et al., 2005; Hara-Kudo
et al., 2007; Yamazaki et al., 2008c; Yoda et al., 2007). Very recently, our research group and
two others independently developed LAMP assays for V. vulnificus detection, of which two
targeted the V. vulnificus hemolysin (vvhA) (Han & Ge, 2008; Ren et al., 2009) and one targeted
the V. vulnificus toxR gene (Nemoto et al., 2008). These assays were reported to be specific and
sensitive; however, none of them applied real-time LAMP for V. vulnificus quantification. One
way to quantify LAMP products is by using a fluorescent DNA-intercalating dye as in a realtime PCR format (Aoi et al., 2006; Hara-Kudo et al., 2005; Monis et al., 2005; Njiru et al.,
2008). Additionally, the formation of a by-product (magnesium pyrophosphate) during LAMP
amplification causes turbidity change, which correlates with the amount of amplified DNA and
could be monitored by a real-time turbidimeter (Mori et al., 2001; Mori et al., 2004).
Built upon our previous report (Han & Ge, 2008), the present study aimed to develop
real-time LAMP assays suitable for the quantitative detection of V. vulnificus in raw oysters by
utilizing two real-time platforms, one was fluorescence-based and the other one turbidity-based.
Materials and Methods
Bacterial Strains and DNA Templates Preparation. Vibrio vulnificus clinical strain
ATCC 27562 was used for sensitivity testing. An additional 37 V. vulnificus clinical and
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environmental strains and 42 non- V. vulnificus strains were used to evaluate assay specificity
(Table 5-3). All Vibrio strains were grown overnight at 35oC on trypticase soy agar or in broth
(TSA or TSB; BD Diagnostic Systems, Sparks, MD) supplemented with 2% NaCl. Non- Vibrio
strains were grown on Luria-Bertani agar or blood agar (BD Diagnostic Systems).
Table 5 - 3 Bacterial strains used in real-time LAMP study to detect total Vibrio vulnficicus
Source and reference
Strain group
Strain ID and serotype a
V. vulnificus, clinical
ATCC 27562
Blood, Florida
(n = 9)
ATCC 29306
Corneal ulcer, Virginia
ATCC 33815
Leg ulcer, Wisconsin
ATCC 33816
Blood, Alaska
C7184
Thumb drainage, Texas (Oliver
et al., 1982)
1003
Wound, Louisiana (Martin &
Siebeling, 1991)
1004
Stool, Louisiana (Martin &
Siebeling, 1991)
1006, 1007
Blood, Louisiana (Martin &
Siebeling, 1991)
V. vulnificus, environmental WR1
Sea water, Washington
(n = 29)
V195
Gulf oyster, Louisiana (Han et
al., 2007)
V244, V262, V350, V353, V398, Retail oyster, Louisiana (Han et
V420, V463, V531, V560, V606
al., 2007)
132 (A1, B5, B8, T5, Z2), 212 Gulf oyster, Louisianab
(B6, E12, F14, F15, F18, S7, S8,
Y10), 342 (E3, E4, E6, E9)
ATCC 17802; O1:K1
Shirasu food poisoning, Japan
V. parahaemolyticus
(n = 20)
ATCC 27969
Blue crab, Maryland
ATCC 33847
Gastroenteritis, Maryland
ATCC 49529; O4:K12
Feces, California
CT-6636; O3:K6
Clinical, Connecticut
M350A; O5
Oyster, Washington
NY477; O4:K8
Oyster, New York
TX-2103; O3:K6
Clinical, Texas
8332924; O1:K56
Oyster, Gulf of Mexico
83AO8757
Clinical, feces
83AO9148
Clinical, feces
83AO9756; O4:K12
Clinical, feces
84AO1516; O4:K12
Clinical, feces
84AO4226
Clinical, feces
916i, 541-0-44c, V68, V69, V155 Oyster, Gulf, Louisiana (Han et
al., 2007)
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Table continued
Other Vibrio spp. (n = 10)
Vibrio alginolyticus
Vibrio cholerae
Vibrio cincinnatiensis
Vibrio fluvialis
Vibrio harveyi
Vibrio mimicus

V86

Oyster, Retail, Louisiana (Han
et al., 2007)

ATCC 17749
ATCC 33787
ATCC 14035; O:1
ATCC 35912
ATCC 33809
ATCC 14126
ATCC 35084
ATCC 33653
ATCC 33655
ATCC 14048

Spoiled horse mackerel, Japan
Seawater, Hawaii
NCTC, United Kingdom
Blood/cerebrospinal fluid, Ohio
Human feces, Bangladesh
Dead amphipod, Massachusetts
Brown shark, Maryland
Human ear, North Carolina
Feces, Tennessee
Salt marsh mud, Georgia

Vibrio natriegens
Non-Vibrio spp. (n = 12)
81-176
Human
Campylobacter jejuni
ATCC 13048
Sputum, South Carolina
Enterobacter aerogenes
ATCC 29212
Urine
Enterococcus faecalis
ATCC 25922
Human
Escherichia coli
ATCC 13932; 4b
Spinal fluid, Germany
Listeria monocytogenes
ATCC 19264
Ulcerous lesion in cod, UK
Litonella anguillarum
ATCC 27853
Human blood
Pseudomonas aeruginosa
LT2; Typhimurium
Unknown
Salmonella enterica
ATCC 12022; 2b
Unknown
Shigella flexneri
ATCC 25931
Human feces, Panama
Shigella sonnei
ATCC 29213
Wound
Staphylococcus aureus
ATCC 49619; type 59
Sputum, Arizona
Streptococcus pneumoniae
a
ATCC, American Type Culture Collection, Manassas, VA; NCTC, the National Collection of
Type Cultures, London, United Kingdom.
b
Isolated from three Louisiana coastal locations (designated as 132, 212, and 342) between
2006-2007.

DNA templates were prepared by suspending a single bacterial colony grown on
appropriate agar plates in 500 µl of TE (10 mM Tris, pH 8.0; 1 mM EDTA; Sigma-Aldrich, St.
Louis, MO), followed by heated at 95oC for 10 min in a dry heating block. After centrifuge at
12,000 g for 2 min, the supernatants were stored at -30oC until use. To prepare templates for
sensitivity testing, an overnight V. vulnificus ATCC 27562 culture was diluted 50 fold in TSB
and incubated at 35°C for 5 h with shaking at 100 rpm. Serial 10-fold dilutions of the mid-log
phase culture were made in phosphate-buffered saline (PBS; Sigma-Aldrich) and aliquots of each
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dilution were used to prepare DNA templates similarly by the boiling method. The exact cell
counts in the templates were obtained by standard plate counting on TSA with 2% NaCl.
Fluorescence-based Real-time LAMP. Four LAMP primers (F3, B3, FIP, and BIP)
targeting the V. vulnificus cytolysin/hemolysin gene (vvhA) as described in our previous report
(Han

&

Ge,

2008)

were

adopted.

Additionally,

a

loop

primer

(5-

TCCATTCGCCAGCAGTTACG-3) was designed using the PrimerExplorer software version 4
(Fujitsu Limited, Japan; http://primerexplorer.jp/e). All primers were synthesized by Invitrogen
(Carlsbad, CA). The LAMP reaction mix (25 μl) consisted of the following: 1 × Thermo buffer
(New England Biolabs, Ipswich, MA), 6 mM of MgSO4, 0.8 M of betaine (Sigma-Aldrich), 1.4
mM of deoxynucleotide triphosphate (dNTP), 0.2 μM of each outer primer (F3 and B3), 1.6 μM
of each inner primer (FIP and BIP), 0.8 μM of the loop primer, 0.4 μM of SYTO-9 green
fluorescent dye (Invitrogen), 8 U of Bst DNA polymerase (New England Biolabs), and 2 µl of
DNA template. A positive control and a negative control were included in each LAMP run.
For the fluorescence-based platform, the LAMP reaction was conducted in a SmartCycler
II System (Cepheid, Sunnyvale, CA) at 63oC for 1 h. Fluorescence readings were obtained every
60 s using the FAM channel (excitation at 450-495 nm and detection at 510-527 nm), followed
by melting curve analysis from 63oC to 96oC with an increment of 0.2oC per second. The
fluorescence threshold unit was set at 30 for background noise deduction.
Turbidity-based Real-time LAMP. The reaction mix was essentially the same as
described above for the fluorescence-based platform except that SYTO-9 was omitted. The
reaction was carried out at 63oC for 1 h and terminated at 80oC for 5 min in a real-time
turbidimeter (LA-320C; Teramecs, Kyoto, Japan), which acquired turbidity readings of the
LAMP reaction mix at 650 nm every 6 second. A turbidity threshold value of 0.1 was used.
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PCR. As a comparison, two sets of PCR assays targeting the vvhA gene were performed,
one using the LAMP outer primers (F3/B3) (Han & Ge, 2008) and the other one using the Vvh785F/Vvh-1303R primers described in the U.S. Food and Drug Administration Bacteriological
Analytical Manual (BAM) (Kaysner & DePaola, 2001). PCR conditions followed those
described previously (Han & Ge, 2008; Kaysner & DePaola, 2001).
Assay Specificity and Sensitivity. Methods published previously were followed (Chen
& Ge, 2010). Briefly, eighty bacterial strains (Table 5-3) were used to determine the real-time
LAMP specificity. Aliquots (2 µl) of each DNA template were subjected to both real-time
LAMP and PCR amplifications. Specificity tests were repeated twice.
To determine LAMP sensitivity, aliquots (2 µl) of the 10-fold serial dilutions of
sensitivity templates prepared above were subjected to both real-time LAMP and PCR
amplifications. Sensitivity tests were repeated five times.
Quantification of V. vulnificus Cells in Spiked Oysters. Oyster samples were obtained
from local seafood restaurants and determined to be V. vulnificus-free as described previously
(Han et al., 2007). Oyster samples were processed following a previous study (Yamazaki et al.,
2008a) with slight modifications. Briefly, 25 g of oyster sample was mixed with 225 ml of
alkaline peptone water (APW; BD Diagnostic Systems) and homogenized in a food stomacher
(Model 400; Tekmar Company, Cincinnati, OH) for 90 s to generate 1:10 oyster in APW
homogenate. After homogenization, aliquots (100 µl) of serial 10-fold dilutions of a mid-log
phase V. vulnificus ATCC 27562 culture were inoculated into 900 µl of the 1:10 oyster in APW
homogenate. The spiked oyster samples were mixed well and centrifuged at 900 g for 1 min to
remove oyster tissues. The supernatants were transferred to a fresh tube and centrifuged at
10,000 g for 5 min to pellet bacterial cells. After removing the supernatants, pellets were
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resuspended in 100 µl of TE and boiled for templates as described above. Aliquots (2 µl) of the
supernatant were used for both real-time LAMP and PCR amplifications. Three sets of
independent spiking experiments were performed, and the LAMP reactions were repeated two
times for each set of inoculation.
Data Analysis. For specificity data, means and standard deviations of Ct (cycle
threshold; for the fluorescence-based platform) or Tt (time threshold; for the turbidity-based
platform) values were calculated by using the Microsoft Excel software (Microsoft, Seattle, WA).
For sensitivity data, means and standard deviations of Ct or Tt values for detecting 10-fold serial
dilutions of V. vulnificus ATCC 27562 in pure culture and spiked oyster homogenates were
calculated similarly using Microsoft Excel. The limits of detection (CFU/reaction in pure culture
or CFU/g in spiked oysters) were determined. In spiked oyster samples, CFU/reaction was
calculated by using CFU/g × 0.09 g/ml × 10 × 2 × 10-3, i.e., CFU/g × 1.8 × 10-3.
Standard curves to quantify V. vulnificus in pure culture and spiked oysters were
generated by plotting Ct or Tt values against log CFU/reaction or log CFU/g and linear
regression was calculated using Microsoft Excel. Amplification efficiency (E; %) was obtained
by using the formula [10(–1/slope) – 1] × 100.
Results
Specificity of Real-time LAMP Assays. Among 80 bacterial strains used to determine
LAMP specificity on two real-time platforms, no false positive or false negative results were
observed. On the fluorescence-based platform performed in a SmartCycler II system, mean Ct
values for 38 V. vulnificus clinical and environmental strains ranged between 15.01 and 24.37
min, with an average of 19.35 ± 2.89 min. The melting temperatures for the 38 V. vulnificus
strains consistently fell between 83.97 and 85.21oC, with an average of 84.79 ± 0.33oC. For 42
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non- V. vulnificus strains, no Ct value was obtained, with melting curve analysis showing either
no peak or a melting temperature at around 63oC, suggesting possible primer-dimer formations.
Using the turbidity-based platform in a real-time turbidimeter, Tt values for the 38 V. vulnificus
clinical and environmental strains ranged from 27.4 to 37.05 min with an average of 32.55 ± 2.92
min. For the 42 non -V. vulnificus strains, no Tt value was obtained, indicating negative results
for LAMP.
Similarly, no false positive or false negative results for the 80 bacterial strains were
observed by PCR using the two primer sets, F3/B3 and BAM primers, indicating good
specificity.
Sensitivity and Quantitative Capability of Real-time LAMP Assays. Figure 5-4
presents sensitivity of the fluorescence-based real-time LAMP assay when testing 10-fold serial
dilutions of V. vulnificus ATCC 27562 DNA templates.
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Figure 5 - 4 Sensitivity of the fluorescence-based real-time LAMP when detecting Vibrio
vulnificus ATCC 27562 in pure culture.
(A) A representative optic graph; (B) Corresponding melting curve analysis for samples shown
in (A); (C) A standard curve generated based on five independent repeats. Samples (1-9)
correspond to 10-fold serial dilutions of V. vulnificus ATCC 27562 cells ranging from 1 × 108 to
1 CFU/reaction; sample 10 is water.
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A representative optic graph, corresponding melting curve analysis, and a standard curve
are shown in Figure 5-4A-C, respectively. For templates ranging in concentration from 1 × 108 to
10 CFU/reaction, the average Ct values of five repeats ranged from 19.26 to 39.79 min, with
melting temperatures consistently falling at around 86oC. For the 1 CFU template, in three out of
five repeats, amplification occurred. Therefore, the detection limit of the fluorescence-based realtime LAMP assay was 1-10 CFU/reaction. From the standard curve (Figure 5-4C) generated by
the fluorescence-based real-time LAMP assay, the correlation coefficient (r2) was calculated to
be 0.98 and the amplification efficiency (E) was 130%.
Figure 5-5 shows the sensitivity of real-time LAMP on the turbidity-based platform when
testing the same set of DNA templates. A representative turbidity judgment graph and a standard
curve are shown in Figure 5-5A and 5-5B, respectively.

Figure 5 - 5 Sensitivity of the turbidity-based real-time LAMP when testing the same set of
Vibrio vulnificus ATCC 27562 DNA templates.
(A) A representative turbidity judgment graph; (B) A standard curve generated based on
five independent repeats. Samples 1-8 are the same as those shown in Figure 5-4, 10-fold serial
dilutions of V. vulnificus ATCC 27562 cells ranging from 1 × 108 to 10 CFU/reaction
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For templates ranging from 1 × 108 to 10 CFU/reaction, based on five repeats, the
average Tt values fell between 34.5 and 51.1 min. In two out of five repeats, amplification of the
1 CFU template occurred. Therefore, the limit of detection for the turbidity-based real-time
LAMP assay was 1-10 CFU/reaction. Based on the standard curve (Figure 5-5B), the turbiditybased real-time LAMP assay had an r2 value of 0.99 and an E value of 111%.
When testing the same set of V. vulnificus ATCC 27562 templates by PCR using F3/B3
and BAM primers, both primer sets detected 100 CFU/reaction, which were up to 100-fold less
sensitive than real-time LAMP assays.
Detection of V. vulnificus Cells in Spiked Oysters. In three independent spiking
experiments, the average Ct values ranged from 25.26 to 34.10 min, whereas the average Tt
values ranged from 39.83 to 54.80 min. The limit of detection by real-time LAMP assays using
the two platforms was 116 CFU/reaction (i.e., 6.4 × 104 CFU/g) of V. vulnificus ATCC 27562 in
spiked oyster samples without enrichment. However, for PCR assays using either F3/B3 or BAM
primers, the limit of detection in spiked oysters was 6.4 × 107 CFU/g (data not shown), 1,000fold less sensitive than that of real-time LAMP assays. Standard curves (Figure 5-6) generated
for the quantitative detection of V. vulnificus cells in spiked oyster samples had an r2 value of
0.99 for both real-time LAMP platforms.
Discussion
In this study, we used our previously designed LAMP inner and outer primers (Han &
Ge, 2008) and added a loop primer to specifically target the V. vulnificus vvhA gene. We further
developed the LAMP assay by running on two real-time platforms, one was fluorescence-based
and the other one turbidity-based, to quantitatively detect V. vulnificus in pure culture and spiked
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oyster samples. This is the first report examining the quantitative capability of real-time LAMP
for detecting V. vulnificus in oysters by targeting the vvhA gene.

Figure 5 - 6 Quantitative detection of Vibrio vulnificus ATCC 27562 in spiked oysters by using
fluorescence-based and turbidity-based real-time LAMP.
Three sets of independent spiking experiments were performed, and the LAMP reactions were
repeated two times for each set of inoculation. (A) A representative optic graph; (B)
Corresponding melting curve analysis for samples shown in (A); (C) A representative turbidity
judgment graph; (D) A standard curve generated for the fluorescence-based real-time LAMP; (E)
A standard curve generated for the turbidity-based real-time LAMP. Samples 1-5 correspond to
10-fold spiked oyster sample ranging from 6.4 × 107 to 6.4 × 103 CFU/g, sample 6 is water.
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Among a total of 38 V. vulnificus and 42 non- V. vulnificus strains tested, the real-time
LAMP assay run on both platforms achieved 100% inclusivity and 100% exclusivity. This level
of specificity was the same as that of two PCR assays tested simultaneously in this study and
several LAMP assays for V. vulnificus reported recently (Han & Ge, 2008; Nemoto et al., 2008;
Ren et al., 2009).
In addition to high specificity, the real-time LAMP assays were able to detect 1-10
CFU/reaction of V. vulnificus, in contrast to 100 CFU/reaction by the two PCR assays. We
previously reported a LAMP sensitivity of 20 CFU/reaction and a PCR sensitivity of 202
CFU/reaction (Han & Ge, 2008), which are comparable to findings of this study. A toxR-based
LAMP assay for V. vulnificus reported a minimum detection level of 1 CFU per test (Nemoto et
al., 2008), whereas another vvhA-based LAMP assay found it to be 10-fold more sensitive than
conventional PCR, although the exact cell number was not reported (Ren et al., 2009).
Additionally, increased sensitivity (at least 10-fold) of LAMP compared to PCR was reported in
studies on the detection of other Vibrio spp. (Fall et al., 2008; Yamazaki et al., 2008a; Yamazaki
et al., 2008b) or other foodborne pathogens (Hara-Kudo et al., 2005; Hara-Kudo et al., 2007;
Yano et al., 2007).
The addition of loop primers generally accelerates LAMP assay by hybridizing to stemloops formed during LAMP reaction and facilitating DNA strand displacement and amplification
(Nagamine et al., 2002). In our previous study, we found that at least 45 min was required to
reach a positive signal without the loop primer (Han & Ge, 2008). In this study, the time to
positive results was shortened after adding the loop primer on both fluorescence- and turbiditybased platforms, confirming the assay accelerating effect of the loop primer. Noticeably, when
testing 38 V. vulnificus strains, the average time to positive results for the fluorescence-based
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platform as indicated by Ct (19.35 min) was markedly shorter than that of the turbidity-based
platform as indicated by Tt (32.55 min). Using YO-PRO-1 as the intercalating dye, a previous
study also found that fluorescence-based real-time LAMP was faster than a turbidimetry realtime LAMP (Aoi et al., 2006). In addition, that study reported that the fluorescence-based LAMP
assay generated anomalous and irreproducible results in low-concentration templates (less than 1
× 103 copies), which could be due to the effect of the intercalating dye on DNA amplification
efficiency (Aoi et al., 2006). Similarly, in our study, the standard curve generated for the
fluorescence-based real-time LAMP (Figure 5-4C) showed less reproducible data when the
templates concentrations were below 3 log CFU/reaction.
Previously, SYBR Green I has been used as a way to visually observe LAMP results after
amplification (Han & Ge, 2008; Parida et al., 2007). Since LAMP reactions generate a large
amount of DNA, this open-tube procedure after amplification potentially acts as a significant
source of cross-contamination, so close-tube endpoint detection has been suggested (Mori et al.,
2006). Real-time LAMP assays run on either platform are advantageous in this regard since the
DNA-intercalating dye was added in the reagent mix before amplification on the fluorescencebased platform or omitted on the turbidity-based platform.
For the fluorescence-based real-time LAMP, SYTO-9 was used in this study as the
intercalating dye instead of the commonly used SYBR Green I for real-time PCR. A previous
study found that SYTO-9 had lower inhibitory effect on the amplification and higher melting
curve reproducibility over a broader range of dye concentrations than SYBR Green I (Monis et
al., 2005). Additionally, EvaGreen (Biotium, Hayward, CA) was tested but showed high
inhibition for LAMP amplification (data not shown). After optimizing SYTO-9 concentration,
0.4 µM SYTO-9 was used.
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The strong linear correlation (r2 = 0.98-0.99) between the number of V. vulnificus cells in
the LAMP reaction and the associated Ct or Tt values over a dynamic range of template
concentrations (108 to 103 CFU/reaction in pure culture and 105 to 102 CFU/reaction in spiked
oyster extract) illustrates the quantitative capability of the real-time LAMP assays when
detecting this organism in both pure culture and spiked oysters. Very few reports have examined
the quantitative ability of LAMP. One study monitoring ammonia-oxidizing bacteria using
LAMP also reported it to possess good quantitative capability between 1 × 104 to 1 × 1010 DNA
copies (Aoi et al., 2006).
In spiked oyster samples, a detection limit of 116 V. vulnificus CFU/reaction was found
for real-time LAMP assays run on both platforms, which translates to 6.4 × 104 CFU/g of oyster
sample. In contrast, the detection limit of two PCR assays was 6.4 × 107 CFU/g, indicating
LAMP was less prone to inhibitor effects in oyster samples compared to PCR. In a most recent
survey of the U.S. market oysters, approximately 44% of live oyster samples harvested from
Lousiana exceeded 10,000 MPN/g for V. vulnificus whereas other states had non-detectable
levels of this organism (DePaola et al., 2010). Nonetheless, given the severe disease symptoms
and low infectious dose (less than 100) of this organism in immunocompromised persons (U.S.
Food and Drug Asministration, 2009), the Interstate Shellfish Sanitation Conference
recommends that all postharvest-processed oysters contain lower than 30 MPN/g of V. vulnificus
(U. S. Food and Drug Administration, 2007). Therefore, without enrichment, DNA amplification
assays such as LAMP, although potentially quantitative, lack the needed sensitivity when applied
in oyster samples (Han & Ge, 2008). Combining MPN overnight enrichment (Nordstrom et al.,
2007) or pre-enrichment for 6 h (Nemoto et al., 2009) with LAMP or other DNA amplification
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assays is a desirable approach to achieve the needed sensitivity, although in that situation, the
quantitative capability of real-time LAMP would not be possible.
The detection limit for V. vulnificus was higher in oyster samples (116 CFU/reaction) vs.
in pure culture (1-10 CFU/reaction). However, since no extensive sample preparation other than
homogenization and two simple centrifugation steps was required, the total assay time was
significantly reduced. Adding the 1 h required for the real-time LAMP run, the complete LAMP
detection system from sample preparation to quantitative result was markedly faster than either
PCR or conventional culture-based methods.
Conclusion
In conclusion, the real-time LAMP assays developed in this study was a highly specific,
sensitive, rapid, and quantitative method for the detection of V. vulnificus in oysters. Comparable
sensitivity was obtained using the two real-time platforms, with the assay limits of detection to
be approximately 1-10 CFU/reaction of V. vulnificus for pure culture, up to 100-fold more
sensitive than PCR. When applied to spiked oyster samples, the real-time LAMP assays were
able to detect 6.4 × 104 CFU/g of oyster without enrichment, 1,000 fold more sensitive than
PCR. Standard curves generated for detecting V. vulnificus in both pure culture and spiked oyster
samples showed good linear regression between cell counts and the fluorescence Ct or turbidity
Tt values. Future testing with natural or commercial oyster samples is desired to further evaluate
the efficacy of the assay.
References
Aoi, Y., Hosogai, M. & Tsuneda, S. (2006). Real-time quantitative LAMP (loop-mediated
isothermal amplification of DNA) as a simple method for monitoring ammonia-oxidizing
bacteria. J Biotechnol 125, 484-491.
Campbell, M. S. & Wright, A. C. (2003). Real-time PCR analysis of Vibrio vulnificus from
oysters. Appl Environ Microbiol 69, 7137-7144.

125

Centers for Disease Control and Prevention (2010). Preliminary FoodNet data on the
incidence of infection with pathogens transmitted commonly through food--10 states, 2009.
MMWR Morb Mortal Wkly Rep 58, 418-422.
Chen, S. & Ge, B. (2010). Development of a toxR-based loop-mediated isothermal
amplification assay for detecting Vibrio parahaemolyticus. BMC Microbiol 10, 41.
Cholera and Other Vibrio Illness Surveillance (2009).Summary of human Vibrio isolates
reported
to
CDC
2007.
Available
at
http://www.cdc.gov/nationalsurveillance/PDFs/CSTEVibrio2007.pdf. Accessed on April 28,
2010.
Coleman, S. S., Melanson, D. M., Biosca, E. G. & Oliver, J. D. (1996). Detection of Vibrio
vulnificus biotypes 1 and 2 in eels and oysters by PCR amplification. Appl Environ Microbiol 62,
1378-1382.
DePaola, A., Jones, J. L., Woods, J. & other authors (2010). Bacterial and viral pathogens in
live oysters: 2007 United States market survey. Appl Environ Microbiol 76, 2754-2768.
Fall, J., Chakraborty, G., Kono, T., Maeda, M., Itami, T. & Sakai, M. (2008). Establishment
of loop-mediated isothermal amplification method (LAMP) for the detection of Vibrio
nigripulchritudo in shrimp. FEMS Microbiol Lett 288, 171-177.
Goto, M., Hayashidani, H., Takatori, K. & Hara-Kudo, Y. (2007). Rapid detection of
enterotoxigenic Staphylococcus aureus harbouring genes for four classical enterotoxins, SEA,
SEB, SEC and SED, by loop-mediated isothermal amplification assay. Lett Appl Microbiol 45,
100-107.
Han, F., Walker, R. D., Janes, M. E., Prinyawiwatkul, W. & Ge, B. (2007). Antimicrobial
susceptibilities of Vibrio parahaemolyticus and Vibrio vulnificus isolates from Louisiana Gulf
and retail raw oysters. Appl Environ Microbiol 73, 7096-7098.
Han, F. & Ge, B. (2008). Evaluation of a loop-mediated isothermal amplification assay for
detecting Vibrio vulnificus in raw oysters. Foodborne Pathog Dis 5, 311-320.
Hara-Kudo, Y., Yoshino, M., Kojima, T. & Ikedo, M. (2005). Loop-mediated isothermal
amplification for the rapid detection of Salmonella. FEMS microbiology letters 253, 155-161.
Hara-Kudo, Y., Nemoto, J., Ohtsuka, K., Segawa, Y., Takatori, K., Kojima, T. & Ikedo, M.
(2007). Sensitive and rapid detection of Vero toxin-producing Escherichia coli using loopmediated isothermal amplification. Journal of medical microbiology 56, 398-406.
Hill, W. E., Keasler, S. P., Trucksess, M. W., Feng, P., Kaysner, C. A. & Lampel, K. A.
(1991). Polymerase chain reaction identification of Vibrio vulnificus in artificially contaminated
oysters. Appl Environ Microbiol 57, 707-711.

126

Kaysner, C. A. & DePaola, A. (2001). Vibrio. In Bacteriological Analytical Manual online,
Chapter 9. Edited by U.S Food and Drug Administration. Rockville, MD.
Martin, S. J. & Siebeling, R. J. (1991). Identification of Vibrio vulnificus O serovars with
antilipopolysaccharide monoclonal antibody. J Clin Microbiol 29, 1684-1688.
Monis, P. T., Giglio, S. & Saint, C. P. (2005). Comparison of SYTO9 and SYBR Green I for
real-time polymerase chain reaction and investigation of the effect of dye concentration on
amplification and DNA melting curve analysis. Analytical biochemistry 340, 24-34.
Mori, Y., Nagamine, K., Tomita, N. & Notomi, T. (2001). Detection of loop-mediated
isothermal amplification reaction by turbidity derived from magnesium pyrophosphate
formation. Biochemical and biophysical research communications 289, 150-154.
Mori, Y., Kitao, M., Tomita, N. & Notomi, T. (2004). Real-time turbidimetry of LAMP
reaction for quantifying template DNA. Journal of biochemical and biophysical methods 59,
145-157.
Mori, Y., Hirano, T. & Notomi, T. (2006). Sequence specific visual detection of LAMP
reactions by addition of cationic polymers. BMC Biotechnol 6, 3.
Nagamine, K., Hase, T. & Notomi, T. (2002). Accelerated reaction by loop-mediated
isothermal amplification using loop primers. Molecular and cellular probes 16, 223-229.
Nemoto, J., Kojima, T., Kusaba, K., Nagasawa, Z., Oishi, H. & Nakashima, M. (2008).
Rapid detection of Vibrio vulnificus using a loop-mediated isothermal amplification method.
Kansenshogaku Zasshi 82, 407-413.
Nemoto, J., Sugawara, C., Akahane, K., Hashimoto, K., Kojima, T., Ikedo, M., Konuma, H.
& Hara-Kudo, Y. (2009). Rapid and specific detection of the thermostable direct hemolysin
gene in Vibrio parahaemolyticus by loop-mediated isothermal amplification. J Food Prot 72,
748-754.
Njiru, Z. K., Mikosza, A. S., Armstrong, T., Enyaru, J. C., Ndung'u, J. M. & Thompson, A.
R. (2008). Loop-Mediated Isothermal Amplification (LAMP) Method for Rapid Detection of
Trypanosoma brucei rhodesiense. PLoS Negl Trop Dis 2, e147.
Nordstrom, J. L., Vickery, M. C., Blackstone, G. M., Murray, S. L. & DePaola, A. (2007).
Development of a multiplex real-time PCR assay with an internal amplification control for the
detection of total and pathogenic Vibrio parahaemolyticus bacteria in oysters. Appl Environ
Microbiol 73, 5840-5847.
Notomi, T., Okayama, H., Masubuchi, H., Yonekawa, T., Watanabe, K., Amino, N. & Hase,
T. (2000). Loop-mediated isothermal amplification of DNA. Nucleic acids research 28, E63.

127

Oliver, J. D., Warner, R. A. & Cleland, D. R. (1982). Distribution and ecology of Vibrio
vulnificus and other lactose-fermenting marine vibrios in coastal waters of the southeastern
United States. Appl Environ Microbiol 44, 1404-1414.
Oliver, J. D. (2006). Vibrio vulnificus, p. 349-366. Edited by F. L. Thompson, B. Austin, and J.
Swings (ed.), The biology of vibrios. Washitonton, DC: ASM press.
Panicker, G., Myers, M. L. & Bej, A. K. (2004). Rapid detection of Vibrio vulnificus in
shellfish and Gulf of Mexico water by real-time PCR. Appl Environ Microbiol 70, 498-507.
Panicker, G. & Bej, A. K. (2005). Real-time PCR detection of Vibrio vulnificus in oysters:
comparison of oligonucleotide primers and probes targeting vvhA. Appl Environ Microbiol 71,
5702-5709.
Parida, M. M., Santhosh, S. R., Dash, P. K. & other authors (2007). Rapid and real-time
detection of Chikungunya virus by reverse transcription loop-mediated isothermal amplification
assay. J Clin Microbiol 45, 351-357.
Ren, C. H., Hu, C. Q., Luo, P. & Wang, Q. B. (2009). Sensitive and rapid identification of
Vibrio vulnificus by loop-mediated isothermal amplification. Microbiol Res 164, 514-521.
Strom, M. S. & Paranjpye, R. N. (2000). Epidemiology and pathogenesis of Vibrio vulnificus.
Microbes and infection / Institut Pasteur 2, 177-188.
Takahashi, H., Hara-Kudo, Y., Miyasaka, J., Kumagai, S. & Konuma, H. (2005).
Development of a quantitative real-time polymerase chain reaction targeted to the toxR for
detection of Vibrio vulnificus. J Microbiol Methods 61, 77-85.
U. S. Food and Drug Administration (2007).National shellfish sanitation program guide for the
control of molluscan shellfish 2007.
U.S. Food and Drug Asministration (2009). Vibrio vulnificus. Available at
http://www.fda.gov/Food/FoodSafety/FoodborneIllness/FoodborneIllnessFoodbornePathogensN
aturalToxins/BadBugBook/ucm070473.htm. Accessed: May 13, 2010.
Wright, A. C., Miceli, G. A., Landry, W. L., Christy, J. B., Watkins, W. D. & Morris, J. G.,
Jr. (1993). Rapid identification of Vibrio vulnificus on nonselective media with an alkaline
phosphatase-labeled oligonucleotide probe. Appl Environ Microbiol 59, 541-546.
Wright, A. C., Garrido, V., Debuex, G., Farrell-Evans, M., Mudbidri, A. A. & Otwell, W. S.
(2007). Evaluation of postharvest-processed oysters by using PCR-based most-probable-number
enumeration of Vibrio vulnificus bacteria. Appl Environ Microbiol 73, 7477-7481.
Yamazaki, W., Ishibashi, M., Kawahara, R. & Inoue, K. (2008a). Development of a loopmediated isothermal amplification assay for sensitive and rapid detection of Vibrio
parahaemolyticus. BMC Microbiol 8, 163.

128

Yamazaki, W., Seto, K., Taguchi, M., Ishibashi, M. & Inoue, K. (2008b). Sensitive and rapid
detection of cholera toxin-producing Vibrio cholerae using a loop-mediated isothermal
amplification. BMC Microbiol 8, 94.
Yamazaki, W., Taguchi, M., Ishibashi, M., Kitazato, M., Nukina, M., Misawa, N. & Inoue,
K. (2008c). Development and evaluation of a loop-mediated isothermal amplification assay for
rapid and simple detection of Campylobacter jejuni and Campylobacter coli. Journal of medical
microbiology 57, 444-451.
Yano, A., Ishimaru, R. & Hujikata, R. (2007). Rapid and sensitive detection of heat-labile I
and heat-stable I enterotoxin genes of enterotoxigenic Escherichia coli by Loop-Mediated
Isothermal Amplification. Journal of microbiological methods 68, 414-420.
Yoda, T., Suzuki, Y., Yamazaki, K., Sakon, N., Kanki, M., Aoyama, I. & Tsukamoto, T.
(2007). Evaluation and application of reverse transcription loop-mediated isothermal
amplification for detection of noroviruses. Journal of medical virology 79, 326-334.

129

Part III: Quantitative Detection of Virulent-Type Vibrio vulnificus in Raw Oysters by Real-Time
Loop-Mediated Isothermal Amplification

130

Introduction
Vibrio vulnificus is a Gram-negative, halophilic bacterium that inhabits warm coastal and
estuarine waters worldwide. The organism is capable of causing fatal diseases such as primary
septicemia and wound infections, with reported mortality rates over 50% and 25%, respectively
(Oliver, 2006). At-risk groups for fatal V. vulnificus infections include people with
immunocompromising conditions, diabetes, and elevated serum iron concentrations due to
chronic liver disease or alcohol abuse (Strom & Paranjpye, 2000). The primary source of V.
vulnificus infection has been reported to be the consumption of raw or undercooked seafood,
particularly oysters (Rippey, 1994). Therefore, rapid and sensitive detection assays are needed to
facilitate better control of potential V. vulnificus infections from oyster consumption.
Besides being an opportunistic human pathogen, epidemiological data suggested that
only a small percentage of V. vulnificus strains in oysters are virulent (Cholera and Other Vibrio
Illness Surveillance, 2008; Jackson et al., 1997). However, none of the virulence factors
identified to date (Jones & Oliver, 2009),

have been shown to be unique for virulent V.

vulnificus. Therefore, alternative strategies are sought. Recently, several biomarkers have been
explored to differentiate virulent- (i.e. clinical-) from non-virulent- (i.e. environmental-) type V.
vulnificus strains, although with varied degree of success. Using a randomly amplified
polymorphic DNA method, a virulence-correlated gene (vcg) was identified in V. vulnificus
(Warner & Oliver, 1999). Testing 55 randomly selected V. vulnificus strains using this biomarker
showed that 90% of clinical isolates possessed the vcgC sequence variant and 93% of
environmental isolates had the vcgE variant (Rosche et al., 2005). One study characterizing vcg
genotypes among V. vulnificus oyster and seawater isolates recovered from the eastern coast of
North Carolina found that 84.4% of the 880 oyster isolates had the vcgE type, while a similar
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distribution of the two vcg genotypes (46.9% vcgE versus 53.1% vcgC) was found among 292
seawater isolates (Warner & Oliver, 2008). Secondly, polymorphism in 17 bp of the V. vulnificus
16S rRNA gene has been explored to differentiate between clinical and environmental strains. A
study showed that that the majority (31 out of 33) of nonclinical V. vulnificus isolates had 16S
rRNA type A, whereas a significant percentage (24 out of 34) of clinical isolates belonged to 16S
rRNA type B (Nilsson et al., 2003). Real-time PCR assays based on 16S rRNA polymorphism
have been developed to differentiate virulent from non-virulent ones (Gordon et al., 2008;
Vickery et al., 2007). Lastly, the capsular polysaccharide operon (CPS) has been identified,
which showed a significant association between clinical isolates and CPS allele 1 whereas
environmental isolates were associated with CPS allele 2 (Chatzidaki-Livanis et al., 2006a;
Chatzidaki-Livanis et al., 2006b). In a previous study, we characterized 349 V. vulnificus isolates
from the Gulf Coast and retail oysters in Louisiana using these biomarkers (Han et al., 2009).
CPS tended to give a low estimate of potentially clinical important V. vulnificus strains compared
to other biomarkers and the agreement between CPS and other biomarkers was poor, whereas
vcg and 16S rRNA demonstrated good correlations (Han et al., 2009).
The application of biomarkers for the detection of virulent-type V. vulnificus has been
mostly used in PCR or real-time PCR assays. However, for both PCR and real-time PCR, a
dedicated thermal cycler is needed, which is rather expensive and hinders the wide application of
such assays. Loop-mediated isothermal amplification (LAMP), is a novel nucleic acid
amplification assay developed in 2000 that utilizes four to six primers to specifically recognize
six to eight regions of the target DNA sequence and amplify millions of DNA copies under
isothermal conditions (60-65oC) within an hour (Notomi et al., 2000). Additionally, LAMP can
be quantitative (i.e., real-time LAMP) by measuring the formation of a by-product (magnesium
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pyrophosphate) during LAMP amplification, which correlates with the amount of amplified
DNA and could be monitored by a real-time turbidimeter (Mori et al., 2001; Mori et al., 2004).
Since its invention, LAMP has emerged as a powerful tool by various investigators for the rapid
detection of multiple bacterial and viral agents (Goto et al., 2007; Hara-Kudo et al., 2005; HaraKudo et al., 2007; Yamazaki et al., 2008c; Yoda et al., 2007). Very recently, our research group
and two others independently developed LAMP assays for V. vulnificus detection, of which two
targeted the V. vulnificus hemolysin (vvhA) gene (Han & Ge, 2008; Ren et al., 2009) and one
targeted the V. vulnificus toxR gene (Nemoto et al., 2008). However, no LAMP assay has been
developed for the detection of virulent-type V. vulnificus.
The present study aimed to develop a real-time-LAMP assay suitable for the quantitative
detection of virulent-type V. vulnificus in raw oysters by targeting vcgC and 16S rRNA type B.
Materials and Methods
Target and LAMP Primer Design. The V. vulnificus vcgC (GenBank accession number
AY626575) and 16S rRNA B type (GenBank accession number X76334) were selected as the
target for LAMP primer design. A set of six primers, two outer and two inner, as well as two
loop primers, that recognize eight distinct regions of the target sequence (Figure 5-7) was
designed

using

the

PrimerExplorer

software

(V4,

Fujitsu

Limited,

Japan;

http://primerexplorer.jp/e). Forward inner primer (FIP) consisted of a complementary sequence
of F1 and a sense sequence of F2. Similarly, backward inner primer (BIP) was a combination of
a complementary sequence of B1 and a sense sequence of B2. The two outer primers, forward
outer primer and backward outer primer, were F3 and B3, respectively. LF and LB were two
Loop primers designed to accelerate the amplification reaction. For 16S rRNA, specific primers
with the potential to differentiate between A and B type sequences were designed using a special
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feature of the software. All primers were synthesized by the Integrated DNA Technologies
(Coralville, IA).
Bacterial Strains and DNA Templates Preparation. V. vulnificus clinical strain ATCC
33815 (vcgC +, 16S rRNA B +) was used for the sensitivity testing in pure culture and spiked
oysters. Another 33 vcgC + and 50 vcgC - (i.e., vcgE type) V. vulnificus, as well as 30 other
Vibrio and 12 non-Vibrio strains were used to evaluate vcgC LAMP assay specificity (Table 54). Similarly, 33 16S rRNA B + and 50 16S rRNA B – (i.e., A type) V. vulnificus, as well as 30
other Vibrio and 12 non-Vibrio strains were used to evaluate 16S rRNA LAMP assay specificity.
All Vibrio strains were grown overnight at 35oC on trypticase soy agar or in broth (TSA or TSB;
BD Diagnostic Systems, Sparks, MD) supplemented with 2% NaCl. Non-Vibrio strains were
grown on Luria-Bertani agar or blood agar (BD Diagnostic Systems).
Table 5 - 4 Bacterial strains used in LAMP to detect virulent-type Vibrio vulnificus
Strain group
Strain ID and serotype a
Source and reference
V. vulnificus, vcgC-type
V199, V214, V241, V246, V332, V358, Gulf and Retail oyster,
(n = 33)
V360, V363, V371, V377, V385, V388, Louisiana (Han et al., 2007)
V389, V414, V419, V443, V444, V447,
V457, V465, V469, V499, V501, V504,
V513, V534, V544, V545, V552, V560,
V576, V601, V616
V. vulnificus, vcgE-type
V209, V213, V217, V223, V225, V238, Gulf and Retail oyster,
V239, V240, V242, V248, V252, V260, Louisiana (Han et al., 2007)
(n = 50)
V261, V274, V280, V292, V297, V299,
V302, V304, V308, V324, V327, V328,
V333, V337, V350, V354, V364, V372,
V381, V383, V387, V392, V416, V432,
V433, V438, V470, V471, V474, V477,
V484, V490, V546, V574, V584, V598,
V606, V631
Other Vibrio spp. (n = 30)
ATCC 17802; O1:K1
Shirasu food poisoning,
Vibrio parahaemolyticus
Japan
ATCC 27969
Blue crab, Maryland
ATCC 33847
Gastroenteritis, Maryland
ATCC 49529; O4:K12
Feces, California
CT-6636; O3:K6
Clinical, Connecticut
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Table continued
M350A; O5
NY477; O4:K8
TX-2103; O3:K6
8332924; O1:K56
83AO8757
83AO9148
83AO9756; O4:K12
84AO1516; O4:K12
84AO4226
916i, 541-0-44c, V68, V69, V 86, V155
Vibrio alginolyticus

ATCC 17749

Vibrio cholerae
Vibrio cincinnatiensis

ATCC 33787
ATCC 14035; O:1
ATCC 35912

Vibrio fluvialis
Vibrio harveyi

ATCC 33809
ATCC 14126

Vibrio mimicus

ATCC 35084
ATCC 33653
ATCC 33655
ATCC 14048

Oyster, Washington
Oyster, New York
Clinical, Texas
Oyster, Gulf of Mexico
Clinical, feces
Clinical, feces
Clinical, feces
Clinical, feces
Clinical, feces
Gulf and Retail oyster,
Louisiana (Han et al., 2007)
Spoiled horse mackerel,
Japan
Seawater, Hawaii
NCTC, United Kingdom
Blood/cerebrospinal fluid,
Ohio
Human feces, Bangladesh
Dead
amphipod,
Massachusetts
Brown shark, Maryland
Human ear, North Carolina
Feces, Tennessee
Salt marsh mud, Georgia

Vibrio natriegens
Non-Vibrio spp. (n = 12)
81-176
Human
Campylobacter jejuni
ATCC 13048
Sputum, South Carolina
Enterobacter aerogenes
ATCC 29212
Urine
Enterococcus faecalis
ATCC 25922
Human
Escherichia coli
ATCC 13932; 4b
Spinal fluid, Germany
Listeria monocytogenes
ATCC 19264
Ulcerous lesion in cod, UK
Litonella anguillarum
Human blood
Pseudomonas aeruginosa ATCC 27853
LT2; Typhimurium
Unknown
Salmonella enterica
ATCC 12022; 2b
Unknown
Shigella flexneri
ATCC 25931
Human feces, Panama
Shigella sonnei
ATCC 29213
Wound
Staphylococcus aureus
Sputum, Arizona
Streptococcus pneumoniae ATCC 49619; type 59
a
ATCC, American Type Culture Collection, Manassas, VA; NCTC, the National Collection of
Type Cultures, London, United Kingdom.

DNA templates were prepared by suspending a single bacterial colony grown on
appropriate agar plates in 500 µl of TE (10 mM Tris, pH 8.0; 1 mM EDTA; Sigma-Aldrich, St.
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Louis, MO) and heated at 95oC for 10 min in a dry heating block. After centrifuge at 12,000 g for
2 min, the supernatants were stored at -30oC until use.
To prepare templates for sensitivity testing, an overnight V. vulnificus ATCC 33815
culture was diluted 50 fold in TSB and incubated at 35°C for 5 h with shaking at 100 rpm. Serial
10-fold dilutions of the mid-log phase culture were made in phosphate-buffered saline (PBS;
Sigma-Aldrich) and aliquots of each dilution were used to prepare DNA templates similarly by
the boiling method. The exact cell counts in the templates were obtained by standard plate
counting on TSA with 2% NaCl.
Real-time LAMP Reaction. The real-time LAMP reaction mix (25 μl) consisted of the
following: 1 × Thermo buffer (New England Biolabs, Ipswich, MA), 6 mM of MgSO4, 0.8 M of
betaine (Sigma-Aldrich), 1.4 mM of deoxynucleotide triphosphate (dNTP), 0.2 μM of each outer
primer (F3 and B3), 1.6 μM of each inner primer (FIP and BIP), 0.8 μM of each loop primer (LF
and LB), 8 U of Bst DNA polymerase (New England Biolabs), and 2 µl of DNA template. A
positive control and a negative control were included in each LAMP run. The reaction was
carried out at 63oC for 1 h and terminated at 80oC for 5 min in a real-time turbidimeter (LA320C; Teramecs, Kyoto, Japan), which acquired turbidity readings of the LAMP reaction mix at
650 nm every 6 seconds. The cutoff values for positive samples were determined when turbidity
increased above the threshold value, which was fixed at 0.1.
PCR. As a comparison, two sets of PCR targeting the vcgC gene were performed: one
using the vcgC LAMP outer primers (F3/B3) and the other one using P1/P3 (Rosche et al., 2005).
Similarly, two sets of PCR targeting the 16S rRNA B type were performed: one using the 16S
rRNA B LAMP outer primers (F3/B3) and the other one using B F1/ B R1 (Warner & Oliver,
2008). The 25 μl PCR mixture contained 1 × PCR buffer, 0.2 mM of each dNTP, 1.5 mM of
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MgCl2, 0.5 unit of GoTaq Hot Start Polymerase (Promega, Madison, WI), 0.2 µM of forward
and reverse primer, and 2 µl of DNA template. The PCR reaction was conducted using 95°C for
5 min followed by 30 cycles of denaturation at 94°C for 1 min, primer annealing at 55°C for 1
min, extension at 72°C for 1 min, and a final extension at 72°C for 7 min in a Bio-Rad C1000
Thermal Cycler (Hercules, CA). PCR products were analyzed by electrophoresis on 2.0%
agarose gel containing ethidium bromide, and visualized under UV light, and documented by a
Gel Doc XR system (Bio-Rad).
Real-time LAMP Optimization. The assay optimization was performed using V.
vulnificus ATCC 33815 by varying assay parameters including the concentrations of MgCl2 (2 to
10 mM in 2 mM increments), betaine (0 to 1 M in 0.2 M increments), dNTP (0.4 to 2 mM in 0.4
mM increments), enzyme (2 to 10 U in 2 U increments), inner primer (1.2 to 2.0 M in 0.2 M
increments), outer primer (0.05 to 0.4 M in 0.05 M increments) and loop primer (0.2 to 1.0
M in 0.2 M increments), assay temperature (60 to 65oC in 2.5 oC increments) and duration (30
to 60 min in 15 min increments). Each of the optimization experiments were repeated three
times.
Real-time LAMP Specificity and Sensitivity. A total of 125 bacterial strains (Table 54) were used to determine the real-time LAMP specificity. Aliquots (2 µl) of each DNA template
were subjected to both real-time LAMP and PCR amplifications. Specificity tests were repeated
twice.
To determine real-time LAMP sensitivity, aliquots (2 µl) of the 10-fold serial dilutions of
sensitivity templates prepared above were subjected to both real-time LAMP and PCR
amplifications. Sensitivity tests were repeated five times.
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Quantification of Virulent-type V. vulnificus Cells in Spiked Oysters. Oyster samples
were obtained from local seafood restaurants and determined to be V. vulnificus-free as described
previously (Han et al., 2007). Oyster samples were processed following a previous study
(Yamazaki et al., 2008a) with slight modifications. Briefly, 25 g of oyster sample was mixed
with 225 ml of alkaline peptone water (APW; BD Diagnostic Systems) and homogenized in a
food stomacher (Model 400; Tekmar Company, Cincinnati, OH) for 90 s to generate 1:10 oyster
in APW homogenate. Aliquots (100 µl) of serial 10-fold dilutions of a mid-log phase V.
vulnificus ATCC 33815 were inoculated into 900 µl of the 1:10 oyster in APW homogenate. The
spiked oyster samples were mixed well and centrifuged at 900 g for 1 min to remove oyster
tissues. The supernatants were transferred to a fresh tube and centrifuged at 10,000 g for 5 min to
pellet bacterial cells. After removing the supernatants, pellets were resuspended in 100 µl of TE
and boiled for templates as described above. Aliquots (2 µl) of the supernatant were used for
both real-time LAMP and PCR amplifications. Three sets of independent spiking experiments
were performed, and the real-time LAMP and PCR reactions were repeated three times for each
set of inoculation.
Data Analysis. For specificity data, means and standard deviations of Tt (time threshold)
for turbidimeter were calculated by using the Microsoft Excel software (Microsoft, Seattle, WA).
For sensitivity data, means and standard deviations of Tt values for detecting 10-fold serial
dilutions of V. vulnificus ATCC 33815 in pure culture and spiked oyster homogenates were
calculated similarly using Microsoft Excel. The limits of detection (CFU/reaction in pure culture
or CFU/g in spiked oysters) were determined. In spiked oyster samples, CFU/reaction was
calculated by using CFU/g × 0.09 g/ml × 10 × 2 × 10-3, i.e., CFU/g × 1.8 × 10-3.
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Standard curves to quantify V. vulnificus in pure culture and spiked oysters were
generated by plotting Tt values against log CFU/reaction for pure culture or log CFU/g for
spiked oyster and linear regression was calculated using Microsoft Excel. Amplification
efficiency (E; %) was obtained by using the formula [10(–1/slope) – 1] × 100.
Results
LAMP Primer Design. We designed a LAMP assay targeting vcgC, which indicates that
six specific locations on the vcgC were recognized by the LAMP primers, along with detailed
information on each LAMP primer (Figure 5-7).

Figure 5 - 7 Partial nucleotide sequence of the vcgC type of Vibrio vulnificus (accession number
AY626575).
F3 and B3 are the forward outer primer and backward outer primer, respectively. FIP and BIP
are the forward inner primer and the backward inner primer, respectively. LF and LB are the
Loop F and Loop B primer, respectively.
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For 16S rRNA, we designed a total of 13 pairs of primers and tested their specificity,
which indicated none of those primers could differentiate virulent-type V. vulnificus from nonvirulent-type strains. The only difference is the virulent-type strains would amplify faster than
non-virulent-type ones (~10 min earlier); however, within one hour, all V. vulnificus strains
could be detected in the turbidimeter regardless of virulent-type and non-virulent-type strains
Figure 5-8 showed the amplification graph by one set of primer in the turbidimeter using V.
vulnificus ATCC 33815 (16S rRNA B +, black line, Tt =19.8 min) and V. vulnificus WR1 (16S
rRNA B -, green line, Tt = 26.2 min), suggesting non-specific amplification. Therefore, after
testing 13 pairs of primers, we withdrew 16S rRNA B type as a target for the remaining sections
of this study.

Figure 5 - 8 16S rRNA-LAMP using Vibrio vulnificus ATCC 33815 and WR1.
Sample 1 is V. vulnificus ATCC 33815. Sample 2 is V. vulnificus WR1. Sample 3 is water.

Real-time LAMP Optimization. The optimized LAMP assay reagent mix and reaction
condition for vcgC were: 6 mM MgCl2, 0 M betaine, 1.2 mM dNTP, 10 U Bst DNA polymerase,
2.0 M each inner primer, 0.05 M each outer primer, and 1.0 M each loop primer at 65oC for
40 min. Figure 5-9 showed the amplification graph in the turbidimeter using V. vulnificus ATCC
33815 under optimized condition (red line, Tt = 18.27 min) compared to the prototype condition
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(black line, Tt = 26.33 min). Besides decreasing Tt values, the optimized LAMP conditions also
achieved higher signal intensity.

Figure 5 - 9 Comparison between optimized LAMP and prototype LAMP using Vibrio vulnificus
ATCC 33815.
Sample 1 is under optimized condition. Sample 2 is under prototype condition. Sample 3 is
water.
Specificity of the Real-time LAMP Assay. Among 125 bacterial strains (Table 5-4)
used to determine LAMP specificity, no false positive or false negative results were observed.
The Tt values for the 33 vcgC-type V. vulnificus ranged from 16.1 to 22.3 min with an average of
18.17 ± 1.45 min. For the other 92 strains, no Tt value was obtained, indicating negative results
for real-time LAMP.
For PCR results, 33 vcgC-type V. vulnificus could amplify using both F3/B3 and P1/P3
primers while no PCR amplification was observed for the other 92 bacterial strains, indicating
good specificity (data not shown).
Sensitivity and Quantitative Capability of Real-time LAMP Assay. Figure 5-10
presents sensitivity of the vcgC real-time LAMP assay in turbidimeter and two sets of PCR
amplification when testing 10-fold serial dilutions of V. vulnificus ATCC 33815 DNA templates.
A representative turbidity graph and a standard curve are shown in Figure 5-10A and 5-10B,
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respectively. For templates ranging from 5.4 × 104 to 5.4 CFU/reaction, based on five repeats,
the average Tt values fell between 17.5 and 31.0 min. In two out of five repeats, amplification of
the 0.5 CFU template occurred. Therefore, the limit of detection for the real-time LAMP assay
was 0.5-5.4 CFU/reaction. Based on the standard curve (Figure 5-10B); the real-time LAMP
assay had an r2 value of 0.97 and an E value of 105%.
When testing the same set of V. vulnificus ATCC 33815 templates by PCR using F3/B3
and P1/P3, F3/B3 PCR detected 5.4 × 102 CFU/reaction (Figure 5-10C) while P1/P3 PCR
detected 5.4 × 103 CFU/reaction (Figure 5-10D), which were up to 1,000-fold less sensitive than
real-time LAMP assay.

Figure 5 - 10 Sensitivity of vcgC real-time LAMP and PCR when testing serial-diluted Vibrio
vulnificus ATCC 33815 DNA templates.
(A) A representative real-time LAMP turbidity graph; (B) A standard curve of real-time LAMP
generated based on five independent repeats. (C) PCR using F3/B3 primer (226 bp). (D) PCR
using P1/P3 primer (278 bp). Samples (1-7) correspond to 10-fold serial dilutions of V. vulnificus
ATCC 33815 cells ranging from 5.4 × 104 to 0.05 CFU/reaction; sample 8 is water. M is
molecular DNA marker.
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Real-time LAMP in Spiked Oysters. A representative turbidity graph and a standard
curve of vcgC LAMP in spiked oyster are shown in Figure 5-11A and 5-11B, in comparison with
PCR using F3/B3 PCR (Figure 5-11C) and P1/P3 PCR (Figure 5-11D). In three independent
spiking experiments, the average Tt values ranged from 17.47 to 25.7 min. The limit of detection
by real-time LAMP assay was 4.52 CFU/reaction (i.e., 2.5 × 103 CFU/g) of V. vulnificus ATCC
33815 in spiked oyster samples without enrichment. However, for PCR assays using F3/B3
primer, the limit of detection in spiked oysters was 2.5 × 106 CFU/g; and PCR using P1/P3 could
detect 2.5 × 107 CFU/g, 1,000-fold less sensitive than that of real-time LAMP assay. Standard
curves generated for the quantitative detection of V. vulnificus cells in spiked oyster samples had
an r2 value of 0.99.

Figure 5 - 11 Quantitative detection of vcgC real-time LAMP and PCR using Vibrio vulnificus
ATCC 33815 in spiked oysters.
(A) A representative real-time LAMP turbidity graph; (B) A standard curve of real-time LAMP
generated based on three independent repeats. (C) PCR using F3/B3 primer (226 bp). (D) PCR
using P1/P3 primer (278 bp). Samples (1-7) correspond to 10-fold spiked oyster sample ranging
from 2.5 × 108 to 250 CFU/g, sample 8 is water. M is molecular DNA marker.
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Discussion
We previously designed a LAMP assay targeting the V. vulnificus vvhA gene, which is a
species-specific gene (Han & Ge, 2008), followed by developing a real-time LAMP assay to
quantify total V. vulnificus (Chapter 4, Part II). Besides our studies, two other LAMP assays for
V. vulnificus detection were reported, one targeting the vvhA gene (Ren et al., 2009) and the
other the toxR gene (Nemoto et al., 2008), both species-specific genes. To our knowledge, this is
the first report examining the quantitative capability of real-time LAMP for the detection of
virulent-type V. vulnificus in oysters by targeting virulence-type biomarkers.
We chose vcgC and 16S rRNA B type as target genes based on our previous study (Han
et al., 2009). The mutual exclusivity of vcgC and vcgE sequences variants in V. vulnificus made
vcgC a good candidate for virulent-type V. vulnificus characterization/detection, which was
confirmed by several studies (Han et al., 2009; Rosche et al., 2005; Warner & Oliver, 2008).
Practically, if a strain shows positive for vcgC by using vcgC LAMP, it would show negative for
vcgE. When applying the vcgC LAMP in microbial ecology or epidemiological studies, it is
acceptable to run the vcgC LAMP only, no need to test vcgE.
For the other target, 16S rRNA B, we failed to generate satisfactory results with LAMP
design. Among a total of 13 pairs of primers designed, none could effectively differentiate
virulent-type V. vulnificus from non-virulent strains. Alignment between 16S rRNA A (nonvirulent-type, GenBank X76333) and B type (virulent-type, GenBank X76334) showed a
difference of 17 bases out of 1,535 bases, with most of the polymorphism centered near helix 10
of the secondary structure for bacterial 16S rRNA (Van de Peer et al., 1996). The alignment
between 16S rRNA A and B type identified three variable regions, positions 177 to 186 (contain
5 bases), 437 to 483 (contain 8 bases), 999 to 1016 (contain 4 bases), which could be used as
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targets to design primers for differentiation of B type from A type. Our LAMP primer design,
although tried on different positions of the three variable regions in our 13 pairs of primer sets,
could not succeed in sufficient differentiation of 16S rRNA B type from A type. In the
previously studies, the 16S rRNA was used in a real-time format which applied primer and probe
to obtain specific amplification (Vickery et al., 2007).
Using the optimized conditions of vcgC LAMP, the amplification time to a positive result
was greatly accelerated compared to the prototype, as shown in Figure 5-9, which requires less
than 20 min to be positive in a turbidimeter. Surprisingly, 0 M betaine was found to be most
effective during assay optimization, which suggested that in a LAMP assay, betaine should be
deleted to make the assay more efficient and cost-effective. Also, using the optimized conditions,
the Tt values for the 33 vcgC-type V. vulnificus in the specificity test had an average of 18.17
min, while the prototype condition has an average amplification time 27.17 min (data not
shown). Currently, most reported LAMP studies did not conduct the optimization; instead using
the amplification kit originally developed by the Eiken company (Tokyo, Japan). Our study,
however, emphasized the importance of optimization studies for each specific primer set
designed.
Among a total of 33 vcgC-type and 50 vcgE-type V. vulnificus, as well as 30 other Vibrio
and 12 non-Vibrio strains tested, the real-time LAMP assay achieved 100% inclusivity and 100%
exclusivity, indicating high specificity. Similarly, the two sets of PCR, F3/B3 and P1/P3, were
highly specific for virulent-type, non-virulent-type V. vulnificus and other strains.
In addition to high specificity, the vcgC real-time LAMP assay was able to detect 0.5-5
CFU/reaction of V. vulnificus, in contrast to 500-5 × 103 CFU/reaction by the two PCR assays.
We previously reported a vvhA-based LAMP sensitivity of 20 CFU/reaction and a PCR
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sensitivity of 202 CFU/reaction (Han & Ge, 2008) and further a real-time LMAP that could
detect 1-10 CFU/reaction and a PCR comparison of 100 CFU/reaction (chapter 5, part II), which
are comparable to findings of this study. A toxR-based LAMP assay for V. vulnificus reported a
minimum detection level of 1 CFU per test (Nemoto et al., 2008), whereas another vvhA-based
LAMP assay found it to be 10-fold more sensitive than conventional PCR, although the exact
cell number was not reported (Ren et al., 2009). Additionally, increased sensitivity (at least 10fold) of LAMP compared to PCR was reported in studies on the detection of other Vibrio spp.
(Fall et al., 2008; Yamazaki et al., 2008a; Yamazaki et al., 2008b; Yamazaki et al., 2010) or
other foodborne pathogens (Hara-Kudo et al., 2005; Hara-Kudo et al., 2007; Yano et al., 2007).
The strong linear correlation (r2 = 0.97-0.99) between the number of V. vulnificus cells in
the LAMP reaction and the associated Tt values over a dynamic range of template concentrations
(104 to 100 CFU/reaction in pure culture and 105 to 100 CFU/reaction in spiked oyster sample)
illustrates the quantitative capability of the real-time LAMP assays when detecting virulent-type
V. vulnificus in both pure culture and spiked oysters. Very few reports have examined the
quantitative ability of LAMP, most on viruses (Mekata et al., 2009; Parida et al., 2006).
Recently, a real-time LAMP assay was developed to target toxR in V. parahaemolyticus, and the
linear correlation (r2) between the number of V. parahaemolyticus cells in the LAMP reaction
and the associated Tt values was 0.94 (Chen & Ge, 2010) .
In spiked oyster samples, a detection limit of 4.5 V. vulnificus CFU/reaction was found
for real-time LAMP assay, which translates to 2.5 × 103 CFU/g of oyster sample. In contrast, the
detection limit of two PCR assays was 2.5 × 106 / 2.5 × 107 CFU/g, indicating real-time LAMP
was much less prone to inhibitor effects in oyster samples compared to PCR. Nonetheless, no
extensive sample preparation other than homogenization and two simple centrifugation steps
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were required. This significantly reduced the total assay time. Combined with less than 1 h for
the real-time LAMP assay, the complete LAMP detection system was markedly faster than either
PCR or conventional methods. On the other side, LAMP can be combined with overnight
enrichment or pre-enrichment for 6 h to achieve higher sensitivity, although in that situation, the
quantitative capability of real-time LAMP would not be possible.
Conclusion
The real-time LAMP assays targeting vcgC developed in this study was a highly specific,
sensitive, rapid, and quantitative method for the detection of virulent-type V. vulnificus in
oysters. The detection limit of the real-time LAMP assay was 0.5-5 CFU in pure cultures, 1,000fold more sensitive than conventional PCR. In spiked oyster samples, the real-time LAMP assay
was able to detect 2.5 × 103 CFU/g of V. vulnificus without enrichment. Standard curves
generated in both pure culture and spiked oyster samples showed good linear relationship
between virulent-type V. vulnificus cell counts and the turbidity signals. This assay may facilitate
regulatory and oyster industry personnel to better control potential V. vulnificus risks associated
with oyster consumption. Future testing with natural oyster samples is desired to further evaluate
the LAMP efficacy in a setting more close to application.
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CHAPTER 6: CONCLUSIONS
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The incidence of infections of Vibrio parahaemolyticus and V. vulnificus due to the
consumption of oysters has shown a sustained increase since 2001, indicating further measures
are needed to prevent human Vibrio illness. Given the lack of information on the prevalence,
antimicrobial susceptibility profiles, and genotypic pattern of those two vibrios in Louisiana
oysters, as well as the lack of sensitive and cost-effective methods that could be applied in the
field sites, we conducted this research project.
We isolated a total of 622 Vibrio isolates, consisting of 252 V. parahaemolyticus and 370
V. vulnificus, from a total of 94 Louisiana oyster samples collected quarterly over a 15-month
period from the Gulf Coast and obtained weekly from four retail outlets for 7 months. Overall,
the prevalence of one or both species fell between 58.3% and 100%. The antimicrobial
susceptibility testing of a randomly selected subset of 319 isolates indicated that the only
resistance detected was for ampicillin, with 136 (42.6%) of the isolates showing either
intermediate or resistant phenotype, all being V. parahaemolyticus. This study represents the first
report on both prevalence and antimicrobial susceptibility of V. parahaemolyticus and V.
vulnificus from Louisiana Gulf and retail oysters since 1998.
Following the isolation, we characterized 349 V. vulnificus oyster isolates by the
presence/absence of a viuB-associated fragment and genotypes of three biomarkers: vcg, 16S
rRNA, and CPS. Genotyping data indicated that environmental-type V. vulnificus strains
accounted for the majority of oyster isolates. Additionally, the presence of the viuB fragment
(41%) was significantly associated with clinical genotypes of V. vulnificus. An interesting
seasonal pattern was observed, with clinical-type V. vulnificus isolates more frequently
associated with warmer months. This is the first study that a combination of these four
biomarkers was used to independently evaluate their usefulness in predicting clinically important

152

V. vulnificus isolates from oysters. This study was followed up with the development of
multiplex PCR assays and demonstrated the detection and characterization of general and
virulent-type V. vulnificus in a single reaction.
Finally, we adopted a novel DNA amplification technique, LAMP to detect assays for
total or virulent-type V. vulnificus. No false positive or false negative results were observed. The
real-time LAMP assay, in both fluorescence- and turbidity-based real-time platforms could
detect approximately 1-10 CFU per reaction of total V. vulnificus for pure culture, and 6.4 × 104
CFU/g for spiked oyster without enrichment. When real-time LAMP was applied for the
quantitative detection of virulent-type V. vulnificus by targeting the vcgC gene, the detection
limit of the real-time LAMP assay was 0.5-5 CFU in pure culture, and 2.5 × 103 CFU/g of V.
vulnificus in spiked oyster without enrichment, up to 1,000-fold more sensitive than conventional
PCR. Standard curves generated in both pure culture and spiked oyster sample testing showed
good linear relationship between total or virulent-type V. vulnificus cell counts and the turbidity
signals.
This dissertation research provided comprehensive information on the genotypes,
population dynamics, and antimicrobial resistance profiles of the two important vibrios. The
development of LAMP assays provided invaluable tools for the regulatory agencies and seafood
industry to facilitate better control of Vibrio in seafood, thereby reducing the incidence of
foodborne illnesses and deaths resulting from the consumption of raw oysters due to the presence
of these important Vibrio spp.
The future study would include the continued surveillance of Vibrio in oysters to ensure
seafood safety. Further evaluation of these assays using natural oysters will move these assays a
step closer to field applications.
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